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ABSTRACT
Genomic RNPs were isolated from influenza A virus particles and the RNA conformation in 
the native structure  was studied by chemical and enzymatical RNA m odification analysis 
on complete RNPs and on RNPs depleted o f polymerase protein. The results suggest tha t NP 
binding to  the genomic RNA does not involve the Watson-Crick positions o f the bases and 
the major part o f the genomic RNA was found to  be in a single-stranded conform ation, 
consistent w ith the idea tha t NP functions as a single-stranded RNA binding protein, tha t 
facilita tes tem plated RNA synthesis by the polymerase. The polymerase, on the other 
hand, was found to  form  a ternary complex w ith both conserved vRNA ends, but in the 
absence o f the polymerase the RNA ends were com plete ly single-stranded despite a 
partial, inverted complem entarity. The implications o f the absence o f a stable panhandle 
RNA secondary structure on possible replicative mechanisms are discussed.
RNP a c tiv ity  assays were employed to  determ ine basic kinetic constants o f the 
transcription reaction catalyzed by RNPs and to  analyse the mechanism o f inhibition by 
2 '-deoxy-2 '-fluo ro ribonuc leo tides , which were found to  be incorpora ted  in to  RNA 
products by the influenza virus polymerase thereby preventing e ffic ien t elongation o f the 
transcrip ts. Transcription reactions in the presence o f ATP analogs and ATPase assays 
revealed a possible requirem ent fo r ATP p-y bond hydrolysis during influenza virus 
transcription.
Finally, a number o f d iffe ren t protein expression system s were tes ted  fo r the 
production and purification o f the PA subunit o f the influenza virus polymerase complex 
fo r structura l and functional studies. In both procaryotic and eucaryotic systems the PA 
protein yield was very low and possible reasons for this lack o f expression effic iency are 
discussed. A ffin ity  purified PA preparations from  bacterial cu ltures and sem ipurified 
fractions from  eucaryotic systems showed tha t an ATPase activ ity  consistently copurified 
w ith PA. Also, preliminary evidence for sequence-specific RNA binding was obtained from 
in vitro  translation experiments.
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Introduction
1. Thesis Introduction
1.1. Influenza, the disease
Influenza is an infectious, acute respiratory disease caused by the influenza virus, 
and it is characterized by an abrupt onset o f symptoms like headache, high fever, chills 
and s ign ificant myalgias. Fever usually declines a t day 2-3 a fte r the onset o f the 
symptoms, but severe cough and general malaise can persist for 1-2 weeks. The infection 
a ffe c ts  and partia lly  destroys the  c ilia ted epithelium  o f the resp ira tory  tra c t, the 
regeneration o f which can take up to  1 month to  be completed. Severe complications 
comprise secondary bacterial infections and viral pneumonia w ith m orta lity  rates up to  
42%  (Tashiro e t al., 1987; Murphy and Webster, 1990). Influenza virus in fections can 
be particularly dangerous fo r people belonging to  certain high risk groups like newborn 
children, people above 65 years o f age, pregnant women or people w ith  chronic 
pulmonary or heart diseases. Considering the number o f affected people worldwide, every 
year, influenza constitu tes one o f the major infectious diseases. The WFIO coordinates a 
surveillance program to  m onitor the epidemiology and the emergence o f new virus strains 
[ h ttp ://w w w .w h o .c h /]. Influenza virus is unique among the respiratory tra c t viruses in 
th a t it  continually undergoes significant antigenic variation. The current vaccines, tha t 
are based on inactivated viruses, have to  be modified every year (Kilbourne, 1987). 
Flowever, they are o f lim ited efficacy especially during the regularly recurring pandemic 
outbreaks, tha t are characterized by a significant increase in the number and the severity 
o f cases. The pandemics are caused by newly emerging influenza virus subtype strains due 
to  genetic reassortm ent o f virus strains. The incorporation o f envelope proteins from 
animal virus sources in to a viral genome optim ized fo r infection in humans can lead to  
h ighly v iru len t, new virus stra ins. The deta iled s tudy and characte riza tion  o f the 
in fluenza virus w ith  m olecular b io logy and biochem ical techn iques w ill provide 
in form ation on the structure  o f the virus, its  genetic variation and its mode o f gene 
expression and replication, and it will eventually lead to  new approaches fo r the control 
o f influenza viruses. A t the same time the study o f the mechanisms involved in the virus 
life cycle will help to  bette r understand the biology o f many related viruses and elucidate 
general principles in eucaryotic molecular and cellular biology and immunology (e.g., the 
concept o f mRNAs as intermediates in gene expression was originally established in the 
E.coli/JZ  bacteriophage system (Brenner e t al., 1961 )).
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1.2. Influenza Virus Structure
Influenza virus is a membrane-enveloped, negative-strand RNA virus w ith  a 
genome size o f about 14 kb. It shares these qualities w ith members o f 3 o ther virus 
families, tha t all comprise im portant human pathogens, the Rhabdoviridae (e.g. vesicular 
s to m a tit is  virus, rabies v irus), Filoviridae (M arburg and Ebola viruses) and the 
Paramyxoviridae, (e.g. parainfluenza viruses, mumps virus, measles virus, respiratory 
syncytia l virus). Because o f some very unique features, influenza viruses have been 
placed in to the ir own family, the Orthomyxoviridae. The m ost characteristic properties 
are a segmented genome structure  w ith 1 0 proteins expressed from  8 d iffe ren t RNA 
molecules, a high rate o f genetic recom bination (m ainly through reassortm ent) and 
genome replication in the nucleus o f in fected cells. The influenza viruses have been 
classified into 3 types (A, B and C) according to  serological cross-reactivities o f internal 
antigens, but they also d iffe r in epidemiology, evolutionary patterns and molecular fine- 
s tructure . in particular, influenza C virus genomes contain only 7 RNA segm ents and 
encode only one outer envelope protein. Most o f the work, including the present study, has 
been done on influenza A viruses, tha t show the most dramatic variability, but in general 
influenza B viruses have been found to  follow very similar molecular mechanisms. The 
influenza virions usually are 90 -120  nm in diam eter (figure 1 A), but also filamentous 
forms w ith iengths up to  several m icrometers have been observed w ith human isolates 
a fte r a single round in cell cu lture (Choppin e t al., 1960; Chu e t al., 1 949 ). The 
membrane envelope contains 3 d ifferent proteins:
- HA (haemagglutinin) forms about 400  trim eric spikes on the outside o f a characteristic 
v irus partic le , well vis ib le on e lectron  m icrographs. HA is responsib le fo r the 
attachm ent o f the virus to  sialic acid containing ta rge t cell membranes and fo r the fusion 
o f viral and cellular membranes during virus entry.
- NA (neuram inidase) is present in about 100 m ushroom -shaped te tram ers . Its 
enzym atic a c tiv ity  hydrolyzes term inal sialic acid residues and is required fo r the 
passage o f the virus through mucus layers in the respiratory tra c t and fo r the release of 
virions during the budding process (White, 1974).
-M2 protein forms about 3-17 tetram eric proton channels in the virus envelope and is 
possibly involved in genome release during cell entry (Zebedee and Lamb, 1988).
In the  in terio r o f the virus particle, the M l protein form s a shell surrounding the viral 
genome and attaching it to  the envelope (Fujiyoshi e t al., 1994; Ruigrok e t al., 1989). 
This layer may consist o f approximately 3000 copies o f the Ml protein, as determined by 
biochem ical p ro te in  analysis and cryoe lectron  m icroscopy (Compans e t al., 1970; 
Fujiyoshi e t al., 1994; Skehel and Schild, 1971 ). Biophysical mass determ ination and 
comparison o f complete and bromelain treated virus particles support a virus structura l 
model w ith a M l protein network consisting o f only 1200 Ml monomers (Cusack e t al., 
1 985; Ruigrok e t al., 1 984).
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The influenza virus genome consists o f single-stranded RNA segments (vRNAs), 
which are packed by nucleoprotein (NP) in to  s truc tu ra lly  d is tin c t ribonucleoprote in  
particles (RNPs). The RNPs are associated w ith a heterotrim eric, RNA-dependent RNA 
polymerase composed o f the  subunits PA, PBl and PB2 (Lamb, 1 9 8 9 ). The vRNA 
terminal sequences o f all genome segments are highly conserved despite a relatively high 
m utation  rate (2 -7  * 10"3 per nucleotide and year) in the rest o f the sequence (S m ith  
and Palese, 1989). The 13 nucleotides at the 5' end are completely conserved among all 
influenza A virus strains, and the 12 nucleotides a t the 3 ' end show only a single base 
d iffe rence in certa in  RNA segm ents. The vRNA ends also show a partia l, inverted 
com plem entarity  over a region o f 15-16 nucleotides, which means th a t they can 
theo re tica lly  base-pair w ith  each o the r and form  a so-called panhandle s tru c tu re  
(Desselberger e t al., 1980; Robertson, 1979; Skehel and Hay, 1978; Stoeckle e t al., 
1987). Support fo r the possible form ation o f such a RNA secondary s truc tu re  in vivo  
came from  psoralen crosslinking studies (Hsu e t al., 1987). The RNPs are the functional 
units fo r viral transcrip tion and replication, th a t take place in the nucleus o f in fected 
cells (Herz e t al., 1981; Jackson e t al., 1982). The RNP structure , as apparent from  
electron microscopy, seems to  be mainly determ ined by the NP polymers (Pons e t al.,
1969; Ruigrok and Baudin, 1995). The RNPs appear as strands w ith loops at one or both 
ends and w ith  d iffe ren t lengths corresponding to  the sizes o f the RNAs they contain 
(Compans e t al., 1972 ). Figure IB  shows an exem plary e lectrom icrograph o f RNP 
obtained w ith a carbon shadowing technique. The RNP te rtia ry  structure  is formed by NP 
inducing a coiled structure o f the RNA. The coil itse lf is folded back on itse lf and arranged 
into a large, helical structure w ith the dimensions o f about 10-20 nm diameter and 50- 
130 nm length (Compans et al., 1972; Pons e t al., 1969; Compans et al., 1972; Pons et 
al., 1969 ; Jennings e t al., 1983 ). The polymerase trim er has been located at, or very 
close to , the end o f each RNP by immunogold labelling (Murti e t al., 1988). A t present it 
is not known how the RNPs are sorted and packaged during virus assembly and how they 
are arranged inside virus particles.
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Figure 1: Influenza virus structure. Electron micrographs (left, courtesy of Dr. Annie Barge) and
diagram (right) of influenza virus (A) and ribonucleoprotein, RNP (B). The viral membrane 
contains three viral transmembrane proteins, hemagglutinin, neuraminidase and M2.The fyil 
protein forms a shell surrounding the genomic RNP particles. RNP consists of a genomic 
RNA molecule, nucleoprotein (NP) and a trimeric polymerase complex.
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1.3. Influenza virus Life Cycle and Host Cell Interactions
Viruses are unable to  generate m etabolic energy or to  synthesize proteins by 
themselves. They have to  enter host cells to  replicate, which o ften  results in an 
exploitation o f host cell molecules at the expense o f the cell, one o f the basic causes of 
viral disease. Influenza virus infection eventually leads to  cell death by apoptosis via the 
PKR (double-stranded RNA activated protein kinase) pathway (Hinshaw e t al., 1994; 
Takizawa e t al., 1995; Takizawa e t al., 1993). Also o ther viruses, e.g. HIV 1, Epstein- 
Barr virus and Sindbis virus, induce apoptosis, which is considered as a host defense 
mechanism to  elim inate the pathogens. Accordingly, viruses are known to  produce 
proteins tha t counteract or delay this host cell suicide response until they have produced 
suffic ient amounts o f progeny virus (Chou and Roizman, 1 992; Clem e t al., 1 991 ; Rao et 
al., 1992).
The virus life cycle can be divided into three major phases: cell entry, genome replication 
and release o f progeny virus (figure 2). Im portant aspects o f each phase in influenza 
virus infection are briefly summarized below.
1.3.1. Virus Entry
The firs t event in viral infection o f a host cell is binding o f the virus to  the cell surface. 
The influenza virus haemagglutinin (HA) is responsible fo r viral a ttachm ent to  cellular 
sia lyloglycolipids or sialyloglycoproteins. The virus particles are then internalized via 
c la thrin  coated p its  and they fuse w ith  the  cell membrane in the  late endosome 
compartm ent, when the pH has dropped below a certain threshold level. The pH drop leads 
to  a conform ational change in the HA protein causing the exposure o f a hydrophobic 
peptide, tha t promotes fusion between the two membranes (Murphy and W ebster, 1 990; 
Skehel e t al., 1982 ). The low pH conditions in the endosome environment are probably 
also im portant fo r the uncoating o f the genome from the M protein shell, possibly due to  
the  acid ifica tion  o f the  virus in te rio r through the  M2 pro ton  channel (M artin  and 
Helenius, 1991 a; Zhirnov, 1 990 ). Finally, virus uptake and tra ns fe r in to  the  late 
endosomes has the  advantage o f providing transpo rt fo r the RNPs through possible 
obstructions in the cytoplasm ic com partm ent delivering them  d irectly  in to  the central 
perinuclear area (Marsh and Helenius, 1989). The M l-p ro te in -fre e  RNPs are then 
active ly  transported  in to  the cell nucleus via the nuclear pore complex (M artin  and 
Helenius, 1991 b).
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Figure 2: Cycle of influenza virus infection schematically depicting the series of events that
lead to  virus multiplication in susceptible cells from the onset of adsorption to  final 
budding and release of progeny virus
2.3.2. Gene Expression (transcription and replication)
Influenza virus transcription and replication take place in the nucleus o f in fected cells in 
close association w ith  the nuclear m atrix (Jackson e t al., 1982; Lopez-Turiso e t al., 
1990). Whereas the genomic RNA o f (+) strand viruses can d irectly function as mRNA in 
in fected cells, (-) strand viruses carry specific polymerases, th a t produce mRNAs by 
transcrip tion  o f the ir genomic vRNAs. Because influenza viruses contain the ir specific 
RNA-dependent RNA polymerase on the RNPs, it was initia lly surprising to  find tha t the 
virus was dependent on functional, cellular RNA polymerase II fo r transcrip tion  (Rott et 
al., 1965; Rott and Scholtissek, 1970; Lamb and Choppin, 1977). The influenza virus 
polymerase harbours a unique endonuclease ac tiv ity , th a t cleaves RNA polymerase II 
derived hnRNAs or mRNAs o f the cell a t certain positions 10-15 nucleotides from  the ir
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cap structures. These capped oligoribonucleotides are then used as primers to  in itia te 
viral transcription from  the second base of the vRNA 3' end (Caton and Robertson, 1980; 
Dhar e t al., 1 980; Krug et al., 1979). The cap snatching stra tegy o f the influenza virus 
no t only provides the  necessary mRNA structures fo r e ffic ien t translation , but also 
strongly interferes w ith cellular gene expression and is probably one o f the causes for the 
s h u t-o ff o f host prote in synthesis in in fected cells (Lazarow itz e t al., 1971; Skehel, 
1972). Transcription term inates at an oligoU stre tch  17-22 nucleotides from  the S' end 
o f the vRNA, where the polymerase adds a polyA tail o f 140-1 60 nucleotides to  the mRNA 
by a presumed s tu tte ring  mechanism (Hay e t al., 1977; Krug e t al., 1989; Plotch and 
Krug, 1977). The firs t step in the replication o f the influenza virus genome is the switch 
from mRNA synthesis to  the synthesis o f cRNA, the full-length copy o f genomic vRNA. The 
cRNAs then serve as tem plates fo r vRNA production. During replication the RNAs are 
synthesized w ithout cap groups and polyA tails and the transcription term ination signal is 
ignored (Hay e t al., 1 982; Skehel and Hay, 1978; Young and Content, 1971 ).
These processes are subject to  a tig h t regulation, tha t results in the synthesis o f 
d iffe rent amounts o f proteins at d ifferent times o f infection, which can be divided into two 
d is tinc t phases. In the  early phase (until 2-3 h p .i.) mRNA, cRNA and vRNA synthesis 
occur in parallel and contro l o f gene expression is mainly achieved by the  selective 
production  o f d iffe re n t amounts o f vRNA fo r d iffe re n t segm ents. In th is  way the 
polymerase subunits, NP and NS1 proteins are p re fe ren tia lly  synthesized. Later in 
in fection mRNA and cRNA synthesis are drastically reduced, whereas the production o f 
vRNA and proteins continues from  persisting cRNA and mRNA tem plates (Krug e t al., 
1989 ; Shapiro e t al., 1987). The mechanisms involved in these crucial regula tory 
processes are only poorly understood. It has, however, been established th a t newly 
produced NP protein early in in fection is required by the polymerase in order to  pass 
through the term ination signal and produce full-length cRNAs and vRNAs in v itro  (Beaton 
and Krug, 1984; Shapiro and Krug, 1988).
Generally, virus m ultip lication involves a lo t o f specific interactions w ith  the host 
cell. Influenza virus is unique among RNA viruses in producing tw o  d iffe re n t proteins 
from  single mRNAs by a lte rna tive  splicing. The splicing is perform ed by cellu lar 
spliceosomes and is tig h tly  regulated to  produce d is tinc t amounts o f each protein. 
Influenza virus gene products (NS1 and polymerase) are involved in the  contro l o f the 
splicing process in favour o f viral gene expression. NS1 prote in  inh ib its splicing by 
specifically capturing an essential component o f the spliceosome, the U6snRNA (Lu et al., 
1994; Qiu e t al., 1995 ). Additionally, NSI protein interferes w ith the nuclear export o f 
polyA contain ing mRNAs, presumably favouring the export o f virus specific messages 
(Fortes e t al., 1994 ; Qiu and Krug, 1994 ). The virus also has to  cope w ith  the 
consequences o f in terferon action and PKR activation  in in fected cells (see above). 
Enhanced translation o f viral mRNAs and a virtually complete shut-down o f host protein
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expression is presumably achieved in several ways. The virus very e ffic ien tly  blocks the 
activation o f the kinase PKR by activating a cellular PKR-inhibitor, called p58 (Lee et 
al., 1990; Lee e t al., 1992). Additionally, NSI protein seems to  block PKR activation by 
binding to  double-stranded RNA (Lu e t al., 1995 ). A ctive  PKR phosphorylates and 
thereby sequesters in an inactive form the translation elongation fac to r eF2-a. Not only 
does influenza virus block this kinase, but viral mRNAs seem to  be capable o f specifically 
rec ru iting  eF2-a, when this facto r becomes lim iting due to  extensive phosphorylation 
(Feigenblum  and Schneider, 1 9 9 3 ). The same authors observed a s ig n ifican t 
dephosphorylation o f the cap-binding in itia tion  fa c to r elF-4E during influenza virus 
in fection, which leads to  a significant downregulation o f cap-dependent transcrip tion  
in itia tion . In addition, elF-4E is the m ost lim iting fa c to r re la tive to  o the r in itia tion  
facto rs  and constitu tes a major ta rge t fo r translational contro l by a large number o f 
e ffectors , e.g. g row th factors (Sonenberg, 1993). Influenza virus mRNAs apparently 
overcom e this in itia tion  block, because they require extrem ely low amounts o f this 
in itiation fac to r due to  the short length and the absence o f secondary structure  in the 5' 
non-transla ted region (Feigenblum and Schneider, 1993 ). The conserved 5' end o f 
influenza virus mRNAs has been shown to  be sufficient to  confer translational advantage to 
chimeric RNAs. Therefore, a binding protein, specific fo r the conserved 5' end, may be 
involved in the influenza virus specific upregulation o f translation (Garfinkel and Katze, 
1993). These examples emphasize how the influenza virus exploits cellular mechanisms 
fo r its own replication and can even take advantage o f cell defense mechanisms.
2.3.3. Release o f progeny virus 
The genomic vRNAs are presumably packaged by NP in to  RNP structures during RNA 
synthesis, which occurs in the nucleus. Then they  are active ly and unid irectionally 
transported  in to  the cytoplasm  to  be incorporated in to  progeny virus particles. This 
transport is dependent on Ml protein entering the nucleus, but the mechanism o f the RNP 
export process is unknown (M artin and Helenius, 1991 a; W h ittake r e t al., 1 99 6 ). 
Influenza virus assembly and budding take place at the plasma membrane o f infected cells, 
or the  apical membrane in the case o f epithelial cells (K ingsbury, 1 99 0 ). Relatively 
large amounts o f the proton channel forming M2 protein are synthesized in infected cells. 
This protein is presumably needed to  equilibrate the pH in the trans Golgi network (TGN), 
which prevents the premature conformational change o f some HA subtypes to  the low pH 
form  (Ciampor e t al., 1992; Sakaguchi e t al., 1996). During virus assembly M2 protein 
is apparently excluded from  virus particles (Zebedee and Lamb, 1988). The enzymatic 
ac tiv ity  o f the NA protein cleaves o ff sialic residues from  neighbouring HA molecules and 
from  any cell surface molecules in the v icin ity. This enables the virus to  leave the cell 
membrane and prevents virus particles from  aggregating (Kingsbury, 1990; Palese et 
al., 1974).
Introduction
2.4. Antiviral Therapy
The currently available vaccines based on inactivated viruses are usually quite e ffective  
in reducing the  frequency and the severity  o f the influenza disease, and annual 
vaccinations are recommended fo r people belonging to  high risk groups (Murphy and 
Webster, 1990; Ruben, 1987). However, the vaccines are not com plete ly p ro tective  
against influenza virus infection. Maximal efficacy o f 80% is only seen w ith homologous 
virus challenge and new vaccines have to  be produced annually in order to  keep up with 
the prevalent virus strains, tha t undergo continuous changes by antigenic d rift. In the 
worst case, major changes o f the surface antigens, haemagglutinin and neuraminidase, can 
occur by recombination and significantly diminish or nullify the protection conferred by 
the vaccines. Antiviral agents are needed fo r the trea tm ent o f acute infections and they 
should ideally be ta rge ted  at virus-specific, essential steps o f the rep licative cycle 
w ith o u t a ffec ting  normal host cell metabolism . The influenza virus in fection  cycle 
provides a number o f potential targets fo r the development o f antiviral agents. Presently, 
the only licensed anti-influenza drugs are amantadine and rimantadine, which are o f 
lim ited u tility , because they very rapidly generate transm issible, res is tan t influenza 
virus m utants and they show adverse renal and neurological side e ffects (Hayden and Hay, 
1992). Both compounds block the ion channel activ ity  o f the M2 protein and inhibit virus 
uncoating and assembly events (Bukrinskaya e t al., 1982; Hay e t al., 1985; Martin and 
Helenius, 1991 a; P into e t al., 1 99 2 ). Resistant viruses have m uta tions in the  
transmembrane region o f the M2 protein (Hayden and Hay, 1992; Houck et al., 1995). A 
number o f a lternative compounds have also been investigated as potentia l anti-influenza 
drugs (figure 3).
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Figure 3: Molecular structure diagrams of compounds, tha t have shown considerable anti­
influenza virus activ ity in vitro  and in vivo
The sialidase activ ity  o f the NA protein constitu tes another virus-specific ta rge t located 
on the envelope o f the virus particles. Knowledge o f the NA crysta l s truc tu re  led to  a 
significant improvement in the e fficacy o f sialidase inhibitors, which are transition  sta te  
analogs o f the sialidase reaction. The neuraminic acid derivatives show sign ificant NA-
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inh ib iting a c tiv ity  in v itro  and e ffic ien tly  prevent virus shedding and pyrexia in vivo 
(Schulman and Palese, 1975; von Itzste in  e t al., 1993b). However, in sp ite  o f the 
conservative nature o f the NA active site, differences in drug sensitiv ity were observed 
among different NA subtypes, and the compounds were completely ineffective against some 
highly virulent, avian influenza A virus strains (Gubareva e t al., 1995). O ther problems 
comprise rapid excretion, very short-te rm  protection from virus challenge and poor oral 
b ioavailability (Colman, 1994). However, randomized, double-blind, p lacebo-controlled 
tria ls w ith healthy, young adults showed tha t the NA inhibitor 4-guanidino-Neu5Ac2en 
(GG167) was safe and e ffec tive  fo r prophylaxis and early trea tm en t o f experimental 
human influenza w ith a H1N1 influenza virus strain (Hayden e t al. 1996). A lternative  
compounds mimicking the s tructure  o f neuraminic acid derivatives are currently  being 
developed, based on the structure  and interaction o f the inhibitors w ith NA, to  address 
these problems (Jedrzejas e t al., 1995 ). The search fo r drugs in terfe ring  w ith the 
interaction o f haemagglutinin and sialic acid was unsuccesful until now, presumably due 
to  relatively weak interaction between these tw o molecules and the lack o f charge-charge 
interactions in the sialic acid binding site o f HA (von Itzstein e t al., 1 993a).
The m ajority o f the presently licensed antiviral agents are nucleoside analogs, tha t 
in te rfe re  w ith  virus-specific  nucleic acid synthesis (Hirsch and Kaplan, 1 990 ). The 
influenza virus RNA-dependent RNA polymerase also possesses a number o f unique 
activ ities, th a t constitu te  ideal drug targets. Ribavirin was the firs t nucleoside analog, 
th a t inh ib ited  influenza virus rep lication, bu t its antiv ira l spectrum  is larger and 
includes several o the r RNA viruses like resp ira tory syncytia l virus (RSV) and Lassa 
feve r virus (McCormick e t al., 1986 ; McIntosh e t al., 1984 ). The mechanism of 
ribavirin action is complex, the  drug in terfe res w ith  cellular GTP pool sizes and a 
number o f adverse side e ffects are known, which lim it the utiliy o f this compound.
2 '-de o xy -2 '-fluo ro ribos ides have shown s ign ifican t inh ib ito ry  a c tiv ity  against 
influenza A and B viruses in standard and human tracheal cell cultures, and they very 
e ffic ien tly  decreased virus titres  in infected mouse lungs. Especially the guanosine analog 
was significanty more e ffic ien t than both ribavirin and amantadine in the mouse model 
(Tisdale e t al., 1993). Because nucleoside analog compounds are targeted to  the highly 
conserved viral polymerase protein, the emergence o f resistant viruses is likely to  be 
significantly delayed compared to  amantadine.
The endonuclease ac tiv ity  o f the polymerase complex is even more specific to  the 
influenza virus, than the  RNA-dependent RNA polymerase module itse lf. Several 
laboratories have recently been trying to  establish endonuclease activ ity  assays to  screen 
fo r influenza virus-specific inhibitors. Dioxobutanoic acid derivatives have turned out to  
specifica lly  inh ib it the  mRNA cleavage reaction, bu t no t transcrip tion  in itia tion  or 
elongation by the influenza virus polymerase protein (Tomassini e t al., 1994 ). Although 
the f irs t series o f compounds could not com plete ly inh ib it virus replication in MDCK
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cells, the results demonstrate tha t the influenza virus polymerase can be a specific ta rge t 
fo r antiviral agents. Further structura l and biochemical characterization o f th is protein 
complex will considerably facilitate the development o f such compounds.
2.5. Objectives
The goal o f this study was to  be tte r understand the structure-function relationship 
o f the influenza A virus polymerase in the context o f the transcriptionally active unit o f 
the virus, the RNP. The influenza virus polymerase is the central protein in the virus 
infection cycle and harbours most o f the activ ities necessary fo r the transcrip tion and 
replication o f the viral RNA genome. The polymerase is composed o f three virally encoded 
protein subunits PB l, PB2 and PA, which form  a heterotrim eric complex in v itro  and in 
vivo  (Akkina e t al., 1987; Detjen et al., 1987; Hagen e t al., 1994; Jones et al., 1986; 
Krug e t al., 1989). The polymerase strongly associates w ith the genomic RNA, and this 
interaction can be stable enough fo r purification on CsCI gradients (Honda e t al., 1 988). 
The exact polymerase binding site on the RNA, however, has only been poorly defined 
(Honda e t al., 1987; Murti e t al., 1988). Considering such a strong interaction on virus- 
derived RNPs, major changes in protein-RNA contacts are likely to  occur in order to  
enable polymerase progression and tem plate copying during transcription and replication. 
The study o f the prom oter structure fo r transcription has been considerably hampered by 
the  lack o f commendable sources o f purified or recom binant polymerase prote in. 
Purification protocols o f polymerase from  viruses or infected cells e ither do not remove 
all endogenous viral RNA or largely denature the protein (Honda e t al., 1990; Seong and 
Brownlee, 1992; Szewczyk e t al., 1988). Recombinant expression systems on the other 
hand usually produce polymerase prote in only in m inute amounts or are defic ien t in 
complex form ation  (Hagen e t al., 1995; Kobayashi e t al., 1992 ) A nother im portant 
factor, tha t could not be considered in most polymerase-RNA binding studies performed so 
far, is the substantial influence o f the nucleoprotein (NP) on the RNA structure  (Baudin 
e t al., 1 994 ). We have therefore decided to  work w ith in tact genomes purified from the 
virus and studied the polymerase-RNA in teraction in the presence o f NP by chemical 
m odification analysis. The results o f this work are presented in chapter I. These studies 
have provided more detailed information on the RNP structure and the interactions o f both 
polymerase and NP with vRNA.
Recom binant expression system s fo r polym erase subun its  and e ff ic ie n t 
re co n s titu tio n  system s will be essential to  find ou t more about the  polym erase 
organization itse lf and to  obtain structura l inform ation o f subunits and active sites. It is 
still far from understood which subunits make contacts w ith the RNA genome and how they 
do so. The polymerase also catalyzes a varie ty o f d iffe ren t reactions which are both 
essential and highly specific fo r influenza viruses. In m ost cases, the im portan t regions 
on the proteins have not been mapped ye t. Especially there is s till not much evidence
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concerning the function o f PA in the viral replication cycle. Studies w ith tem perature 
sensitive viruses suggested tha t PA function was mainly required during replication, but 
possibly not during primary transcrip tion (Krug e t al., 1 975; Palese e t al., 1977). We 
have therefore cloned the PA subunit gene into a variety o f expression vectors in order to 
find a system  tha t might provide us w ith suffic ient amounts o f protein fo r functional or 
even s tru c tu ra l studies. Chapter II compares the  results obta ined w ith  d iffe re n t 
expression systems and discusses their potential use to  determine PA function.
As outlined above, the  unique ac tiv ities  o f the  influenza virus polymerase 
constitu te  ideal targets for antiviral chemotherapy. Chapter III describes work on in v itro  
transcrip tion  assays in order to  determ ine the mechanism o f transcrip tion inhibition by 
2 '-fluororibonucleotides. These compounds may become valuable too ls to  study early 
transcriptional processes and specific polymerase activities in vitro.
___________ Chapter I :_________________ RNA modification analysis____________________1_4
Chapter I 
RNA modification analysis of native RNPs
1.1. Introduction
Influenza virus RNPs, composed o f RNA, nucleoprotein (NP) and polymerase, can be 
considered as the minimal units to  perform  viral RNA synthesis. The selective separation 
o f NP from  polymerase-RNA complexes in vitro  leads to  a significant loss o f transcription 
a c tiv ity  and mainly a ffects elongation (Honda e t al., 1 98 8 ). This suggests th a t the 
polymerase complex contains the enzymatic activities needed fo r transcription in itiation, 
whereas NP has mainly a structura l role, presumably in presenting the tem plate  RNA to 
the polymerase in a conform ation optim al fo r transcrip tion  elongation. In vivo, the 
expression and replication o f virus-like RNAs requires the polymerase and NP as the 
minimal se t o f proteins (de la Luna e t al., 1993; Huang e t al., 1990; Kimura e t al., 
1992; Mena et al., 1994). The RNP structure (see introduction, page 4, figure 1) cannot 
be functionally reconstitu ted by simply mixing purified proteins w ith RNA, although the 
resu lting  s truc tu res  resemble RNPs on e lectron m icrographs (Honda e t al., 1988; 
Kingsbury e t al., 1987; Krug e t al., 1989). RNA m odification analysis was employed to  
study the  RNA conform ation in the context o f the in tac t RNP structure  and to  obtain 
information on the protein-RNA interactions within this structure.
1.2. RNA modification analysis: a method to  study the conformation o f RNA molecules in 
solution
The methodology to  study RNA conform ation in solution is based on the availability o f a 
va rie ty  o f specific chemical and enzym atic probes, th a t allow the analysis o f single 
nucleotides along a RNA molecule (reviewed by Ehresmann e t al., 1987). These probes 
indicate if specific nucleotide positions are either freely accessible from  the  solvent or 
p ro tected by a RNA secondary structure  or a bound protein. This method is based on the 
chemical sequencing reactions developed in the laboratory o f Walter Gilbert (Peattie and 
Gilbert, 1980) and has been used extensively in the study o f protein-RNA complexes, e.g. 
in spliceosomes (Jandrositz and Guthrie, 1995), ribosomes (Holm berg e t al., 1992; 
Moazed e t al., 198 8 ) or regu la to ry  mRNP complexes (Li e t al., 1 99 5 ). Figure 1.1 
illustra tes the  principle o f the method. In the firs t step, the  RNPs are enzym atica lly 
cleaved or chem ically modified at a s ta tis tica l and low level (less than one cu t or 
m odification per molecule). A fte r stopping the reaction, the RNAs are purified by phenol 
extraction and hybridized to  a radioactively labelled DNA oligonucleotide complem entary 
to  a chosen sequence on the RNA.
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Modification and detection of modified positions on RNA 
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Figure 1.1: Schematic representation of the general principle of RNA modification analysis
and the primer extension method for the detection of modified bases. 
(GGGGGGGG) stands for a random RNA sequence, ( •  ) indicates modified bases, 
( D ) a protected region (binding protein or RNA secondary structure), ( ■  ) 
represents a labelled primer DNA and ( ■■—  ) an extended primer.
The cleavage sites or the modified bases are then identified in a primer extension reaction 
with reverse transcriptase. The elongation during reverse transcription is prematurely 
terminated at cleavage sites or one nucleotide before a base, that has been modified at a 
Watson-Crick position. The cDNA fragments synthesized by this procedure are labeled at 
the ir 5 ' ends and can be visualized by autoradiography after denaturing gel 
electrophoresis (urea-PAGE). A sequence-specific ladder of bands will be produced on 
such gels, when single-stranded, naked RNA is analyzed (figure 1.1, left). However, RNA 
binding proteins or RNA secondary structure elements can protect bases from being 
modified, which results in the absence of a band at the corresponding place on the gel 
(figure 1.1, right). Control reactions are performed in parallel by incubating the RNAs in 
the absence of modifying agents. In this case the primer extension reaction primarily 
produces full-length transcripts. Additional bands in the control reactions can be caused 
by nicks in the RNA or unspecific stops of the reverse transcriptase.
The reverse transcription reaction only resolves RNA sequences upstream of the chosen 
primer binding site. An alternative approach has to be used to identify modified base 
positions at the extreme 3' ends of RNA molecules. In the present study, the modified
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influenza virus RNPs were phenol-extracted, and the resulting vRNAs 3' end-labelled 
w ith  T4 RNA Ligase and radioactive cy tid ine-3 '-5 '-b isphosphate  (pCp). The labelled 
RNAs could then be specifically cleaved at the modified positions by a fu rthe r chemical 
treatm ent. This approach requires base-specific chemicals modifying the bases in such a 
way, th a t the  RNA can be chem ically cleaved a fte r the  m od ifica tion  reaction. 
D im ethylsu lfa te  (DMS) is a t present the only chemical, th a t sequence-specifically 
in teracts w ith Watson-Crick positions o f bases and cytidine residues can afterwards be 
detected by chemical RNA cleavage.
1.2.1. Chemistry o f modification probes
Figure 1.2 shows a W atson-Crick base-pairing scheme illus tra ting  the  sites o f base 
reactiv ity w ith the probes, tha t have been used in this work.
G
o
U HO
F igure 1.2: Watson-Crick base-pairing scheme Illustrating the interference of base-pairing
interactions with the sites of modification by DMS ( •  ) and kethoxal ( © ).
Dimethylsulfate (DMS):
A t neutral pH DMS methylates positions N7 o f guanines (G), N1 o f adenosines (A) and N3 
o f cytosines (C). The methylated C and A can be detected by reverse transcription. The RNA 
can also be specifically cleaved at DMS modified C residues by a sequential trea tm ent with 
hydrazine and aniline (Ehresmann et al., 1987; Peattie and Gilbert, 1980).
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p-ethoxy-a -ketobutyraldehyde (Kethoxal)
Kethoxal interacts w ith the Watson-Crick positions N1 and N2 o f G residues. The reaction 
forms a new ring structure, which is unstable in basic conditions. Borate ions are added 
a fte r the reaction to  stabilize the product.
R N A s e ll
RNAse T1 forms specific hydrogen bonds with N1 and 06 o f G residues before hydrolyzing 
the RNA via the form ation o f an interm ediate guanosine 2 '-3 '-cyc lic  phosphate. The 
hydrolysis generates fragm ents w ith a 3' phosphate and can be used as an indicator for 
unpaired G.
1.3. Modification analysis o f native influenza virus RNPs
1.3.1. Purification o f RNPs
Influenza A /P R /8 /3 4  virus RNPs were purified from  egg-grown virus according to  a 
protocol, th a t is currently used in similar forms in several laboratories (see chapter IV 
B1.2. as adapted from  Honda e t al., 1988). Briefly, the virus particles, purified on a 
sucrose gradient, are pelleted by u ltracentrifugation  and resuspended in a lysis buffer 
containing 1% Triton X-100 and 1% lysolecithin. The released RNPs are then purified by 
glycerol gradient centrifugation. Figure II.3A shows an analysis o f gradient fractions by 
denaturing gel electrophoresis (SDS-PAGE). The RNP peak fractions, characterized by NP 
and polymerase bands on the gel (figure I.3A, lanes 7-9), are pooled and concentrated 
before m odification experiments. The in teg rity  o f the RNA in RNP preparations can be 
analyzed by electrophoresis on 6% polyacrylamide gels (figure I.3B). The genomic RNA 
segments o f d iffe ren t lengths have been visualized in th is case by ethid ium  bromide 
staining. Only 6 bands are readily visible on the RNA gels, because RNA segments 1-3 
m igrate toge ther in the topm ost band due to  their very similar sizes. In v itro  transcribed 
segment 8 RNA (890  n t) served as a size standard on this gel.
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Figure 1.3: Glycerol gradient purification of influenza virus RNPs from detergent disrupted
virus. Viral proteins in fractions collected from the bottom of a 30-60% 
continous glycerol gradient were analyzed by 1 2% SDS-PAGE and Coomassie 
staining (A). RNPs in fractions 7-9 were pooled and analyzed for RNA content by 
6% urea-PAGE and EtBr-staining (B, lane 1). Lanes 2-5 show vRNA samples 
from different RNP preparations. NS vRNA shows in vitro transcribed segment 8 
vRNA
1.3.2. Analysis o f DMS modification patterns on RNPs
The accessibility o f bases near the S' end of the RNP structure was studied with the 
segment 8 RNP coding fo r the NS proteins. The vRNA on the RNPs is readily modified by 
DMS as can be seen on figure 1.4, which shows a set o f DMS m odification reactions 
comprising control (C) and three reactions with increasing amounts o f DMS.
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Figure 16% PAGE autoradiogram of the cDNA fragments produced a fte r reverse 
transcription o f DMS modified RNPs using a primer specific for segment 8 vRNA. 
The unreactive bases at the S' end of the vRNA are indicated by a bracket. The 
reactivity o f all As and Cs of the vRNA are shown from nucleotides 23 to  52. 
The star indicates nucleotide 27, where the sequence of our virus preparation 
deviates from the published NS vRNA sequence of influenza A /P R /8 /34 . Lane C 
is an incubation control o f unmodified RNPs. Lanes 1,2 and 3 represent 
incubation of RNPs with 0.1, 0.2 and 0.6^J\ DMS respectively. Lanes ACGU are 
vRNA dideoxy-sequencing reactions of segment 8 vRNA.
On the right side o f the gel is a RNA sequencing reaction (ACGU) to  identify the modified 
positions on the vRNA sequence. The modified positions have been resolved by the reverse 
transcription technique (see 1.2). All A and C residues downstream from A23 are reactive 
at the ir Watson-Crick positions and appear as bands on the analytical gel. This indicates 
th a t NP binding to  vRNA does not involve the Watson-Crick positions o f bases. The RNA 
bases are freely accessible from  the solvent. The residues near the top  o f the gel
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corresponding to  the conserved 5' end o f the vRNA, in particular A4, A6, A7, A8, C9, A 10 
and A 1 1, indicated by the square bracket, were not modified. This base protection could in 
principle partially be caused by base-pairing o f the conserved ends o f the vRNA as has 
been observed on small model RNAs. Figure 1.5 shows the secondary structure , tha t is 
formed between the conserved influenza virus vRNA ends on a naked, 84 nucleotide model 
RNA in solution according to  Baudin et al. 1 994.
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F igure  1.5: Partially base-paired secondary structure ("panhandle") formed between the
ends o f segment 8 vRNA on small, naked model RNA in solution. Adapted from 
Baudin et al. (1994).
Of particular in terest are the adenines A4 and A lO , tha t are located in bulges and have 
been shown to  be exposed in this RNA secondary s tructure . The fac t tha t they prove 
com pletely unreactive on native RNPs strongly suggests an interaction o f the polymerase 
prote in w ith  the 5' end o f the vRNA. To d irectly  dem onstrate this in teraction  and to  
possibly iden tify  polymerase subunits responsible fo r vRNA binding, we searched fo r 
means to  selectively remove polymerase subunits from the RNPs.
1.3.3. Removal o f the polymerase from RNPs
Polymerase binding to  RNPs had been found to  be sensitive to  incubation with deoxycholate 
(DOC) (Inglis e t al., 1 976). The e ffect o f increasing amounts o f DOC on the composition of 
RNPs was analyzed by SDS-PAGE and it  was confirm ed, th a t DOC was capable o f 
preferentia lly dissociating polymerase proteins from  RNP structures. No changes in the 
sedimentation pattern o f the RNPs were observed on glycerol gradients, tha t were used to  
separate the residual RNPs from  detached polymerase proteins. Figure 1.6 shows tw o 
silver-sta ined gels o f a SDS-PAGE analysis a fte r a succession o f glycerol gradients to  
prepare polymerase-free RNPs. The top  gel shows a typical separation o f viral envelope 
and Ml proteins from  com plete RNPs on 30 ml continuous glycerol gradients similar to  
th a t shown in figure I.3A. Polymerase-free RNPs were obtained a fte r incubation in 1 % 
DOC and recentrifugation on either a 12 ml glycerol step gradient (figure I.6B), in order 
to  concentra te  the RNPs on top  o f a 70%  glycerol cushion, or a 30-60%  glycerol
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continous gradient, where the polymerase-free RNPs sedimented to  regions o f roughly 
40%  glycerol similar to  complete RNPs (not shown).
A RNP
polymerase
 NP
 HA1
M l + HA2
Bottom Top
B
polymerase
F igure  1.6: (A), 12% SDS-PAGE of fractions from 30 ml 30-60% glycerol gradients for the
isolation o f complete RNPs. Fractions indicated by the bracket were pooled, 
concentrated, treated with 1% DOC and loaded onto a 70%, 30%, 20% glycerol 
step gradient, the fractions of which were analyzed in the same way. Both gels 
were silver stained.
The efficiency of polymerase removal was dependent on the concentration o f RNPs. A t 1 
m g /m l RNP, even elevated concentrations o f DOC did never com plete ly remove the 
polymerase from  the RNPs. The DOC trea ted  RNPs were centrifuged through a 25 % 
glycerol cushion, and the pellet and supernatant fractions were analyzed by SDS-PAGE 
(figure 1.7). A fast m igrating polymerase subunit was dissociating from  RNPs at lower 
DOC concentrations than the others. This subunit was identified as PA by Western b lo t 
analysis, but it could not be excluded, th a t both PA and PB2 dissociated simultaneously 
under these conditions. Complete and selective removal o f polymerase proteins as shown
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in figure 1.6 was best achieved w ith 0.1 m g/m l o f RNPs in 1 % DOC. Interm ediate  
concentrations o f DOC (0-1 %) did reproducibly and preferentially remove the faste r 
migrating polymerase band from the RNPs. However, according to  Western b lo t analysis, 
complete, selective removal o f only the PA protein could not be achieved. PA started  to  
dissociate at 0.025 % DOC, but was only below detection level on the RNPs after 1 % DOC 
incubation, when the o ther subunits had also dissociated. We did not succeed in the 
preparation o f PA-free RNPs w ith this method. The efficacy o f DOC was presumably 
related to  the ionic nature o f the detergent, because the RNPs remained complete even in 
the presence of up to  2 % CHAPS.
DOC [% ] 0
P S
PB1
PB2, PA 
NP
Figure 1.7: 12% SDS-PAGE of RNPs incubated at 1 mg/ml with different concentrations of
DOC, as indicated above the gel, then centrifuged through a 25% glycerol 
cushion. One of the smaller polymerase subunits is separated from RNPs at 
lower DOC concentrations than the others. DOC dependent dissociation of 
polymerase subunits from RNPs is dependent on RNP concentration. "P" and "S" 
stand for pellet and supernatant fractions.
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1.3.4. Comparison o f modification patterns; RNP versus RNP -pol
Figure 1.8 shows a DMS m odification experim ent w ith RNP, similar to  th a t described 
above (figure 1.4), compared with the m odification o f RNPs devoid o f polymerase (RNP 
-pol). No changes are observed in the NP binding pattern. All A and C residues downstream 
o f position 23 are reactive with DMS in both cases. However, the residues at the 5' end of 
the vRNA, tha t are protected on complete RNPs become reactive a fte r removal o f the 
polymerase complex.
RNPs RNPs - pol
CO nse rved 
vRNA 
S' end
o lig o -U
s tre tc h
'A  23
^  ^
C 1
A 23
F igure  1.8: 16% PAGE analysis o f the cDNA products from DMS modified RNPs and RNPs
lacking the polymerase complex (RNPs-pol). The reactive bases are Indicated on 
the right. Lane C is an incubation control o f unmodified RNPs. Lanes 1-3 are 
incubations of RNPs with 0.1, 0.2 and 0.6 pi DMS, lanes AGCU are RNA dideoxy- 
sequencing reactions.
Similar information, but now on the guanosines, was obtained by the analysis o f 
RNPs by kethoxal modification, specific fo r N1 and N2 of G (figure 1.9) and RNAse T1 
digestion, specific fo r unpaired G (figure 1.10). On complete RNPs, the guanines G5, G12, 
G1 3 and G14 were not accessible for either kethoxal or RNAse T 1 . The protection of G5 
was again a direct evidence for the presence o f the polymerase complex at the 5' end.
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because this base shows significant reactiv ity on the model panhandle structure  o f naked 
RNA (figure 1.11 ), which suggests tha t the observed G5 protection was not due to  a RNA 
secondary structure. The reactiv ity of base G1 6 in the segment 8 sequence could not be 
determined because o f modification unrelated stops of the reverse transcriptase in this 
region. The next G residue in the segment 8 vRNA sequence is located at position 35. G35 
and all following G residues were reactive to  Watson-Crick specific modification on RNPs.
RNPs RNPs - pol
1*:;^
G 2 
G 5
,G 12 
■G 13 
G 14 
G 16
— G 35
« — G 38
Figure 1.9: 16% PAGE analysis of the cDNA products from kethoxal modified RNPs and RNPs
lacking the polymerase complex (RNPs-pol). The reactive bases are indicated on 
the right. Lane C is an incubation control of unmodified RNPs. Lanes 1-3 are 
incubations of RNPs with kethoxal for 5, 10 and 20 min. RNPs-pol were 
incubated 20 and 60 min, lanes 1 and 2.
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conc. DOC [% ] 0 0,05 o.s i i
G 3 
G 5
G 12 
G 14
G 27 
G 30
G 36 
G 39
G 42
G 50 -
F igure  1.11: RNAse T1 digestion of a 3 ’ end labeled, 81 nt panhandle model RNA in the 
presence of increasing concentrations of deoxycholate (DOC). The positions of G 
residues are indicated on the le ft. G12, G13 and G14 are protected from 
hydrolysis by base-pairing with C residues at the 3' end of the molecule. The 
base-pairing interactions are not disturbed in the presence of DOC. PhyM and T1 
denote sequencing reactions of the panhandle RNA with the corresponding 
RNAses under denaturing conditions performed with 1 U and 0.5 U o f enzyme 
respectively. Lanes "C" are incubation controls w ithout RNAse. Lanes "1" are 
RNAse T1 digestions of panhandle RNA under native conditions with 0.5 U of 
enzyme.
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DMS
5m in 1 0 min
conserved
vRNA
3' end
L C 1 2 3 C 1 2 3
C 11'
F igure 1.1 2: Autoradiograph of chemical cleavage reactions of a mixture of all 3' end labeled 
vRNAs after DMS modification of complete RNPs, The position of the conserved 
3' end on the sequence is shown by the black bar and all C residues in this region 
are indicated on the left (C4' to  Cl 2 '). Further upstream, the sequence of the 
different genome segments diverts, and strongly reactive positions have been 
marked by numbers according to  the ir position in the sequence. The 
autoradiograph depicts two sets of DMS reactions performed on RNPs for 5 min 
and 10 min respectively, each time with increasing amounts o f DMS. Lanes "L" 
are alkaline hydrolysis ladders of vRNA, lanes "C" incubation controls w ithout 
DMS. Lanes 1-3 are incubations o f RNPs w ith 0.2, 0.5 and 1 pi DMS 
respectively.
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1.3.6. Compilation o f base reactivities on Influenza virus RNPs 
Figure 1.13 gives an overview o f the modification data from  com plete RNPs (to p ) and 
polymerase-free RNPs (bo ttom ) compared to  data obtained w ith naked, panhandle model 
RNA. Circles and squares around the bases indicate the re a c tiv ity  o f Watson-Crick 
positions o f the bases on RNPs, stars and cubes above and below the bases the reactivity of 
bases on perfectly base-paired, small, naked RNA as indicated in the figure. The absence of 
circles or squares means tha t the reactiv ity could not be determined. The pattern o f base 
m od ifica tion  on RNPs is d iffe re n t from  naked panhandle RNA and from  in v itro  
re co ns titu ted  NP-RNA complexes (Baudin e t al., 1 9 9 4 ) a t the  vRNA ends. The 
observation, on complete RNPs, o f protected bases, tha t are accessible fo r modification on 
optim ally base-paired panhandle structures, toge the r w ith the fac t th a t NP binding to  
vRNA does not involve the Watson-Crick positions o f bases, indicates tha t the polymerase 
protein is bound to  the conserved 5' end o f the vRNA on native RNPs. The 3' end is part o f a 
ternary complex toge ther w ith the polymerase and the 5' end, resulting in the protection 
o f bases until position 1 5' on the 3' end and at least position 14 on the 5' end. Downstream 
o f the polymerase binding site the bases are exposed and highly reactive to  all modification 
reagents tested. In the absence o f the polymerase the vRNA ends do not in teract with each 
other and the RNA is devoid o f any secondary structure. The extent o f base protection from 
m odification, which is observed in the presence o f the polymerase, correlates well w ith 
the boundary o f the theoretical panhandle structure, tha t can in principle be formed by 
base-pairing o f the vRNA ends. Depending on virus stra in and RNA segm ent, 12-17 
nucleotides from  the 3' end could in theory be annealed w ith the corresponding 5' ends 
(see figure 1.14 and (Robertson, 1979; Skehel and Hay, 1978; Stoeckle e t al., 1987). 
This suggests th a t the polymerase in teracts w ith both conserved vRNA ends and this 
process may lead to  the annealing o f the complementary sequences.
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Figure 1.13: Compilation of modification data from complete RNP (top) and polymerase-free 
RNP (bottom) compared to data obtained with a 84 nt, in vitro transcribed 
panhandle RNA. Circles and squares around bases indicate the reactivity of 
Watson-Crick positions of the bases on RNP. Stars and cubes above and below 
bases indicate reactivity of bases on naked, annealed panhandle RNA. The 
absence of circles or squares means that the reactivity could not be determined. 
The cleavage by RNAse T1 is indicated by arrowheads. The scheme is drawn 
with the sequence of segment 8 vRNA in the center. The base reactivities at the 
3' end have been determined in a mixture of all segments. The sequence 
deviations in the different RNA segments of influenza A/PR/8/34 are shown 
between nucleotides 13'-21' of the 3' end. The numbers denote the segments, 
that carry the respective cytosine at the specific position of the sequence. The 
nucleotides 13'-15' are usually, but not always, complementary to nucleotides 
14-16 of the 5’ end (compare figure 1.14). The sequences have been extracted 
from the GENBANK/EMBL database.
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Figure i.14: Sequences at the ends of Influenza A/PR/8/34 virus show a partial, inverted 
complementarity. The conserved sequences are in red characters. Blue letters 
show the extension of complementarity into the non-conserved sequence. The 
sequences at the 5' end are shown until the oligoU transcription termination 
signal. The S' end sequences are shown until the UAC, which encodes the 
translation start codon. 0  residues, that have been reactive on RNPs are 
accentuated by a grey background. The sequences have been extracted from the 
GENBANK/EMBL data base.
1.4 Discussion
The polymerase is the central protein complex of the influenza virus replication 
cycle. It is bound to the genomic RNPs in the virion, but the binding site has only been 
poorly defined (Honda et al., 1987; Murti et al., 1988). After the RNPs have entered the 
cell nucleus, transcription of viral mRNA starts from the 3' ends of the vRNA templates 
and terminates at an oligoU stretch near the 5' end of the vRNA. Later in infection the 
polymerase generates full-length complementary transcripts (cRNA), which serve as 
templates for the production of secondary, genomic vRNAs. There is still considerable 
uncertainty concerning the nature of the cis-acting sites and the mechanisms, that are 
involved in the regulation of the replicative processes. All necessary signals for 
replication and genome packaging seem to reside in the terminal sequences of the vRNA, 
which are partially complementary (Luytjes et al., 1989), and several lines of evidence 
have implied a crucial regulatory role for a double stranded panhandle structure in viral 
transcription (Cianci et al., 1995; Fodor et al., 1995; Hsu et al., 1987; Li and Palese, 
1994).
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1.4.1 Binding o f nucleoprotein and polymerase to  the genomic RNA
The results outlined above suggest tha t on the RNP the polymerase forms a ternary 
complex including both conserved ends o f the viral RNA. D irect in te ractions o f the 
polymerase w ith  Watson-Crick positions at the  5' end could be inferred from  RNA 
m odification analysis and the base protection observed at the 3' end indicates tha t it is 
part o f the complex. However, the studies on complete RNPs alone could not clearly 
determine if the vRNA 3' end was held in the complex mainly by the polymerase protein or 
by base-pairing in teractions w ith the 5' end. This problem has been approached by 
studying RNPs from  which the polymerase was selectively separated. Both vRNA ends 
become com pletely exposed and single-stranded a fte r removal o f the polymerase by the 
dete rgen t DOC. Furthermore, DOC itse lf has no e ffe c t on RNA secondary s tructures in 
solution and it is therefore unlikely, th a t DOC would in terfere w ith a possible panhandle 
s truc tu re  form ed by the vRNA ends in RNPs. The separation o f the vRNA ends is most 
likely a d irect consequence o f the absence o f the polymerase. Even a t very low DOC 
concentrations (0 .1 -1% ), th a t only partia lly remove the fas te r m igrating polymerase 
band from  the RNPs, the vRNA ends in RNPs already became reactive. Additionally, very 
low DOC concentrations already strongly inhibited in v itro  transcrip tion ac tiv ity , before 
any dissociation o f protein could be observed on SDS-PAGE gels (figure 1.14-2, page 33). 
Therefore, DOC does no t in terfe re  w ith  RNA secondary s truc tu re , bu t w ith  protein 
interactions in the polymerase complex and between polymerase and vRNA.
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Figure 1.14-2: Effect of low concentrations of sodium deoxycholate (DOC) on the influenza 
virus polymerase complex. RNPs have been incubated with the indicated 
concentrations of DOC and either loaded onto a 500 pi glycerol step gradient 
(25, 30, 40, 50, 60 and 70%) and analyzed by Western blot (A), or employed 
in ApG primed transcription assays (B). In (A), six 1 2% SDS-PAGE gels have 
been blotted onto the same nitrocellulose membrane and developed together 
with L35E12 monoclonal anti-PA antibody. In (8), transcription activity was 
determined by counting the amount of nucleotides incorporated into TCA- 
insoluble material. Incorporation of 400 pmol DTP label per pmol RNP in 1 
hour was set as 100% activity. Transcription activity of RNP is already 
maximally inhibited by DOC, when the majority of the polymerase is still 
bound to the RNP.
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The spontanous form ation of a panhandle structure has been observed on small (<100  n t) 
model RNAs in solution (Baudin e t al., 1994) and reproduced in this study (figure 1.11 ). 
The genomic vRNAs, on the o ther hand, are much longer, i.e. between 890  and 2341 
nucleotides length. Modification analysis of naked, in v itro  transcribed segm ent 8 RNA 
(890 nt) showed tha t the vRNA ends were separated on these molecules and did not form a 
stable panhandle s tructure  (figure 1.15, courtesy o f Dr. Florence Baudin). The bases in 
the region o f the conserved ends were reactive w ith modifying agents and appear as stops 
of the reverse transcription reaction on the gel.
vRNA
A C G U
CO nse rve d 
vRNA 
5' end
oligo-U
s t r e t c h
m t s s
A 44
A 46
Figure 1.1 5: 12% PAGE auoradiogram after DMS modification of naked segment 8 vRNA. The
reactive bases are marked on the left. The position of the conserved S' end on 
the sequence is indicated by a bracket, the position of the oligoU stretch by a 
hatched bar. Lane "C" is an incubatipn control of unmodified RNA. Lanes 1-3 
represent reactions of RNA with 0.1, 0.2 and 0.6 pi DMS respectiely. Lanes 
ACGU are vRNA dideoxy-sequencing reactions.
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This suggests tha t protein interactions are required to  result in the extent o f base- 
protection from modification as observed on complete RNPs. The absence o f a panhandle 
s truc tu re  on naked, genomic RNA has been observed before in psoralen crosslinking 
studies (Hsu e t al., 1987). The RNA modification results clearly show tha t NP binding to 
the vRNA exposes the bases to  the solvent. Downstream o f the presumed polymerase 
protected site on the vRNPs the vRNA is held in a single-stranded conform ation by NP. In 
addition, reconstitu tion  experiments w ith purified NP and a small RNA containing the 
conserved influenza virus vRNA ends dem onstrate tha t NP binding to  RNA can result in 
the melting out o f RNA secondary structures all along the RNA molecule (Baudin e t al., 
1994). NP can therefore be excluded as the protein tha t pro tects the vRNA ends from 
m odification. On the other hand, the comparison o f RNPs and polymerase free RNPs by 
modification analysis indicates tha t the polymerase holds the ends together. This clamping 
o f the vRNA ends could be visualized by Dr. Rob Ruigrok using negative stain electron 
microscopy (figure 1.16). The complete RNPs appear as relaxed, helical strands, tha t are 
wound back on themselves, o ften  showing a loop at one or both ends (compare w ith 
Jennings et al., 1983). A fte r removal o f the polymerase complex, the strands come apart 
at one o f the ends o f the RNP structure, indicated by arrow heads in figure 1.1 6. Otherwise 
the morphology is not changed by the DOC treatm ent. The alteration in the interaction at 
the ends becomes even clearer a fte r the incubation o f RNPs in high or low salt conditions. 
Surprisingly, in both cases the com plete RNPs unwind to  circular s truc tu res  (figure
1.16, middle and bo ttom  le ft) . Polymerase-free RNPs unwind to  elongated structures 
under low salt conditions, but form  very tig h tly  packed structures in high salt (figure
1.16, middle and bo ttom  righ t). Both observations illustra te  the loss o f a res tric tive  
contact between the vRNA ends caused by removal o f the polymerase from  the RNPs.
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Figure 1.16: Electron micrographs of negatively stained RNPs and RNPs-pol diluted and
incubated with phosphate buffered saline (PBS), 5 times diluted in 2 M NaCI (1.6 
M NaCI) or 5 times diluted in HgO (30 mM NaCI). The stars indicate 
contaminating rosettes of hemagglutinin. The arrows in RNP-pol in PBS (top 
right) indicate where the ends of the RNPs have come apart.
The images o f the conformational changes o f sa lt-treated RNPs correlate well w ith the ir 
behaviour in glycerol gradients. Figure 1.17A shows fractions from glycerol gradients of 
sa lt-treated RNPs. In 0.1 M salt, RNPs are found in the region o f about 40-50%  glycerol 
(top  le ft, fractions 5 and 6). Under high salt conditions a large portion o f the RNPs 
remain near the top  of the gradient and do not pass through 30% glycerol. The RNPs tha t 
stay at the top exclusively retain the polymerase proteins and only these to p  fractions 
show specific transcription activ ity  a fte r dialysis, a lbeit at reduced level (figure 1.1 78). 
Therefore, they possibly represent the circular forms of the complete RNPs. Sometimes, 
the same RNP preparation contained both complete and polymerase-free RNPs. The la tte r 
could be recovered from fractions at the bottom  of the gradient. They sedimented further 
into the gradient presumably due to  the compact, polymerase-free high-salt structures. 
This means tha t according to  virus preparations e ither a fraction o f the RNPs can lose
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the ir polymerase complex during RNP preparation, during incubation in high salt, or it 
m ight also be possible th a t sometimes polymerase-free RNPs are included in to virus 
particles. Murti e t al (1 9 88 ) reported tha t about 30% o f the RNPs in the ir preparations 
could not be labelled w ith anti-polymerase antibodies. We have also observed considerable 
varia tions in transcrip tion  a c tiv ity  depending more on virus batches than on RNP 
prepara tions (see chapter III). Using RNP preparations o f low level transcrip tion  
ac tiv ity  in RNA modification experiments we hardly observed complete pro tection  at the 
vRNA ends and the background in the modification reactions was higher. The above shown 
RNA m odification results were obtained w ith a virus preparation th a t showed almost 
maximal transcrip tion  ac tiv ity  in v itro  (400  pmol UTP incorporated per pmol RNP per 
hour). All these observations toge ther are consistent w ith the idea th a t the polymerase 
complex is responsible fo r holding the ends o f the vRNA together by interacting with both 
term ini on the viral RNPs. In the absence o f the polymerase the ends are single-stranded 
and free to  move and ro tate  a fte r incubation in d ifferent salt conditions.
1.4.2 Implications o f the RNP structure for transcription and replication 
The remarkable conservation o f the end sequences o f the genomic RNA and the ir partial 
inverted com plem entarity suggested a possible function o f a panhandle RNA secondary 
s tru c tu re  du ring  v irus  tra n s c r ip tio n  a n d /o r  re p lic a tio n , a lth o u g h  p a rtia lly  
complem entary sequences at both ends are also expected, when the polymerase needs 
sim ilar p rom ote r sequences fo r plus and minus strand synthesis during replication 
(Skehel and Hay, 1 978). The present results, suggesting the vRNA ends to  be apart in the 
absence o f the polymerase, seem to  exclude the requirement o f a preform ed panhandle 
s tru c tu re  fo r polymerase binding to  tem pla te  RNA and ra ther support a model o f 
sequential or independent binding to  single vRNA ends, as has been proposed by Cianci e t 
al. (1 9 9 5 ). Considering the extent o f base protection at the Watson-Crick positions tha t 
we observe on native RNPs, toge ther w ith the fac t tha t the vRNA ends on RNPs could be 
crosslinked by psoralen (Hsu e t al., 1987), it  is very likely th a t polymerase binding to  
the vRNA term ini induces the form ation o f a certain amount o f base-pairing. This agrees 
w ith in v itro  transcription studies using m utant tem plate RNA, which suggested tha t the 
form ation  o f a so-called term inal RNA fork  is a prerequisite fo r transcrip tion  in itia tion 
(Fodor e t al., 1 99 5 ). These authors propose th a t a few base pairs in the  region o f 
nucleotide 11 and downstream at the 5' end with the corresponding bases at the 3' end have 
to  occur fo r transcription to  be in itiated in the ir system. They find no evidence fo r base- 
pairing w ith  bases upstream o f nucleotide 11 until the vRNA 5' end. This is consistent 
with the idea tha t the extreme 3' end o f the vRNA has to  be available in order to  function as 
a single-stranded tem plate during transcription initiation.
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Figure 1.17: Distribution of RNPs in glycerol gradients and influence of salt conditions. (A)
shows two silver-stained 1 2% SDS-PAGE gels w ith fractions from three glycerol step gradients 
(1 ml 70% glycerol cushion, 500 pi steps of 60%, 50%, 40%, 30% glycerol in 0.1 M NaCI). 
RNPs were incubated 10 min at 37°C in different salt concentrations, as indicated, before being 
loaded onto the gradients, and centrifuged 2h at 240000 x g. Fractions of one time 1 ml, then 250 
pi, have been collected from the bottom. (B) depicts relative, ApG primed transcription activity 
o f fraction 5 (from  2 experiments) and fraction 12 (from  4 experiments) counting the 
incorporation of radioactively labelled UTP into TCA insoluble material. In 0.1 M salt activ ity is 
detected in fraction 5, but not in fraction 12. A fte r incubation in 1M salt, transcription activity 
can be recovered in fraction 12, but not in fraction 5. All fractions were dialysed against 0.1 M 
NaCI before the activity assay.
From the  behaviour o f the RNP pro te ins in RNA m od ifica tion  experim ents, 
in fluenza virus RNP appears to  be assembled from  tw o  an ta go n is tic  p ro te ins: 
nucleoprotein ac tiv ity  favours the melting o f RNA secondary structures and exposes the 
bases to  the environment, whereas the polymerase complex anneals the two vRNA ends and
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causes base p ro tec tion . This antagonism cons titu tes  an ideal arrangem ent fo r the 
regulation o f a switch between a closed and an open RNP form , because in this situation 
such a switch only requires the manipulation o f the fastening polymerase complex. An 
opening o f the RNP is presumably needed fo r the production o f full-length RNAs during 
replication, when the 5' end has to  be freely accessible. On the other hand, during 
transcrip tion , the  5' end o f the vRNA tem plate  is not available since the mRNAs are 
incomplete transcripts term inated at the downstream oligoU stretch.
In electron microscopic studies the structure o f complete RNP appears to  be under 
a certain tension to  be opened. Even under standard conditions, terminal loops o f d ifferent 
sizes are o ften  observed and the RNPs completely open up to  circular structures a fte r any 
changes o f the salt concentration. This feature, tha t the RNP is poised to  be unwound, 
resembles plasmid supercoiling in certain aspects and m ight be im portant fo r e ffic ien t 
transcrip tion. The coiling o f the influenza virus RNP has been found to  be o f opposite 
sense to  the coiling o f RNP from  other negative strand RNA viruses (Heggeness et al., 
1982). Moreover, the opening up o f influenza virus RNP in high salt has been used in the 
past as an argum ent th a t influenza virus RNPs d iffe r s ignificantly from  o ther negative 
strand RNPs, which form  very tig h t structures in high salt and extended structures in low 
salt conditions (Heggeness et al., 1 980). We find tha t in the absence o f the polymerase, 
the influenza virus RNP behaves identical to  the other RNPs in this respect. In the absence 
o f constra in t a t the ends, the influenza virus RNPs extend in low salt and tigh ten  up in 
high salt. To fu rthe r follow this aspect o f influenza virus RNP structure, tha t seems to  be 
brought in to  tension by directed supercoiling and end clamping, it will be in teresting to  
determ ine the d irection o f coiling on complete RNPs compared to  polymerase-free RNPs 
and the factors involved in this mechanism.
Previously, a double-stranded RNA panhandle structure  has been suggested to  be 
im portan t fo r transcrip tion  term ination (Li and Palese, 1994; Luo et al., 1991 ). Several 
lines o f evidence are in conflic t w ith this in terpreta tion. Our results suggest tha t, in the 
absence o f the polymerase, the vRNA ends are not base-paired in RNPs. Even naked, full- 
length vRNA does not form a panhandle structure in solution according to  RNA modification 
analysis (fig .4B ), which is in agreement w ith the studies by Hsu e t al. (1 9 8 7 ), who could 
not crosslink the  ends o f protein-free vRNA w ith psoralen. These observations make it 
d iffic u lt to  explain how the ends could stay base-paired w ith  each o the r once the 
polymerase has le ft a fte r transcription in itiation. Nevertheless, all the structura l studies 
on RNPs, all those on transcrip tiona l mechanisms and even those on transcrip tion  
term ination are consistent w ith a model, where the form ation o f a partially base-paired 
RNA-fork, annealed by the polymerase complex, is necessary fo r transcrip tion in itia tion 
only. This initial annealing of the ends by the polymerase prior to  in itiation would explain 
the dependence o f transcription activ ity on a short, complementary sequence near the end. 
Because the theoretical panhandle RNA secondary structure  appears to  be unstable in the
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absence o f the polymerase, transcription term ination at the oligoU stre tch  may rather be 
controlled by a regulatory protein binding to  the conserved 5' end o f the vRNA. This 
hypothetical, regulatory protein could participate in the switch between transcription and 
replication by determining the accessibility o f the 5' end fo r being copied. Because RNA 
modification analysis shows tha t the polymerase interacts with the 5' end on native, viral 
RNPs, the polymerase itse lf or one o f its subunits are prime candidates to  harbour this 
regula to ry function . In one possible model o f the influenza virus rep lication cycle, 
extended from  Cianci e t al. (1 9 9 5 ) and illus tra ted  in figure 1.18, the  polymerase 
sequentially interacts w ith the 5' end and the 3' end o f the viral RNA to  form  a functional 
transcription in itation complex. The polymerase then advances along the vRNA tem plate 
from  the 3 ' end, but a t the same tim e m ight stay bound to  the  5' end. Transcription 
term ination and polymerase s tu tte ring  a t the oligoU stre tch  would then be imposed by 
sterical reasons. Replication is performed by a d iffe ren t form  o f the polymerase, tha t is 
only present in infected cells and has d iffe ren t RNA binding patterns (Beaton and Krug, 
1986 ; Hay e t al., 1980 ; Shapiro and Krug, 1 98 8 ). This a lte rna tive  form  o f the 
polymerase has no endonuclease activ ity , s ta rts  RNA synthesis w ithou t a primer RNA, 
releases the tem plate 5' end and produces full-length replicates, which are concom itantly 
packaged by NP into RNP structures (figure 1.1 8).
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Figure 1.18: Possible models o f influenza virus transcription and replication combining the 
present results on panhandle s tab ility  w ith previous results from  other laboratories as 
mentioned in the text. On complete RNPs the vRNA ends are engaged in a ternary complex with 
the polymerase (a and e). Transcription is initiated with a capped primer RNA (b) and elongation 
o f the primer occurs in the presence of NTPs from the 3 ' end of the vRNA. During elongation the 
polymerase might stay bound to the 5' end (c). The vRNA loop on the RNP decreases during this 
process and transcription term ination is imposed by sterical reasons in combination with a 
"slippery" oligoU stretch (d). A different form of the polymerase performs replication (e), which 
initiates w ithout a primer at the 3' end of the vRNA and involves an "open" RNA with accessible 
5' end (f). Replication is dependent on soluble NP, which binds to the newly synthesized RNA (g). 
RNA synthesis terminates at the last base of the vRNA 5' end, and complete, cRNA containing 
RNPs are produced during the process (h).
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A t present, the available evidence suggests tha t polymerase binding to  the vRNA 5' 
end is required for transcription initiation from the 3' end, but both ends do not in teract 
in the absence o f the polymerase. Similar genome binding patterns have been described for 
o ther multi-subunit, RNA-dependent RNA polymerases. The polymerase o f Brome Mosaic 
V irus, a segm ented positive  strand RNA virus, requires an in te rac tion  w ith  an 
intercistronic region on the genome for initiation o f RNA synthesis from the S' end (Quadt 
e t al., 1 9 95 ). The replicase o f QP phage binds to  an internal site o f the genomic (+)RNA 
and remains attached there, while in itia ting  (-) strand synthesis from  the 3' end. 
Moreover, the  binding pattern to  (+ ) and (-) strand RNAs is d iffe ren t, consistent w ith 
d iffe ren t functions o f the strands in the replication cycle (Barrera e t al., 1993; Schuppli 
e t al., 1994 ). Poliovirus RNA replication involves polymerase complex form ation  w ith  
both ends o f the viral RNA, although in this case the complex formed at the S' end o f (+) 
RNA has been proposed to  catalyze in trans initiation o f synthesis from the 3' end o f a (-) 
RNA (Andino e t al., 1993; Harris e t al., 1994). Finally, the  (+ ) RNA o f Saccharomyces 
cerevisiae L-A virus also contains an internal binding site, tha t binds stronger to  the L-A 
polymerase, than the RNA 3' end, and which is required fo r in v itro  replication (Esteban 
e t al., 1989 ; Fujimura and W ickner, 1 992 ). This so-called "action  at a distance" 
phenomenon is common in polymerase-enhancer system s to  regulate transcrip tion  
processes and to  correctly position the polymerase subunit to  the transcription in itiation 
site. The polymerase-promoter interaction itse lf has to  be relatively weak to  enable easy 
prom oter clearance a fte r transcription initiation. The strong influenza virus polymerase 
binding site a t the S' end o f the viral RNA assures high specific ity  recognition o f viral 
RNAs and at the same tim e brings the polymerase into the v ic in ity o f the low a ffin ity  3' 
end binding site to  s ta rt transcription.
The studies on NP interaction w ith  the genomic RNA outline another problem of 
RNA virus replication, namely the need to  release the RNA replicates from  the tem plates 
in order to  make them available fo r several rounds o f RNA synthesis. Many positive strand 
viruses presumably encode RNA helicases to  surm ount th is  problem (Gorbalenya and 
Koonin, 1993; Lain e t al., 1990; Warrener and Collett, 1995), but influenza virus, and 
m ost likely o the r negative strand viruses as well, make use o f cooperative single­
stranded RNA binding proteins, analogous to  the single stranded DNA binding proteins tha t 
are cofactors o f DNA directed RNA polymerases and DNA polymerases. It has been found 
tha t NP binding to  RNA removes secondary structures and keeps the RNA single stranded. 
Influenza virus replication is dependent on soluble NP produced in infected cells, which 
packages the newly synthesized RNAs during the ir synthesis. Cooperative NP binding will 
prevent base-pairing between tem plate  and replicate to  occur and keep the tem plate  
available fo r fu rthe r rounds o f replication. A very sim ilar a c tiv ity  has recently  been 
described during poliovirus replication. The 3D protein o f poliovirus displays cooperative 
single-stranded RNA binding a c tiv ity  during replication (Pata e t al., 1995 ) and it is
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thereby able to  unwind RNA duplexes o f over 1000 base pairs length w ithout the need to  
hydrolyze ATP (Cho et al., 1 993). On the other hand, the viral mRNAs are not dependent 
on NR to  e ffic ien tly  separate from the ir complementary tem plate strands. The influenza 
virus polymerase uses host cell derived, capped RNA primers fo r transcrip tion initiation, 
which m ost likely results in the assembly o f cellular cap-binding and hnRNA-binding 
complexes on the viral mRNA and thereby prevents base-pairing w ith the tem plate RNA 
(Izaurralde e t al., 1995; Matunis e t al., 1993; Pihol-Roma and Dreyfuss, 1992). These 
examples illu s tra te  th a t d iffe re n t viruses encounte r sim ilar problems during the 
replication cycle and tha t apparently there exist only a lim ited number o f concepts to  
solve them. The negative strand viruses transcribe mRNAs from their genomic RNAs a fte r 
cell entry, whereas the genomes o f the positive strand viruses are already in mRNA sense 
and can be d irec tly  translated in in fected cells. This is the  m ajor reason fo r the 
differences in the genome structure  optim ized e ither fo r virus specific transcrip tion  or 
fo r translation. The influenza virus RNPs, as packaged into virus particles, are ready to  
s ta rt transcrip tion  having the polymerase bound to  both vRNA ends and the  bases 
presented fo r transcription by the nucleoprotein.
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Chapter II
Expression o f recombinant PA protein
II. 1. Introduction
One o f the major goals o f research on influenza virus replication is to  unravel the 
s tructure  and function o f the polymerase complex, which harbours all presently known 
enzymatic functions required for specific RNA synthesis. In order to  be tte r understand the 
structura l basis o f these activities, to  focus on the biochem istry o f certain activ ities in 
v itro  and to  exploit them  fo r the developm ent o f potentia l antiv ira l compounds it is 
necessary to  synthesize and purify  the polymerase in reasonable quan tities  from  
recombinant sources. Because the polymerase consists o f three subunits, encoded by three 
d iffe ren t viral genes, the problem o f expression and purification o f the polymerase can 
either be approached w ith systems tha t express all subunits toge ther at the same time, or 
w ith  system s th a t express single subunits and make it possible to  recons titu te  the 
polymerase complex from  the purified precursors afterwards. Recombinant proteins will 
be needed to  map polymerase activ ities to  certain subunits and protein domains and the 
structures o f these domains will help to  understand how they function.
Il.l .1. Polymerase Subunit Functions
Many laboratories are presently working at mapping known polymerase activ ities  to  
subunits, try ing  to  establish subunit domains and subunit in teraction  surfaces. These 
problems are generally approached using the only system th a t has convincingly produced 
functional, recombinant polymerase, namely expression o f subunits in mammalian cells. 
Permanent cell lines derived from  murine NIH 3T3 and C l 27 cells, th a t express the 
polymerase subunits, can com plem ent tem pera ture  sensitive virus stra ins (B ra a m - 
Markson e t al., 1985; Krystal e t al., 1986) and are active in influenza virus specific 
transcrip tion  and replication, if  the nucleoprotein and a virus-like tem p la te  RNA are 
expressed as well (Kimura e t al., 1993; Kimura e t al., 1992 ). Sim ilarly, polymerase 
subunits expressed from  recom binant vaccinia or SV40 viruses assemble to  active 
polymerase complexes in a variety o f cell types (Huang e t al., 1 990 ; de la Luna et al.,
1993). These systems have provided the major part o f the inform ation concerning the 
functions o f the polymerase subunits. PBl is most likely the subunit responsible for the 
actual addition o f nucleotides to  the growing RNA chains during RNA synthesis. The PBl 
pro te in  contains conserved sequence m otifs  o f RNA virus polymerases (Poch e t al., 
1990), th a t have been shown by m utational analysis in the recom binant vaccinia virus 
system  to  be essential fo r influenza virus polymerase a c tiv ity  (Biswas and Nayak,
1 99 4 ). Additionally, the  firs t nucleotide incorporated in to  transcrip ts  could be UV- 
crosslinked to  PB l, and during elongation PBl remained at the 3' ends o f the growing
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mRNAs (Braam e t al., 1983). The PB2 subunit can bind to  RNA cap s tructures, and
specific anti-PB2 antibodies abolish the endonuclease activ ity  required to  produce primer 
RNAs for viral transcription (Blaas e t al., 1982; Blok e t al., 1996; Licheng e t al., 1995, 
Ulmanen e t al., 1981; Ulmanen et al., 1983). L ittle  is known about the function o f PA in 
the virus life cycle. PA has proven indispensable fo r transcription and replication in in 
vivo reconstitu ted systems based on recombinant vaccinia or SV40 viruses (de la Luna et 
al., 1993; Hagen e t al., 1994; Huang e t al., 1990). Also, it advances along the viral 
tem plate  RNA and can be crosslinked to  the 3' end o f the growing mRNA chain during 
transcrip tion  tog e the r w ith  the o the r polymerase subunits, dem onstra ting  th a t it 
cons titu tes  an integral part o f the viral polymerase complex (Braam e t al., 1983). 
Recent studies, perform ed w ith  perm anent murine cell lines expressing d iffe re n t 
combinations o f influenza virus polymerase subunits, suggest th a t PBl alone is suffic ient 
fo r a basic level o f positive strand RNA synthesis and polyadenylation, but PA strongly 
increases cRNA production and is absolutely essential fo r vRNA synthesis in this system. 
PB2 seems to  be required only to  provide a cap-structu re  fo r the  mRNAs during 
transcription (Nakagawa et al., 1995; Nakagawa et al., 1996).
PA m ight also have an additional function outside the polymerase complex. The
nuclear im port o f PA is delayed with respect to  the other subunits and in some systems PA 
remains partia lly cytoplasm ic (Akkina e t al., 1987; Jones e t al., 1986; N ieto e t al., 
1992 ). A tem pera ture  sensitive PA m utan t showed deregulated transla tion  o f viral 
prote ins (Herget and Scholtissek, 1993). Finally, PA expression appears to  be toxic, 
leads to  aberrant nuclear morphology and induces a generalized proteolysis, th a t reduces 
the s teady-sta te  levels o f coexpressed proteins (Sanz-Ezquerro e t al., 1 99 5 ). A t the 
mom ent it is no t ye t clear how all these observations can be f it te d  in to  an additional 
func tion  o f isolated PA during influenza virus replication. W ith purified PA prote in 
available it  would be possible to  tes t some o f the functional hypotheses tha t have come up 
from  the above mentioned experiments. The identification o f an independent PA activ ity  
would stand fo r a novel, influenza virus specific function and eventually a novel antiviral 
target.
The amounts o f recombinant polymerase protein produced in mammalian cells are 
far too  small to  a ttem p t purification fo r structura l studies. This chapter summarizes the 
results from  evaluating a number o f a lternative  expression system s fo r higher level 
expression and purification of functional influenza virus PA protein.
Il.l .2. The PA protein
RNA segm ent 3 o f influenza viruses encodes the PA protein in influenza virus A and B 
subtypes and the equivalent P3 protein in influenza C viruses. It is presumed tha t PA/P3 
pro te ins form  complexes w ith  the  o the r tw o  polymerase subunits, PBl and PB2, 
resulting in active polymerase proteins. However, functional studies have m ostly been
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done with influenza A viruses. The amino acid sequences o f PA/P3 proteins show sequence 
identities between 28% and 38% among the virus A,B and C subtypes and between 91% 
and 99% among influenza A virus strains. The extent o f conserved amino acid sequences 
suggest a common ancestor and similar functions fo r these proteins in the virus subtypes 
(Akoto-Am anfu e t al., 1 987; Okazaki e t al., 1 989; Yamashita e t al., 1 989). The PA genes 
o f influenza A viruses code fo r a polypeptide o f 716 amino acids w ith a predicted 
molecular weight o f 82 kD. The sequence alignment o f PA proteins from d iffe rent origins 
suggests a division o f the protein in to at least tw o domains. The N-terminal domain is 
characterized by the accumulation o f m utations, th a t are specific fo r virus lineages 
(human, swine, avian or equine viruses). The N-term inal part has the re fo re  been 
implicated in the determination o f the host range o f viruses and possible interactions with 
cellular factors. The C-terminus is s ign ificantly more highly conserved among the PA 
proteins and is presumed to  contain critical structures fo r the enzym atic a c tiv ity  o f the 
p ro te in  (Okazaki e t al., 1989). The amino acid sequence o f PA shows no strik ing 
similarities to  other known sequence motifs. There are, however, sequence elements, tha t 
resemble the  NTP-binding m otifs  orig inally described by Walker e t al. (figu re  I l . l )  
(Walker e t al., 1 982; Yoshida and Amano, 1 995).
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Figure Il. l PA sequence elements, tha t resemble the Walker NTP-binding motif. Boxed residues are conserved in A, B and C viruses. The residues marked with 
dots are functionally conserved and have been exchanged only with amino 
acids o f similar hydrophobicity, po larity or charge. "!" stands for 
hydrophobic residues, X for any amino acid.
All the  elements o f the possible Walker-like m o tif are located in a highly conserved 
region, where no m utations have been introduced during PA evolution in influenza A 
viruses. This C-terminal region also shows very high conservation among virus subtypes.
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The tw o glycins o f the Walker NTP phosphate binding loop are conserved in PA/P3 
proteins from  all three influenza virus subtypes, bu t an arginine in m o tif A is only 
retained in influenza A and B viruses. The im portant param eters characterizing the 
additional elements o f the NTP binding m otif are not as unique as fo r m o tif A, but similar 
elements are found at similar distances in the PA sequence.
PA from influenza A /P R /8 /34  virus has a negative net charge o f -13.5 a t pH 6.5 
and an estimated pi o f 5. The amino acid composition shows a very high percentage of 
g lutam ic acid (E = 10.75% ) and methionine (M = 3.49% ), which both are considerably 
above the average values o f 6.16%  and 2.27%  respectively (Sharp and Cowe, 1991). 
Secondary structure  analysis has been performed w ith various programs and predicts a 
high percentage o f a-helix and only few p-sheet structures in the protein. Figure 11.2 is a 
graphic representation o f the consensus secondary s tructure  as predicted from  several 
algorithms (Chou and Fasman, 1978; Gamier e t al., 1978; Geourjohn and Deléage, 1994; 
Rost and Sander, 1994). The longest a-helical stre tches are predicted at the very N- 
term inus (positions 5 -45) and near the C-terminus between amino acids 570 and 610. 
There is also a large region from residues 140 to  200, which is predicted to  be mostly a- 
helical. These theoretica l a-helices are also conserved in the  same location in PA/P3 
proteins from  influenza B and C viruses. These PA protein characteristics have to  be 
considered in the choice o f purification conditions and the search fo r protein folding units 
by gene fragm entation.
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Secondary structure prediction for PA/P3 proteins from influenza A, B and C 
igure . . The PA/P3 proteins of the virus strains noted on the le ft of the picture
have been analyzed with several structure prediction programs. The consensus 
elements have been drawn as rectangulars of d ifferent sizes according to  the 
extension of the structures. The bottom line shows the structure elements, that 
are present in proteins of the three influenza virus subtypes.
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11.2. Expression systems used for the production of recombinant PA
Table Il.l gives an overview o f the expression systems, tha t have been used in this study. 
Although the purification o f full-length PA protein was not ye t achieved with any o f these 
systems, the experiments provided a number o f valuable results concerning possible PA 
activities in isolated form and suggested possible strategies fo r the future improvement of 
PA expression.
Cell Type organism purification tag /  expression vector promoter
orocarvotic E. coli
N-terminal poly-Flis-tag 
pRSET vector (Invitroqen)
T7
N-terminal Maltose binding protein (MBP) 
pMAL-c2 (NEB)
tac
N-terminal biotinylated peptide 
Pinpoint™ sytem (PROMEGA)
tac
N-terminal biotinylated peptide and 
C-terminal poly-Flis-taq
tac
eucaryotic
SF9, HighS 
insect cells
no tag 
recombinant baculovirus
polvhedrin
Pichia pastoris
no tag
recombinant yeast clones
A0X7
Wheat germ 
extract
no tag 
pGEM 7Zf+ (PROMEGA)
T7
Table I l . l  : Compilation of the protein expression systems used to  express influenza A virus
PA protein
11.2.1 E.co//based expression systems
The most widely used expression systems are those using E.coli as the host cell. The major 
reason fo r th is is th a t in many cases large amounts o f recom binant prote ins can be 
produced in a re latively short tim e due to  the rapid doubling tim e o f the bacterium 
combined w ith  the possibility o f using high copy number plasmids fo r expression. The 
biology o f E.coli is well studied and the  bacterium can be re la tively easily grown and 
genetically manipulated. A varie ty  o f expression systems d iffe ring  in p rom oter type, 
inducib ility and protein fusion stra teg ies are commercially available, but the ir value for 
the synthesis o f recombinant proteins is o ften largely dependent on specific properties of 
the protein in question and cannot easily be predicted. Several expression systems have 
been employed in this study in order to  find the optimal combination o f parameters for the 
p roduction  o f PA prote in  in E.coli. The m ajor problems encountered were prote in
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insolubility in the pRSET and Pinpoint™ systems and extensive fragm entation o f the full- 
length PA protein in all bacterial systems. A series o f N-terminal and C-terminal deletion 
mutants o f PA was screened for the identification o f functional domains according to  the 
presumed NTP-binding site at the C-terminus and the nuclear localization sequences at 
the N-terminus o f the protein. Figure 11.3 schematically shows the PA fragm ents, tha t 
have been looked at in detail in this study.
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Figure 11.3: Schematical overview of the PA deletion mutants, tha t have been used in this 
study. The striped boxes on the full-length PA w ild-type protein sequence 
indicate the regions I and II implied in nuclear transport o f PA .(Nieto et al., 
1992). The shaded box shows the relative position of the sequence m otif 
reminiscient of a NTP binding m otif (see figure 11.1).
11.2.1.1 Expression o f PA from the pRSETa vector
The pRSET vectors promote expression o f the recombinant proteins under the control of 
the T7 promoter and they add a polyhistidine tag to  the N-terminus o f the protein, tha t can 
be removed by tre a tm e n t w ith  enterokinase. Recombinant E .co li host stra ins are 
available, th a t express the T7 polymerase from  an IPTG inducible lacUVS prom oter. The 
polyhistid ine  tag provides a possib ility  fo r a ffin ity  purifica tion  o f the  recom binant 
protein on Ni-chelate resins. The complete coding sequence o f PA and several deletion 
m utants o f PA have been amplified by PCR and cloned into the pRSET vecto r by Dr. Martin 
Ford. The pRSET derived constructs, in contrast to  the rest o f the PA encoding plasmids,
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encode additional 22-28  amino acid extensions at the C-termini o f the PA fragm ents. 
Full-length PA and three PA fragm ents were expressed in E.coli BL21(DE3) cells. The 
E.coli B strains are optim ized fo r protein expression, as they lack the Ion and omp T 
proteases, thereby reducing prote in  degradation during cell harvesting and lysis. 
Induction o f PA expression was performed in 500 ml shaker flask cultures a t 30° C or 
37° C w ith 100 -500  pU  IPTG fo r 2-5 hours. The cells were harvested and lysed by 
sonication in a buffer containing EDTA and TritonX-100. The expression o f protein was 
analyzed by denaturing gel electrophoresis and Western b lo t w ith specific monoclonal 
antibodies. Under these conditions the m ajority  o f PA protein was found insoluble in 
inclusion bodies, tha t could be washed w ith up to  8 M urea w ithou t s ign ificant loss o f 
recombinant protein. Apart from the respective PA fragments, a large number o f smaller 
bands were also recognized by PA specific antibodies in whole cell extracts and inclusion 
bodies. This suggested tha t the PA proteins were either already considerably degraded in 
the cells or were subject to  a defic ien t processivity during translation. Whereas full- 
length PA remained largely insoluble even in 6 M guanidinium hydrochloride (Gua-FICI), 
the PA fragm ents PA.N, PA.L and PA.E (figure 11.3) could be solubilized and purified to  
hom ogeneity by Ni-chelate chrom atography w ith  a 3 0 -10 0  mM im idazole gradient. 
Figure II.4A shows E.coli whole cell extracts before (lanes 2 and 5) and a fte r (lanes 3, 4 
and 6, 7) induction o f PA.L and PA.N, as well as an example o f the insoluble fraction (lane 
1 ). Induced bands o f the expected sizes are readily visible on this Coomassie stained SDS- 
PAGE gel and indicated w ith arrowheads and circles. The purified PA fragm ents remained 
soluble a fte r dialysis in renaturation buffer and could be concentrated in Centricon tubes 
to  2 m g/m l. They were stored in 50% glycerol at -20° C and remained stable fo r at least 
one year as judged by SDS-PAGE analysis. About 10-fold higher amounts o f recombinant 
prote in were obtained w ith  the 36 kD PA-E fragm ent from  the C-term inus o f the PA 
coding sequence. It was purified, dialyzed in renaturing buffe r and stored in the same 
manner as the above mentioned proteins. Figure II.4B shows the soluble PA-E and PA.L 
fragm ents obtained a fte r dialysis in renaturation buffer on a 1 2 % coomassie stained 
SDS-PAGE gel, figure II.4C is a W estern b lo t o f the same samples. Full-length PA, 
purified by a ffin ity  chrom atography partia lly  aggregated during dialysis and partia lly 
degraded to  a 36kD band, so tha t the actual full-length band virtually disappeared during 
dialysis (figure II.4C, arrowhead).
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Figure 11.4: Expression of PA fragments (see figure 11.3). (A): Coomassie-stained, 12% 
SDS-PAGE gel showing whole cell extracts from E.coli BL21 (DE3) cells 
transfected with pRSETa-PA.L and pRSETa-PA.N respectively. Protein bands 
induced after IPTG addition are marked with arrowheads. Lanes 1, insoluble 
fraction of PA.L expressing cells; 2, PA.L expressing cells before induction; 3 
and 4, PA.L expressing cells 2 h and 4 h after induction; 5, PA.N expressing 
cells before induction; 6 and 7, PA.N expressing cells 2 h and 4 h after 
induction; 8, insoluble fraction from PA.L expression after washing the pellet 
with 2 M urea; M, BIORAD low range, prestained standards.
(B): Coomassie-stained 12% SDS-PAGE o f soluble PA fragm ents a fte r 
solubilization in 6M Gua-HCI, nickel a ffin ity  chromatography in 8 M urea, 
dialysis in refolding buffer and concentration in Centricon tubes.
(C): Western blot analysis of the samples shown in (B). The blot was developed 
with the monoclonal anti-PA antibody L35E12, specific for an epitope near the 
C-terminus of PA. A small amount of full-length PA protein was detected after 
dialysis of PA-wt (arrowhead), but most of the immunoreactive material was in 
large, soluble aggregates or gave rise to a 36 kD breakdown product.
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The purified proteins were analyzed fo r ATPase and RNA binding a c tiv ity .’ To this 
end, the proteins were titra ted  into an ATPase reaction with radioactive y-^^p-ATP in the 
presence or absence o f in v itro  transcribed segment 8 vRNA. ATP, ADP and phosphate 
were then separated by thin-layer chromatogaphy. RNA binding a c tiv ity  was analyzed in 
f ilte r  binding experim ents w ith  radioactively labelled segm ent 5 cRNA or segm ent 8 
vRNA. In both cases no ac tiv ity  was observed w ith any o f the PA proteins. The proteins 
were also analyzed by circular dichroism spectroscopy (CD) a fte r a buffe r change from 
the renaturation buffer to  a phosphate/DTT buffer, pH 7.6. The CD spectra obtained were 
typical o f random coil polypeptides, strongly suggesting tha t the PA proteins did not refold 
in to  functional structures albeit resting perfectly  soluble in renaturation buffe r (figure 
11.5).
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F igure  11.5: CD spectroscopy of purified, soluble PA polypeptides compared with purified influenza 
virus Ml protein, which is predominantly a-helical (provided by Dr. Christine Elster). 
All proteins were at 0.1 mg/m l. The middle inset shows a magnification of the CD 
spectra for PA.L and Pa-wt. The apparent minima at 210 and 220 nm may indicate that 
in the PA-wt sample a small fraction of the protein has adapted a folded conformation. 
The right inset shows the absorption spectrum of PA.L, which was identical for the 
other PA fragment and demonstrates the purity and the absence of nucleic acids in the 
samples.
We did not succeed in refolding any o f the PA fragments either by dialyis in d iffe ren t steps 
or by gel filtra tion . However, additives like polyethylenglycol, which may help refolding, 
were not extensively tested. Considering tha t even the relatively small PA-E fragm ent did 
not form  stable secondary structures in the renaturation solution, it may be possible tha t
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long-range interactions are im portant in the form ation o f the PA te rtia ry  structure . On 
the other hand, there seemed to  be a minute fraction o f folded polypeptide in the PA-wt 
preparation. PA-wt was the only protein preparation tha t gave rise to  m ultip le bands 
a fte r dialysis and protein concentration. The spontaneous form ation o f a 35 kD breakdown 
p roduc t m igh t possibly ind icate  a fragile  spacer region in the  p ro te in  and the 
determ ination o f the sequence o f this fragm ent could help to  identify a stable C-terminal 
domain.
11.2.1.2 Pinpoint™ system: expression o f PA with a biotinylated peptide tag 
The switch from the pRSET to  the pinpoint system involves changes in the prom oter (T7 
to  tac) and the host cell strain (BL21 to  JM109) fo r protein expression, as well as in the 
N-terminal sequences o f the fusion protein, tha t m ight influence translational in itiation 
effic iency. The Pinpoint™ vectors carry a segment encoding a 13kD peptide, which is 
b io tiny la ted  by the b io tin  ligase o f E.coli a t a single lysine residue. Fusion proteins 
contain ing th is peptide can be a ffin ity  purified on avidin resins. Full-length PA, full- 
length PA w ith  a C-term inal poly-Flis ta il and a N-term inal fragm en t o f PA were 
produced by PCR and cloned in to  the pinpoint pXA3 vec to r downstream  o f the tac  
prom oter, the biotin-peptide coding sequence and a cleavage site fo r the endoproteinase 
fac to r X. The tac  p rom oter is controlled by binding o f the lac repressor prote in and 
provides inducib ility  o f gene expression by the addition o f isopropyl-th io-ga lactoside 
(IPTG). Protein expression from  the plasmid pXA3-PA a fte r induction w ith 100 pM IPTG 
at 30°C or 37°C produced only small amounts o f mainly insoluble PA protein. During PA 
expression, an extra band corresponding to  fu ll-length PA, although d ifficu lt to  see in 
whole cell extracts, became visible as soon as 2 hours a fte r induction. This band did 
slightly increase w ith time. Western blot analysis w ith the monoclonal antibody L35E12, 
specific fo r a C-terminal epitope of PA, showed tha t, as before in the pRSET system, a 
large number o f smaller, immunoreactive bands were produced toge the r w ith the 97 kD 
fu ll-length PA band. An 80 kD PA fragm ent constitu ted  one o f the major bands (figure 
II.6A, w hite arrow). The expression of the 40 kD PA N-terminal fragm ent from  plasmid 
pXA3-PA-NT (see figure 11.3) was slightly more e ffic ien t and could already be visualized 
by d irect detection w ith streptavidin-horseradish peroxidase conjugate a fte r b lo tting  onto 
n itrocellu lose, an assay in which the  fu ll-length  PA was hardly de tec tab le  (II.6B). 
Because most o f the recombinant PA protein was insoluble, only very low amounts o f PA 
specific bands could be purified from the soluble fraction on Soft-Link Streptavidin resin. 
The a lternative expression plasmid pXA3-His-PA contains a C-terminal polyhistid ine tag 
in addition to  the N-terminal biotinylated peptide. The plan was to  separate full-length PA 
specifically from  the smaller PA fragm ents in tw o  successive a ffin ity  purification steps. 
Flowever, the amount o f soluble PA protein obtained after the streptavid in column was not 
suffic ient as starting material for a following Ni-chelate chromatography.
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Figure 11.6: Western blot analysis o f PA expression In the pinpoint system. (A): Western
blot o f a time course of PA expression in JM109 cells, developed with L35E12 
C-terminal anti-PA antibody. Lanes 1, whole cell extract o f PA-NT 3 hours 
after induction (negative control, showing the specificity of the antibody); 2, 
whole cell extract o f PA-wt before induction; 3 -5 , PA-wt cell extracts 1, 3 
and 5 hours after induction. The positions of molecular weight markers are 
shown on the left. The black arrowhead indicates the band that corresponds in 
size to  the expected 97 kD full-length biotinylated PA fusion protein, the white 
arrowhead a major 80 kD PA fragment (see text).
(B): Western blot directly developed w ith peroxidase-coupled streptavidin. 
Lanes 1, control cell extract 3 h after induction; 2, control cells before 
induction; 3, PA-NT expressing cells 3 h after induction; 4, PA-NT cells before 
induction; 5, PA-wt expressing cells 5 h after induction; 6, PA-wt cells 3 h 
a fter induction. The arrowheads on the right indicate the positions of 
crossreactive bands.
Low level protein expression as well as protein fragm entation in E.coli m ight result 
from  lim iting  amounts o f so-called rare tRNAs, because prote ins th a t are highly 
expressed in E.co//show a codon bias towards 22 of the 61 coding trip lets. The sequences 
o f eucaryotic genes are known to  sometimes deviate considerably from  this preferred 
codon usage in bacteria. In particular the arginine encoding trip le ts  AGA and AGG are 
common in eucaryotic genes, but they are the least used codons in E.coli (M attes, 1 993 ). 
It has also been reported tha t the limiting levels o f the tRNAarg4, tha t translates the AGA 
codons, can cause +1 ribosomal frameshifts at tandem AGA and AGG codons .(Spanjaard et 
al., 1 9 9 0 ). The argU gene, encoding the tRNAarg4, has been cloned into an helper plasmid 
and successfully used fo r improving the expression o f various human and plant genes in 
E.coli (Schenk et al., 1 995). Because 32 out o f 40 arginines in the PA protein are encoded
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by these rare codons and tandem rare arginine codons occur tw ice in the PA sequence, the 
e ffe c t o f a coexpression o f the the tRNAarg4 was analyzed in the pinpoint system . The 
pACYCI 77 based tRNA expression vector pUBS520 was obtained from Dr. Ralf Mattes and 
the tRNA coexpressed in JM109 cells toge ther w ith w ild-type PA. Figure 11.7 illustrates 
the e ffec t o f this coexpression with 1 00 pM IPTG induction a t 30°C for 3 hours. A strong 
band is induced in the cells coexpressing pUBS520 (lane 5, black arrow), but not w ith 
pXA3-PA alone (lane 2). The corresponding Western b lo t (figure II.7B) shows tha t the 
coexpression o f the rare arginine codon tRNA significantly increases the amount o f PA 
specific protein bands (compare lanes 1-3 w ith lanes 4 -6 ). The strongly induced band in 
figure 11.7, lane 5 migrates at about 80 kD in the SDS gel and m ight therefore constitu te  
the major PA fragm ent, tha t was mentioned above. This 80 kD polypeptide com pletely 
remains in the insoluble fraction (lane 6) and is absent in the fraction  loaded onto the 
strep tavid in  column (lane 7) so, consequently, no prote in is e luted from  the  column 
(lanes 8-11 ). A major 80 kD band was also seen on the Western b lo t developed w ith the 
L35E12 monoclonal antibody (figu re  II.7B, black arrowhead) tog e the r w ith  the full- 
length PA band (sprinkled arrowhead). This 80 kD polypeptide m ight e ither constitu te  a 
re latively stable interm ediate o f proteolysis or be derived from  translation term ination 
a t a signal o ther than a fra mes hi f t  induced by consecutive, rare arginine codons in the PA 
sequence. These results demonstrate tha t the coexpression o f the tRNA expressing plasmid 
pUBS520 can significantly increase the to ta l yield o f recom binant PA protein in E.coli. 
A no the r s trik ing  d iffe rence between PA expression in the  absence (lanes 1-3) or 
presence (lanes 4 -6 ) o f overexpressed "rare" tRNA was the production o f a strong 32 kD 
band only when tRNA was lim iting (figure II.7A, w h ite  arrow). A band o f th is  size is 
expected to  be produced from a theoretical +1 fram eshift a t the tandem rare argine codon 
m o tif a t position 369 in the PA gene sequence. Taken together, the large number o f rare 
arginine codons does indeed appear to  s ign ifican tly  lower PA yield in th is  bacterial 
system, but overexpression o f the corresponding tRNA was not su ffic ien t to  prevent PA 
fragm entation. In addition, the presence of the tRNAarg4 did not influence the solubility o f 
the PA protein in this system. Further evidence fo r a role o f rare codons in reducing PA 
yield were obtained from the maltose binding protein system  (see 11.2.1.3 and discussion 
11.3).
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Figure 11.7: Effect of the coexpression of PA and a rare arginine codon tRNA in JM109
cells. Samples without, lanes 1-3, or with, lanes 4-12, tRNA coexpression.
( A) ,  Coomassie-stained 12 % SDS-PAGE; the black arrowhead indicates an 
overexpressed 80 kD polypeptide in lane 5, the white arrowhead a 32 kD band 
only present in lanes 1-3; (B), Western blot with L35E12 C-terminal anti-PA 
antibody. The sprinkled arrowhead indicates full-length PA, the black 
arrowhead a 80 kD PA fragment.
Lanes 1 and 4, cell extract before induction; 2 and 5, cell extract after 
induction; 3 and 6, insoluble fraction; 7, soluble fraction; 8, flow-through of 
streptavidin column; 9-12, elution from streptavidin column; M, BIORAD low 
range, prestained standards.
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11.2.1.3 The Maltose-binding-protein system (MBP)
In the MBP system the relatively large maltose binding protein (43 kD) is fused to  the N- 
term inus o f the recombinant protein sequence and the fusion protein is expressed from 
the IPTG-inducible tac  prom oter (see 11.2.1.2). The use o f an E.coli derived protein at the 
N-terminus o f a fusion protein ensures optim ally adapted transcrip tion and translation 
in itia tion in the bacterial host cells. The MBP is well expressed, highly soluble in E.coli 
and can increase the expression and the solubility o f attached polypeptides. In addition, the 
specific binding o f MBP to  maltose resins can be exploited for a ffin ity  purification o f the 
fusion proteins. There is a polyasparagine spacer and a fac to r X recognition sequence 
between the MBP and the recombinant protein in order to  insulate the MBP domain and to  
allow the specific disconnection o f MBP respectively. The pMAL-PAM2 plasmid contains 
the complete coding sequence o f PA downstream o f the fac to r X cleavage site, pMAL- 
PAB2.7 encodes six additional amino acids between the cleavage site and the PA start codon 
(ISEFGS). Both plasmids were provided by Dr. Martin Ford.
The use o f the maltose binding protein (MBP) fused to  the N-terminus o f PA led to  a 
significant increase in the solubility o f the PA protein, ye t significant fragm entation was 
again reproduced. Figure II.8A shows a typical purification profile on an amylose resin. 
A lthough an additional band o f the expected size is visible in whole cell extracts a fte r 
induction and is not present in the flow-through fraction, this band is not concentrated on 
the amylose column and most o f the eluted proteins are o f smaller size. The m ajority o f 
these eluted bands appear to  crossreact w ith monoclonal antibodies raised against an N- 
term inal fragm ent o f PA (figure II.9B, right panel). Flowever, only a small number o f the 
bands contain the epitope for the monoclonal antibody L35E12, tha t was raised against a 
C-term inal fragm ent o f PA (II.8B). This remarkable d ifference m ight be caused by a 
protection from  proteolysis o f the PA N-terminus by the MBP moiety. On the other hand, 
ine ffic ien t translation w ith many stops, once the coding sequence o f the MBP has been 
passed by the ribosomes, would also result in this biased pattern  o f fragm entation. A 
number o f d iffe ren t cell lines were compared fo r PA expression, but all produced the 
same pattern  o f fragm entation (figure II.8B). Strikingly, fu ll-length PA was produced in 
largely unfragmented form  in the absence o f IPTG in uninduced cell cultures. This leaky 
PA production stems from  non-repressed tac promoters due to  lim iting concentrations of 
the lac repressor. Accordingly, much less PA was produced in uninduced JM 1 09 cells, 
which overexpress the  lac  repressor. The s trong  increase in fragm en ta tion  upon 
activa tion  o f large numbers o f tac  prom oters may re flec t the increased lim ita tion  of 
translation by rare tRNAs. However, as was seen in the pXA3 system, the coexpression o f 
pUBS520 (see 11.2.1.2) did not s ign ifican tly  reduce the  num ber o f PA fragm ents 
produced, but rather led to  an increase in to ta l protein yield (n o t shown). This could 
e ither imply th a t a t least some o f the PA fragm ents in figure II.8B are derived from
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proteolysis, or tha t rare codons other than arginine codons are involved (see table 11.3 in 
discussion 11.3).
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Figure 11.8: Expression of PA as a MBP-fusion protein. (A), Coomassie stained, 12 % SDS-
PAGE gel. PA was expressed in JM109 cells from plasmid pMAL-PAM2. An 
additional band of the expected size (124 kD) is induced by IPTG (lane 2) and 
indicated by the arrowhead and a circle. Lanes 1, cell extract before induction; 
2, cell extract 3 h after induction at 37°C; 3, flow-through fraction of an 
amylose column; 4-7, elution of bound protein from an amylose column; M, 
BIORAD low range, prestained standards.
(B), Comparison of different E.coli strains for MBP-PA expression. Western 
blot o f whole cell extracts developed with L35E12 anti-PA antibody. Pairs of 
uninduced (le ft) and 3 h induced (right) whole cell extracts have been loaded 
onto the gel. The corresponding E.coli strain is indicated above these pairs.
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The a ffin ity  purified MBP-PA fusion prote in preparation was analyzed fo r ATP 
binding and ATPase activities. ATP binding was performed w ith periodate oxidized ATP, 
tha t crosslinks to  proteins by forming covalent bonds with exposed amino groups. Specific 
nucleotide binding sites can be identified in the presence o f excess unlabelled ATP, which 
e ffic ien tly  p rotects these sites from being crosslinked (C lertant and Cuzin, 1982; Jindal 
e t al., 1 99 4 ). The MBP-PA fusion prote in was incubated w ith  oxidized ATP in the 
presence o f d iffe rent nucleotides, the resulting Schiff-base between oxidized ATP and the 
protein was reduced w ith cyanoborohydride, the crosslinked proteins were separated by 
SDS-PAGE, b lo tted  onto  nitrocellulose membranes and analyzed by autoradiography 
(figu re  11.9). Two major bands in the PA preparation are reproducib ly labelled w ith 
oxidized ATP. They are polypeptides o f about 85 kD and 80 kD respectively. The labelling 
is specific fo r ATP, because only ATP, but not UTP, CTP or GTP can com pete fo r the 
crosslinking by oxidized ATP. In addition, specific labelling o f proteins a fte r amylose 
a ffin ity  purification was only observed w ith oxidized ATP, but not w ith  o the r oxidized 
NTPs (no t shown). These results indicate tha t e ither PA is an ATP binding protein, or 
another ATP binding protein is copurifying w ith PA on the amylose resin. In an a ttem p t to  
identify  the ATP binding polypeptides, the a ffin ity  purified PA protein preparations were 
preincubated w ith anti-PA antibodies. Neither the monoclonal antibody L35E12, raised 
against the C-terminus o f PA, nor a pool o f monoclonal antibodies specific fo r the N- 
term inus o f PA could inh ib it ATP labelling o f the 85 kD and 80 kD bands (figure  11.9, 
lanes 7, 8). We never de tected  labelling w ith ATP o f the  fu ll-length  MBP-PA fusion 
p ro te in  (1 2 7  kD). The same n itroce llu lose  membrane, th a t had been used fo r 
autoradiography was subsequently probed w ith a pool o f monoclonal antibodies to  the N- 
term inus o f PA (figure II.9B, right panel). As mentioned above, the N-specific antibodies 
detected a large number o f PA derived protein fragments, whereas they did not crossreact 
w ith  any bacterial proteins. The 85 kD and 80 kD ATP binding polypeptides com igrate 
w ith tw o  major bands on the corresponding Western blot, leaving it possible th a t the ATP 
labelled proteins are PA fragm ents derived from  the MBP-PA fusion protein. However, if 
the ATP binding polypeptides are to  comprise both MBP, fo r binding to  the  amylose 
column, and the PA N-terminus, fo r crossreaction w ith  anti-PA-N antibody, they are 
unlikely to  extend to  the presumed ATP-binding m o tif in the C-terminal half o f PA. 
Accordingly, the analysis o f b lo tted  ATP-binding reactions w ith PA C-terminus specific 
L35E12 antibody failed to  establish the presence o f the C-terminal epitope on the ATP- 
binding polypeptides.
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F igure  11.9:
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ATP binding o f a ffin ity  purified MBP-PA prote in  prepara tions. (A ), 
autoradiogram of a 12% SDS-PAGE gel showing ATP crosslinking to  a MBP-PA 
fusion protein preparation. Essentially all polypeptides in the preparation are 
radioactively labeled w ith oxidized ATP. Binding specific ity  is shown by 
specific competition with unlabeled nucleotides. Lanes, land 2, 1 pg and 0.6 pg 
MBP-PA incubated with 0.25 pM ox-ATP; 3 -6 , binding reactions with 0.6 pg 
MBP-PA in the presence of 5 mM unlabeled ATP (3), UTP (4), GTP (5 ) and CTP 
(6); 7 and 8, binding reactions with 0.6 pg MBP-PA after preincubation with 8 
p\ L35E12 antibody (7 ) or N-antibody (8 ); 9, binding reaction w ith 0.25 pg 
influenza virus RNPs. The positions of RNP proteins are marked on the right. 
The arrowheads indicate the positions of two specific ATP binding polypeptides. 
(B), Autoradiogram (le ft) and immunodetection of PA specific bands with 
monoclonal anti-PA N-terminus antibodies (right) after blotting of the binding 
reactions shown in (A) onto a nitrocellulose membrane.
Consistent w ith the ATP binding results, the MBP-PA preparations showed significant 
ATPase ac tiv ity  in vitro. As described above (11.2.1.1), ATP hydrolysis was followed by 
separation o f the products on TLC plates. As shown on figure 11.10, the PA preparation 
produced free phosphate from y32p-ATP (lane 4). This reaction was independent o f added 
RNA (lane 5). Lane 6 is a control reaction performed w ith a fraction eluted from the same 
amylose column a fte r the passage o f an E.coli cell ex trac t containing the pGEM7Zf+
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plasmid. These cells do not produce PA protein, were lysed in the same way as the MBP- 
PA expressing cells and the cell extract passed through an amylose resin. In the fractions 
corresponding to  the PA elution fractions, no proteins were visible on Coomassie stained 
gels, and no ATPase a c tiv ity  was detected. These results indicate th a t the present 
purification o f a polypeptide with ATPase activ ity  on the amylose resin was dependent on 
MBP-PA expression.
1 2 3 4 5 6 7
P i - ¥
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Figure 11.10: ATPase activity in amylose purified MBP-PA protein preparations. 0.6 pg
MBP-PA was incubated with [y-^^P]-ATP in ATPase buffer. 30 ng aliquots 
were analyzed by thin-layer chromatography in 1 M LiCI, 0.5 M formic acid. 
Lanes 1, ATP control incubation in the absence of protein; 2 and 3 early 
elution fraction from amylose resin without (2) or with (3 ) Ipg NS vRNA; 4 
and 5, PA elution peak from amylose resin without (4) or with (5) 1 pg NS 
vRNA; 6, fraction corresponding to PA elution peak, obtained by passing 
control cell extract through the same amylose column; 7, phosphate standard, 
derived from incubation of [y-^^P]-ATP with alkaline phosphatase.
11.2.2 Expression o f PA from recombinant baculoviruses
In order to  get around the problems o f unfavourable codon bias o f the  PA gene fo r 
expression in E.coli and protein fragm entation , eucaryotic  prote in  overexpression 
systems were tested fo r PA protein production. In the baculovirus system recombinant 
proteins are expressed from the polyhedrin prom oter during the late stage o f a viral 
in fec tion  o f insect cells. The system  relies on the  construc tion  o f recom binant 
baculoviruses through homologous recombination o f w ild-type virus and special transfer 
vectors (O'Reilly e t al., 1992). The polyhedrin prom oter is especially strong, because 
large amounts o f polyhedrin protein are required in the course o f a normal infection cycle 
to  package virus particles into inclusion bodies, called polyhedra. These polyhedrin based
____________Chapter II :___________________Expression of PA____________________________ 62
inclusion bodies are ingested by insect larvae and s ta rt a new in fection  cycle. The 
polyhedrin prote in  is, however, not essential to  maintain a baculovirus in fec tion  in 
cultured insect cells, which means tha t the strong, late polyhedrin prom oter can be used 
to  express foreign proteins. The PA protein has been repeatedly reported to  possess 
considerable to x ic ity  in mammalian cells. It was there fo re  considered to  be a major 
advantage o f the late expression in the baculovirus system  th a t recom binant protein 
synthesis starts only a fte r the maturation o f new, infectious virus particles. This ensures 
th a t even the expression o f cy to tox ic  proteins will not prevent virus replication. The 
AcMNPV (Autographa californica  multinuclear polyhedrosis virus) derived, recom binant 
baculovirus BacPAK6 (K itts  and Possee, 1993) and transfe r vectors provided by Dr. 
Robert Krug (St.Angelo e t al., 1987) were used to  produce recombinant baculoviruses 
containing the coding sequences o f all three influenza virus polymerase subunits. The 
recombinant, plaque purified viruses were then analyzed by DNA do t b lo t assays fo r the 
incorporation o f the polymerase coding sequences. Dot b lo t positive viruses were obtained 
fo r the three influenza virus polymerase subunit genes.
11.2.2.1 Time course o f expression
The recombinant baculoviruses expressed the influenza virus polymerase subunits 
only a t low levels, and no additional bands were observed on Coomassie-stained acrylamide 
gels comparing to ta l insect cell extracts a fte r in fection w ith  recom binant and contro l 
viruses. However, all three subunits could be identified on Western blots. Figure 11.11 
shows a tim e course o f expression fo r the d iffe rent proteins in whole cell extracts. PA was 
detectable at 32 hours p.i. and reached maximal level at 40  hours p.i. S ignificant amounts 
o f degradation products were detected a t 72 hours p.i. and they increased in in tensity  
the rea fte r. In con tras t to  the bacterial systems, PA is mainly produced in fu ll-length  
form  albeit a t very low levels. Similarly, the PBl protein was expressed at low levels and 
did not accumulate to  larger amounts during the time course. A p-galactosidase expressing 
baculovirus was used as a contro l in these experiments. Because the polyclonal antisera 
against PBl and PB2 had been raised in rabbits against p-galactosidase fusion proteins, 
the control extracts were strongly labelled by the antisera. It was not determined which o f 
the lower molecular weight bands in the PBl tim e course were PBl specific degradation 
products and which were unspecific crossreactions o f the antiserum. In con tras t to  the 
o ther tw o  subunits, PB2 appeared to  slightly accumulate w ith tim e. However, in all cases 
the recombinant protein levels remained below 0.5% o f to ta l cellular protein.
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Figure 11.11: Western blot analysis of protein expression in baculovirus infected SF9 cells.
3-10^ cells have been infected with 10 pfu/cell of recombinant viruses 
expressing PBl (A), PB2 (B) or PA (C), as indicated above each picture. Two 
different clones are shown for PBl expressing viruses, four clones for PB2 
expressing viruses and one for PA. Aliquots were taken at different time 
points after infection and total cell extracts separated by 1 2% SDS-PAGE. The 
blots were developed with polyclonal antisera against PBl- and PB2-p- 
galactosidase fusion proteins, provided by Dr. Paul Digard, and L35E12 
monoclonal antibody against PA. Lane "C" contains cell extracts from SF9 cells 
infected with a (3-galactosidase expressing baculovirus. The position of p-gal is 
marked on the left (116 kD), and arrowheads denote the presumed polymerase 
specific bands.
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11.2.2.2 Cell lysis and clarification
Up to  50% o f PA remained insoluble, when the cells had been lysed w ith a standard 
buffer containing between 0  and 1% NP40 and sonication. In contrast, m ost o f PA was 
found soluble in the supernatant o f cytoplasmic extracts prepared by incubation o f insect 
cells in a hypotonic lysis buffer and 0.5 % NP40 followed by a 20000xg centrifugation. 
This result suggested tha t PA can become attached to  insoluble macromolecules during the 
preparation o f whole cell extracts or may become denatured by detergent trea tm ent and 
sonication. In addition, this confirmed previous observations by others, who had reported 
tha t PA was not transported into the nucleus o f insect cells in contrast to  mammalian cells 
(Kobayashi e t al., 1992). It is also an illustration of the idea tha t the nuclear localization 
signal o f PA is more complex than tha t o f other influenza virus encoded nuclear proteins 
(P B l, PB2, NP), tha t are transported to  the nucleus even in insect cells (Galarza et al., 
1992 ; Kobayashi e t al., 199 2 ). The possib ility  to  prepare a cytop lasm ic e x trac t 
conta in ing  m ost o f the  recom binant PA provided an im p o rta n t f irs t  s tep  in PA 
purification. In particular, the contam ination o f PA preparations w ith large amounts o f 
nucleic acids was avoided. A major problem o f cell ex trac t preparation was to  avoid 
extensive PA degradation. Whereas most o f the protein was produced in full-length form 
in the cells, it very rapidly became degraded during cell harvesting, presumably due to  
the disruption o f cellular lysosomes. A significant amount o f PA was also detected in the 
supernatant o f insect cell cultures, probably orig inating from  cell leakage during the 
harvesting procedure. The PA from  this source was virtually free o f degradation products 
as Judged by Western b lo t and the large volume promised considerable amounts o f 
recombinant protein to  be present in this fraction. Taken toge ther a very gentle cell lysis 
w ith minimal disruption o f lysosomes may be crucial fo r an optim al harvesting procedure 
o f PA expressing insect cells. PA protein became relatively stable a fte r one purification 
step on an anion exchange column (see below).
11.2.2.3 Anion exchange chromatography of PA
The goal o f the firs t purification step was to  concentra te  the PA prote in  while 
removing as much o f the major contaminants as possible. The relatively low pi o f 5 was 
taken into consideration for MonoQ anion exchange chromatography, which was performed 
in Bis-Tris buffers, pH 6, 50 mM NaCI. Under optimal conditions about 75% o f the loaded 
proteins were separated from  the PA (figure Il.l 2), which was mainly e luted a t about 
300  mM NaCI. The PA peak fractions contained full-length PA protein, stable fo r at least 
one year when stored in glycerol at -20°C as judged by Western blot. However, although a 
d is tin c t PA e lu tion peak was evident (frac tions  4 8 -5 2 ), PA was no t s ign ifican tly  
concentrated in the eluted fractions compared to  the starting material ("load"), and the PA
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protein remained a minor band on Coomassie stained gels (no t shown). PA could also be 
bound to  a MonoQ column from  cell cu lture supernatant w ith  a sim ilar purifica tion  
e ffic iency (figure  11.13). A bout 97 % o f to ta l prote in , in th is  case mainly serum 
albumin, were separated by the ion exchange procedure. Again, a polypeptide band o f full- 
length PA size accumulated in the column fractions o f the PA peak (figure 11.1 3B). The 
same Western blot shows PA also in flow-through and washing fractions (1, 10, 15, 31), 
because the MonoQ column was voluntarily used at maximal binding capacity in order to  
obtain maximally concentrated PA elution fractions, tha t m ight have fac ilita ted  fu rther 
chromatographic steps. However, the PA protein was never observed as a major protein in 
the elution fractions, due to  the low abundance in the starting material. Because o f the low 
PA concentration, fu rther purification procedures were d ifficu lt to  assess. PA was found 
to  bind to  Reactive Red and Reactive Green dyes and could be eluted from such dye columns 
w ith  salt gradients. However, PA binding to  the dyes was never quantita tive  (30-50%  
binding) and the resolution was low, presumably because the  dye columns mainly 
functioned as anion exchangers in this case and were therefore not well suited to  resolve 
proteins, th a t had previously bound to  a MonoQ column. As a result, the reactive dye 
columns separated only another 50-70%  o f the loaded protein from the PA elution peak 
fractions.
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Figure 11.12: Binding profile of baculovirus expressed PA protein on a MonoQ column. (A), 
Protein distribution in the column fractions as determined by Bradford staining. 
The three major protein peaks correspond to flow-through (575 ijg), washing 
(435 ijg) and gradient elution (639 ^g). Chromatography was performed in 
buffer A (50 mM Bis-Tris-HCI), pH 6.0, the column was washed with buffer A 
plus 50 mM NaCI and bound proteins eluted with a 10 ml 0-1.5 M NaCI gradient.
(B), dot-blot of the column fractions shown in (A) and developed with L35E12 
anti-PA antibody. PA cross-reactive material was only detected in the eluted 
fractions. (C), Western blot of column fractions as indicated above each lane. 
Mainly full-length PA was recovered from the MonoQ column
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Figure 11.13: Purification profile o f baculovirus expressed PA from the culture supernatant. 
(A), protein distribution in the column fractions as determined by Bradford staining; (B), 
Western blot of column fractions, developed with L35E12 anti-PA antibody; (C), coomassie- 
stained, 12% SDS-PAGE gel of column fractions as indicated. The arrowhead indicates a band, 
which corresponds in size to  PA and is accumulated in the PA containing peak fractions. 
Chromatography was performed in buffer A (50 mM Bis-Tris-HCI, pH 6), the column washed 
with 100 mM NaCI in buffer A and bound proteins eluted with a 20 ml 0-1.5 M NaCI gradient.
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11.2.2.4 NTPase activ ity  copurifies w ith PA on MonoQand reactive dye columns 
The PA containing, semipurified fractions were assayed fo r ATPase a c tiv ity  as 
described before fo r the a ffin ity  purified prepara tions from  bacteria l expression 
(11.2.1.3). The MonoQ, Reactive Red and Reactive Green PA peak fractions all contained 
ATPase activ ity . Figure 11.14 shows tha t several nucleotide triphosphates (NTPs) could 
serve as substrate fo r this activ ity , «-labeled NTPs were exclusively transform ed into 
labeled NDPs, which demonstrates tha t all phosphatase activ ity  from the cell extracts was 
separated from  the PA peak fractions in one MonoQ chrom atography step. The spot 
intensities d iffe r fo r the d iffe ren t nucleotides because they were o f d iffe ren t specific 
activ ity  and equimolar amounts were used in the assay. The NTPase activ ity  in the PA peak 
fraction utilized ATP and UTP with the highest efficiency, followed by GTP. The incubation 
o f GTP and dCTP w ith theses protein preparations gave rise to  a low concentration o f a 
labeled product o f intermediate size between NDP and free phosphate. This product could 
not be identified.
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F igure  11.14: NTPase activ ity assay with a PA peak elution fraction from a MonoQ column, 
corresponding to  fraction 50 in figure 11.12 and containing an estimated protein 
content of 0.2 pg/pl. 0.2 and 1 pg protein was incubated with a or y- labeled 
NTP in ATPase buffer. 1 /2 0  of the reaction was analyzed by thin-layer 
chromatography in 1 M LiCI, 0.5 M formic acid. Lanes, 1-5, incubation of NTPs 
(y3 2 p_ATp^ (x32p_GTp^ c^32p_uTP, a^^P-CTP, a^^p-dCTP) in the absence of 
protein; lanes 6-10, incubation of the nucleotides in the same order with 0.1 U 
alkaline phosphatase; lanes 11 and 1 2, incubation of Ipg  PA peak protein with 
y32p_ATP in the presence of nucleotide analogs, 4pM 2'-FdGTP and 2'-FdCTP 
respectively; lanes 13 and 14, incubation of Ipg  and 0.2 pg PA peak protein 
with f  2p_ATp; lanes 1 5 and 16, incubation of Ipg  and 0.2 PA peak protein
with a^Zp.QTp. janes 1 7 and 1 8, incubation of Ipg  and 0.2 ijg  PA peak protein
with a^^P-UTP; lanes 19 and 20, incubation of Ipg  and 0.2 pg PA peak protein
with a^Zp-CTP; lanes 21 and 22, incubation of Ipg  and 0.2 jug PA peak protein
with a^P-dCTP. The positions of marker molecules are indicated on the left.
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These results correlate well w ith the measurements perform ed on E.coli derived PA 
fractions (see 11.2.1.3). It remains therefore possible tha t PA possesses NTPase ac tiv ity  
or associates w ith an NTPase in both cell types. With appropriate antibodies available for 
im m unopurifications it  may be w orth  try ing  to  determ ine the nature o f th is NTPase 
activ ity.
11.2.2.5 Conclusion on PA expression in the baculovirus system
The recombinant baculoviruses, tha t have been produced in this study, express the 
PA protein a t low levels, but in full-length form. Cell disruption can induce very fast and 
extensive degradation o f the PA protein, but the protein appears to  be stable a fte r an 
initial capture step performed w ith MonoQ anion exchange chromatography. Any analytical 
work on PA function and ac tiv ity  w ith recombinant protein from  this system  will require 
such a separation o f proteases from the PA protein fraction. The purification o f PA was 
a ttem pted from baculovirus infected cells, but the expression levels are too  low to  obtain 
pure PA prote in by conventional methods or to  envisage upscaling o f the expression 
procedure. The conditions worked ou t fo r anion exchange chrom atography o f the PA 
prote in may be im portant fo r fu tu re  purification tria ls o f PA expressed in engineered 
form  and /o r in a lternative expression systems. Considering the fac t th a t baculovirus 
in fe c te d  cells produce m ain ly fu ll- le n g th  PA p ro te in , im m un o p réc ip ita tio n  or 
im m unoaffin ity purification o f PA m ight be a promising way to  obtain reasonably pure 
protein preparations fo r the analysis o f possible PA activ ities and fo r controlled protease 
trea tm ent to  identify independent folding units.
11.2.3 Expression o f PA in Pichia pastoris
From the above mentioned results it  appears th a t eucaryotic expression system s may 
conta in  essential fac to rs  required to  obta in  fu ll-leng th  PA pro te in . The yields o f 
recom binant prote in in baculovirus in fected insect cells were low, bu t s ign ifican tly  
higher than in the vaccinia virus system  albeit not su ffic ien t fo r the purification o f PA 
protein. Because exceptionally high amounts o f recombinant protein have been reported to  
be synthesized in Pichia pasto ris  in certain cases, th is system  was considered as an 
alternative fo r PA expression in eucaryotic cells. Recombinant yeast clones were produced 
by homologous recombination o f the yeast genome w ith a transfer vector, similar to  the 
baculovirus system  and fo llow ing the  instructions o f the  Invitrogen Pichia cloning 
handbook. The genomes o f recombinant yeast clones were analysed by PCR and genomic 
DNA dot b lotting in order to  find out the locus and the type o f gene integration. Single and 
m ultip le insertion clones have been screened for PA expression. The expression level o f 
PA was comparable to  the baculovirus system and clearly below 0.5%  o f to ta l cell protein 
a fte r 4-5 days o f induction. PA was again expressed in mainly fu ll-length form , but the
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inrelative amounts o f PA were, as before, too  small to  achieve e ffic ien t enrichm ent i 
standard chrom atographic steps. Initial tria ls o f pro te in  capturing by Sepharose Q 
chrom atography showed tha t the protein behaves very similar to  baculovirus expressed 
PA protein, and PA peak fractions from the sepharose Q columns again showed ATPase 
a c tiv ity  (n o t shown). However, the yeast system  did no t im prove the  yields o f 
recombinant PA as compared to  the baculovirus expression system. The amounts are so 
low tha t it  even remains unclear if a specific a ffin ity  purification scheme will be suitable 
to  purify  and concentrate  PA up to  microgram quan titites  as would be required fo r 
functional studies. The principal advantage o f the yeast system is the high cell density to  
which the cultures grow resulting in high protein concentration per culture volume. Even 
if the  observed PA expression in Pichia pastoris  was low and w ith 0.1%  similar to  the 
o ther expression systems, the high to ta l protein production in small volumes (2 g to ta l, 
soluble protein per lite r cell cu lture) leads to  the presence o f an estim ated 2-5 mg PA 
protein per lite r o f cell culture. Considering tha t upscaling o f the cultures is cheaper and 
easier compared to  insect cells, it m ight eventually be possible to  obtain the  required 
amounts o f pure protein fo r functional assays presuming su ffic ien t s tarting  material and 
a highly specific capturing method like a ffin ity  chromatography.
11.2.4 In v itro  translation o f PA protein
The in v itro  translation system only produces small amounts o f recombinant protein, but 
can be a very im portant too l in studying specific activ ities o f proteins, especially binding 
in teractions w ith  o ther proteins or nucleic acids. The available systems are well defined 
and rapid. The expressed prote ins can be specifically labelled by incorpora tion  o f 
radioactive amino acids and background labelling o f o ther proteins is very low. Mutations 
in the  recom binant protein sequences can be produced relatively fast. The expression 
plasmids are usually stable during propagation in E.coli, even if they contain coding 
sequences o f tox ic  pro te ins, because viral polymerases are required fo r prote in  
expression. These are all advantages, tha t made it worthwile expressing PA in this system 
in order to  study potential RNA binding activ ity  o f this protein. The PA protein sequence 
does not contain any o f the described RNA binding m otifs (Burd and Dreyfuss, 1994 ). 
Nevertheless, it  is part o f the influenza virus polymerase complex and could be UV- 
crosslinked to  nascent RNA transcrip ts (Braam e t al., 1983). Also, a presumed function 
in translational contro l m ight involve RNA binding. A significant amount o f nucleic acid 
bound to  the amylose resins during the purification o f MBP-PA fusion proteins as judged 
by UV absorption spectroscopy. These nucleic acid moieties could be partially removed 
from  PA by washing the columns with elevated NaCI concentrations. All these observations 
suggest th a t PA m ight be a RNA binding protein, and if so, it may contain a novel RNA 
binding structure. The expression o f PA in wheat germ extracts was tested fo r its use to  
study PA protein function in vitro. To this end, full-length PA and tw o PA fragm ents from
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the termini o f the protein were cloned into T7 polymerase directed expression vectors. An 
optim al Kozak sequence fo r e ffic ien t transla tion  in itia tion  was added im m ediately 
upstream o f the s ta rt codon during the cloning procedure (Cavener and S tuart, 1991). 
The coding sequences were transcribed and translated in the combined TNT™ system of 
Promega and analyzed for RNA binding activ ity  by measuring the binding o f ^ss-labelled 
PA to  biotinylated RNA molecules according to  a procedure originally described by Scherly 
e t al., 1989. RNA-bound protein is then detected a fte r precipitation o f the RNA substrates 
w ith streptavidin coated magnetic beads.
The RNAs, th a t have been used in these binding experiments, have e ither been 
chemically synthesized and biotinylated by the oligonucleotide service group at EMBL, 
Heidelberg, or they have been in vitro  transcribed w ith the concom itant incorporation o f 
biotinylated UTP (table 11.2, page 74). The magnetic Dynabeads (DYNAL) were blocked by 
a preincubation in KTN-buffer containing 10 m g/m l E.coli tRUA and 1.5 m g/m l BSA to  
avoid nonspecific interactions o f the PA protein w ith the streptavid in  beads. For RNA 
binding, in v itro  translated PA protein was incubated w ith 2 /lvM biotinylated RNA in the 
presence o f 300 pM polyA RNA fo r 10-30 min a t RT. The binding reaction was then 
diluted 20-fo ld w ith KTN-buffer, 0.^5 pg o f magnetic beads were added and le ft 30 min at 
RT fo r RNA capturing. The beads were washed three tim es w ith  20-fo ld  excess KTN- 
buffer, the bound material was eluted in SDS-loading buffer and analyzed by 1 2 % SDS- 
PAGE and autoradiography. In this assay, the PA protein showed selective binding to  some, 
but not all RNAs tested. Figure 11.15 shows the coprecip itation o f in v itro  translated PA 
w ith  d ifferent, biotinylated RNA molecules. The blocking o f the beads w ith unspecific RNA 
and BSA resulted in very low background binding o f PA to  the beads in the absence of RNA 
or in the presence o f non-biotinylated RNA (figure 11.1 5A, lanes 3 , 5 , 1 0 , 1 3  from  le ft to  
right). PA was found to  precipitate w ith a RNA oligonucleotide containing the conserved 5' 
end sequence of influenza virus vRNA (con5), but not w ith the conserved 3' end sequence 
(PAV3 and con3). PAV3 corresponds to  the 3' end of influenza A virus segments 1,2,3,5 
and 7, con3 to  the 3' ends o f segments 4, 6 and 8 (see figure 1.14, page 31). In addition, 
PA apparently associated specifically w ith the RNA oligonucleotide "oNS-mRNA" (figure
11.1 5A, lane 7). oNS-mRNA represents the 5' end o f influenza virus specific mRNA coding 
fo r NS1 protein. The coprecip ita tion o f PA w ith oNS-mRNA was independent o f a cap 
s truc tu re  and presumably mediated by the influenza virus-specific sequence, because 
pucT7bam RNA did not precipitate PA in spite o f containing the primer sequence present 
in oNS-mRNA at the 5' end. Also, b iotinylated UGsnRNA did not precip ita te  PA from  in 
vitro  translation extracts.
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Figure IM  5: RNA binding o f in vitro  translated PA protein. 12% SDS-PAGE autoradiograms 
showing coprecipitation of radioactively labeled PA protein with biotinylated RNAs. (A), specific 
binding of PA to  vRNA 5' end (con5) and influenza virus mRNA. The RNAs used in the binding 
assay are indicated above the corresponding lanes. "PA" is an acetone precipitation of 1 /10  of 
the protein in the binding reaction. (B), Cap independence and effect of non-specific competitors 
on PA binding to  NS-mRNA. indicates the absence of competitor in the reaction. Lanes 11 and 
1 2 are binding reactions with oNS-mRNA, capped and uncapped, that has been polyadenylated in 
v /frow ith  E.coli poly(A)-polymerase (Pharmacia).
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Figure 11.1 5B illustrates tha t the RNA dependent precipitation o f PA was not inhibited by 
up to  625 fold molar excess o f polyA, polyU or tRNA. Similar results were obtained with 
capped or uncapped mRNA analogs. Binding was not changed by the presence or absence o f a 
polyA tail added to  the mRNA analogs in v itro , which is consistent w ith the absence of 
com petition  by polyA RNA. These results suggest th a t PA m ight specifically bind to  
influenza virus specific sequences from the 5' ends o f vRNA and cRNA, but not to  the 3' end 
o f vRNA. The d ifferentia l binding o f full-length PA to  the RNAs implies specific ity  o f the 
binding ac tiv ity . The point m utant PAL219F showed similar binding characteristics to  
w ild -type  PA, bu t prelim inary results w ith  the  PA-NT and PA-CT deletion m utants 
suggests very strongly reduced binding in this assay.
Taken together, the expression o f PA in wheat germ extracts provided PA protein 
preparations, th a t may be used to  study RNA binding in vitro. The results so far are 
consistent w ith the idea o f a function o f the PA protein in isolated form. However, others 
have failed to  d e te c t any specific RNA binding a c tiv ity  o f iso lated influenza virus 
polymerase subunits expressed in the vaccinia virus system. (Tiley e t al., 1994). The 
specific ity  o f this assay will have to  be scrutinized and RNA binding be shown w ith ye t 
another method, e.g. gel sh ift or UV-crosslinking. If RNA binding ac tiv ity  o f PA can be 
established w ith this system, PA point and deletion m utants will possibly help to  identify 
the RNA binding site on the PA primary sequence. On the other hand, a mutational analysis 
o f the RNA molecules will help to  determ ine the character and spec ific ity  o f the RNA 
binding site.
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RNA sequence length
[n t]
origin PA
binding
con 5 5' bio-AGU AG A AAC AAG GGT G 3 16 chem. syn. +a
con 3 5' bio-CAC ecu  GCU UUU GCU 3' 15 chem. syn. -
oNS-mRNA
5' GGG CGA UCA AGA GCA AAA GC 
GGG UGG CAA AT-bio 3'
A
32
chem. syn. 
capping reaction‘s
+
PAV 3 5' bio-GUA ecu  GCU UUC GCU 3' 16 chem. syn. -
U6 snRNA
5' GGGUGCUUGCUUCGGCAGCAC 
AUAUACUAAAAUUGGAACGAUAC 
AGAGAAGAUUAGCAUGGCeCCUG 
CGCAAGGAUGACACGCAAAUUCG 
UGAAGCGUUCCAUAUUUUU 3'
109
T7 transcription 
from Dra 1 cut 
pUC9U6 plasmid^
(in the presence of 
biotinylated UTP)
pucT7bam
5' GG GCG AUC AAG CUA UGC AUC 
UCG AGG AAU UCG 3'
32
T7 transcription 
from Bam HI cut 
pUCT7 plasmid^
(in the presence of 
biotinylated UTP)
Table 11.2: Characteristics of the RNAs, that have been used in PA binding studies.
a PA binding determined by precipitation with streptavidin beads, 
b In v itro  capping o f RNAs was performed w ith vaccinia virus guanylyl- 
transferase as described in chapter IV (Mat/Met).
c Plasmid pUC9U6 was obtained from Dr. lain Mattaj and contains the coding 
sequence for Xenopus tropicalis UGsnRNA downstream of a T7 promoter 
d Plasmid pUCT7 was constructed by ligating the annealed DNA oligonucleotides 
T7PGEMT0P and T7PGEMB0TT0M into H/ndlll/eamHI cut pUClB plasmid.
11.3. DISCUSSION
Very litt le  is known about the s tructu re -function  relationships o f RNA dependent RNA 
polymerases, which are the central enzymes in the life cycles o f RNA viruses. On the one 
hand, they contain highly conserved domains present in most RNA polymerases and they 
seem to  follow  basic rules o f tem plated RNA synthesis, as established fo r cellular RNA 
polymerases. On the other hand, they show v irtua lly  no sequence sim ilarities in o ther 
p rote in  domains apart from  the polymerase module, and they  usually perform  very 
unique, virus-specific activ ities required fo r genome transcrip tion  and replication. These
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additional activ ities potentia lly  constitu te  very powerful ta rge ts  fo r antiviral therapies. 
The viral RNA-dependent RNA polymerases are large protein complexes (> 200  kD), 
sometimes including a varie ty  o f cellular proteins (especially in positive-strand RNA 
virus groups). The rules tha t govern the assembly o f functional polymerase complexes 
are not well understood, partly because o f considerable d ifficu lties in expressing single 
subunits and the reconstitution o f specific activities in vitro.
The goal o f the present study was to  assess a number o f protein expression systems 
to  try  to  find a way to  produce functional influenza virus polymerase subunits fo r 
structural studies. In addition, we attem pted to  detect a specific activ ity  o f the PA subunit 
to  help understand the function o f this protein in the virus life cycle. In m ost cases the 
production o f fu ll-length , recom binant PA prote in was below 0.5%  o f to ta l cellular 
protein. A number o f reasons could theoretically account for this observation and it has to  
be discussed, if  any promising strategies to  increase protein yield became apparent from 
the experiments. As a firs t obstacle, plasmid instab ility  was observed during overnight 
cu ltures o f E .co li cells carrying recom binant plasmids encoding PA pro te ins. The 
com parative screening o f colony form ation  on agar plates w ith  d iffe re n t additives 
suggested tha t an overnight culture grown until ODgoo = 2 could lose the PA expression 
plasmid from  more than 66% o f the cells. A sim ilar segregation process has been 
described fo r the expression o f toxic gene products in bacterial cells (Novagen pET system 
manual). The most likely reason fo r this phenomenon is the production and secretion o f 
large amounts o f (3-lactamase in E.coli cell cultures carrying the recombinant plasmids. 
Accordingly, ampicillin selection is lost re latively early in cell cu lture. Colonies, th a t 
have lost the plasmid, will s ta rt to  overgrow the cell cultures as soon as su ffic ien t 13- 
lactamase has accumulated, especially in cases, where the re tention  o f the plasmid is 
unfavourable  fo r the  cells. To suppress th is  problem , cell cu ltu res fo r plasmid 
production, before protein induction, were not allowed to  grow fu rthe r than ODgoo = 0.5. 
The fraction  o f plasmid containing cells was monitored during the cultures to  minimize 
unspecific overgrow th. However, it  was d ifficu lt to  avoid plasmid loss during protein 
induction itse lf. A fte r the addition o f IPTG at ODeoo < 0 .5, plasmid conta in ing cells 
virtually ceased to  grow and started to  lyse 2 hours later, as apparent by a decrease of the 
optic  density (ODgoo)- Protein induction at higher op tic  densities had e ithe r similar 
e ffects or increases of ODgoo levels were measured, which had resulted from overgrowth 
by plasmid-less cells, as could be seen in plate screening assays. These observations 
suggest tha t the expression o f PA is deleterious fo r the bacteria. This apparent tox ic ity  of 
the PA gene product m ight possibly indicate tha t PA possesses an activ ity  in isolated form 
and tha t this activ ity  is deleterious for bacterial cells.
Most o f the recombinant PA protein was produced in an insoluble form  from  the 
pRSET and pinpoint systems, both o f which add short extra-sequences to  the N-terminus 
o f PA. Similar results have been obtained w ith d iffe ren t E.coli expression system s in
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o ther laboratories (Akkina e t al., 1987; Barcena e t al., 1994; Jones e t al., 1986; 
Kobayashi e t al., 1992). Consistent w ith previously published results, the yields o f full- 
length proteins were very low, whereas certain protein fragm ents could be produced to  
much higher levels. We did not succeed in refolding PA or smaller PA fragm ents into 
functiona l s tructures a fte r the purification o f PA from  bacterial inclusion bodies. By 
fusing the maltose binding protein (MBP) to  the N-terminus o f PA, it  could fo r the firs t 
tim e be produced in soluble form  in E.coli. However, PA was largely fragm ented into 
polypeptides o f all sizes and the yield o f full-length PA itse lf was again very low. The 
addition o f a large varie ty o f protease inhibitors, single and in com binations, did not 
significantly reduce the extent o f protein fragmentation. The fragments were also detected 
in whole cell extracts prepared from  in tact cells solubilized in SDS-loading buffer. We 
conclude th a t to  a large ex te n t th is fragm entation  already occurs in vivo  and the 
contribu tion  o f protein degradation during cell lysis was not easy to  estim ate on this 
background. High level degradation in vivo  m ight be due to  problems during protein 
folding, because proteins w ith abnormal conform ations are known to  be tunneled into 
protein degradation pathways in t.co//(G oldberg, 1992; Gottesmann and Maurizi, 1992). 
Coexpression o f molecular chaperones (e.g. DnaK, GroEL, GroES) could be used to  answer 
this question. However, these chaperones have been reported to  stim ulate proteolysis in 
E.coli w ith  polypeptides, th a t fail to  develop a stable conform ation. Therefore, this 
s tra tegy does not generally lead to  improved protein expression (Kandror e t al., 1994). A 
second reason fo r intracellular fragm entation o f PA m ight be ine ffic ien t p rocessivity 
during transcrip tion  or mRNA instab ility . In E.coli, mRNA turnover is regulated by the 
coordinated action o f endo- and exonucleases. The best studied pathway starts  w ith the 
initial cleavage o f mRNAs near the 3' end by endonuclease RNase E (Hajnsdorf e t al.,
1 994 ). The s tab ility  and half-life o f the PA mRNAs in the respective expression systems 
has not been looked at in this study, but several, putative RNAse E cleavage sites, tha t are 
common to  extremely unstable mRNAs, are also present in the PA gene sequence. An RNAse 
E-like ac tiv ity  has also been described to  be im portant in the contro l o f mRNA decay in 
eucaryotes. Repeated AUUUA m otifs and AU-rich regions are common in human oncogene 
and growth fac to r mRNAs and significantly reduce the half-life o f the mRNAs (Wennborg 
e t al., 1995). Figure 11.16 shows the distribution o f possible RNase E recognition sites on 
the PA gene sequence. The conservation o f these signals between bacteria and eucaryotes 
may partly explain the low expression levels o f PA in both procaryotic and eucaryotic 
protein expression systems.
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PA
406 AAUAAAAUUAAAT 418
680 AAAAUUUUAGA 690
862 UUAAAAUUAA 872
996 AAAUUAU 1002
1442 AAUUAAUU 1449
1713 AAAAAUUAAAAUGAAAU 1729
1935 UAUUUAA 1940
2081 UAAUUAAUGAU 2091
RNase E 
consensus 
cleavage site
A A
—  A U U —  
G U
Figure 11.16: Motifs in the PA gene sequence (IA /P R /8 /3 4 ), tha t resemble RNase E
cleavage sites implied in the regulation of mRNA stability in both procaryotic 
and eucaryotic cells (Ehretsmann et al., 1992; Mackie and Genereaux, 1993; 
Wennborg et al., 1995). Very low half-life mRNAs are characterized by 
clusters of the RNAse E recognition motif.
As mentioned above (11.2.1.2), the presence o f large numbers o f rare codons in 
eucaryotic genes has also been suggested to  reduce the levels o f protein production in 
bacteria and can lead to  protein fragm entation. Table 11.3 shows the codon usage o f PA 
compared to  highly expressed genes in E.coli and in Saccharomyces cerevisiae. The most 
striking deviations are found in the codon redundancy families fo r arginine and glycine. 
The codons tha t are used in the PA gene for these amino acids are only rarely used in E.coli 
and S.cerevisiae w ith the exception o f the AGA codon, th a t is common in yeast genes. In 
addition, the codons tha t are preferentially used in the PA gene fo r leucine, threonine and 
asparagine are rare codons in the microbial organisms. A helper plasmid expressing the 
tRNA fo r the rare arginine codons has been reported to  improve the expression o f various 
genes o f plants, plant viruses and Agrobacterium  in d iffe rent laboratories (Schenk e t al., 
1 995). The AGA/AGG contents o f these genes ranged between 1.8% and 7.8%, which is 
comparable to  PA w ith 4.4%. Indeed, the coexpression o f the tRNAgrg4 also increased the 
level o f PA production  in E.coli, but did not s ign ifican tly  reduce the  level o f PA 
fragm entation. For the fu tu re  it m ight therefore be w orth  try ing  to  coexpress all rare 
tRNAs together w ith PA in bacterial cells.
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c AA PA E.C. S .0. c AA PA E.C. s. c. c A A PA E.C. s.c. C A A PA E.C. s. c.
TTT F 0,44 026 on TGT S 0.19 036 057 TAT Y 065 026 0.06 TGT G 0.4 036 0.93
TTC F 0.56 074 089 TGG s 0.17 034 038 TAG Y 035 0.74 0.94 TGG G 0.6 0.64 0.07
TTA L 0.11 003 oil TGA s 021 002 001 TAA Z TGG Z
TTG L 0.17 004 085 TGG s 0.08 004 000 TAG Z TGG W 1.00 1.00 1.00
GTT L 034 006 001 GGT p 0.13 010 006 GAT H 015 020 0.19 GGT R 005 0.67 0.09
GTC L 0.09 006 000 GGG p 0.19 001 001 GAG H 085 0.80 0.81 GGG R 005 0.30 0.00
GTA L 0.12 001 003 GGA p 0.48 012 093 GAA Q 058 0.18 0.98 GGA R 008 0.01 0.00
GTG L 0.17 079 000 GGG p 0.19 077 000 GAG Q 042 0.82 0.02 GGG R 003 0.00 0.00
ATT 1 048 020 0.50 ACT T 024 036 0.48 N 0.65 008 006 AGT S 0.19 004 002
ATG 1 025 0.79 0.50 AGG T 019 0.48 0.51 AAG N 0.35 092 094 AGG S 0.17 019 002
ATA 1 027 0.01 0.00 AGA T 057 0.05 0.01 AAA K 0.58 071 010 AGA R 0.45 001 091
ATG M 1.00 1.00 1.00 AGG T 000 0.10 0.00 AAG K 0.42 029 090 AGG R 0.35 000 000
GTT V 023 0.44 0.55 GGT A 021 037 0.76 GAT D 0.64 036 039 GGT G 0.11 054 098
GTC V 010 0.09 0.44 GGG A 029 0.10 023 GAG D 0.36 064 061 GGG G 0.14 041 002
GTA V 037 027 0.00 GGA A 049 025 0.01 GAA E 0.55 076 098 3GA G 0.51 001 000
GTG V 030 0.19 0.01 GGG A 001 028 0.00 GAG E 0.45 024 002 3GG G 026 003 000
Table 11.3: Codon usage of the influenza A /P R /8 /34  PA virus gene (PA) as the fraction of 
each codon in its redundancy family, compared to  strongly expressed genes in 
E.coli (E.c.) (Grosjean and Piers, 1982) and Saccharomyces cerevisiae (S.c.) 
(Sharp and Cowe, 1991). Boxes indicate a significant deviation in the codon 
preference o f the PA gene. "C" stands for codon, "AA" for amino acid. Amino 
acids are denoted in the standard one-letter code.
PA fragm entation in vivo  was not a problem in the eucaryotic expression systems. In both 
insect and yeast cells, PA was mainly produced as a full-length protein and smaller bands 
detected on Western blots were generally derived from  proteolysis a fte r cell lysis, which 
could be minimized by appropriate harvesting procedures. However, the am ount o f PA 
protein was very low and comparable to  the E.coli systems, i.e. PA protein accumulated to  
about 0.1% o f to ta l cellular protein. This means th a t roughly 0.2-1 mg PA was produced 
per lite r o f insect cell cu lture  and 2 mg per lite r o f yeast cu lture. The low level 
expression in all systems suggests tha t the signals preventing the accumulation o f PA are 
conserved between bacteria and eucaryotes.
The PA protein may be toxic in both cell types. The plasmid instability and decrease 
in ODeoo a fte r induction in E.coli are signs fo r tox ic ity . The yeast cell cultures expressing 
PA showed reproducib ly and s ign ificantly  reduced grow th  compared to  contro l cells 
expressing a recombinant tRNA synthetase. Possible to x ic ity  in insect cells is hard to  
determine, because during the late phase o f infection the cells s ta rt to  be lysed by the 
replicating baculovirus. The PA expressing baculoviruses did not grow to  very high tite rs
____________ Chapter II :___________________Expression of PA____________________________ 79
and considerably less recombinant virus clones were obtained w ith PA compared to  PB1 
and PB2, which both may be signs fo r PA tox ic ity . Similar observations have been 
reported from other laboratories as well. Trials to  produce stable cell lines expressing PA 
from  A2G mouse kidney tum or cells were unsuccessful, because transfected cells stopped 
growing a fte r a few days (Stranden e t al., 1993). Nieto e t al., (1 9 9 2 ) reported tha t 
nuclear location o f PA correlated w ith  chrom atin condensation and aberrant nuclear 
morphology. One reason for this tox ic ity  may be the induction o f a generalized degradation 
o f proteins induced by the expression o f PA and shown to  occur in d iffe ren t cell lines 
(Sanz-Ezquerro e t al., 1995). The mechanism and the physiological role o f this induction 
o f proteolysis are not known. Since the N-terminus o f PA appears to  be required fo r this 
a c tiv ity  (Sanz-Ezquerro e t al., 1 99 6 ), in order to  reduce to x ic ity  and increase 
expression efficiency it m ight be worthwile to  try  and express N-terminally truncated PA 
proteins and see if they can be accumulated to  higher concentrations and if they retain 
certain activ ities like in teraction w ith o ther polymerase subunits and RNA binding (see 
below). However, it is not known if similar reasons can account fo r tox ic ity  in bacterial 
cells.
A tte m p ts  by o the r groups to  produce recom binant influenza virus polymerase 
subunits in insect cells were sim ilarly hampered by low expression levels and to  my 
knowledge no one has succeeded so far in obtaining pure and functional single subunits 
(Kobayashi e t al., 1992; Shi e t al., 1995; St. Angelo e t al., 1987). The com plexity o f 
possible reasons for low level expression o f PA makes it  unlikely tha t simple strategies 
exist to  s ignificantly increase the yield o f recombinant PA protein. Only highly specific 
a ffin ity  purification approaches m ight provide a means to  obtain recombinant protein for 
functional studies.
The PA preparations from d iffe ren t systems showed similar features in ATP binding 
and ATPase activities. A certain specificity o f these activities was implied by the absence 
o f ac tiv ity  in protein preparations from control cell extracts tha t had expressed either no 
prote in, an unspecific protein or a N-terminal fragm ent o f PA. In addition, the  binding 
was specific fo r ATP, as none o f the o ther nucleotide-triphosphates was bound or could 
compete fo r ATP binding. Also, no phosphatases copurified w ith PA. However, in E.coli the  
ATP-binding a c tiv ity  was correlated to  a specific breakdown product o f the fu ll-length 
MBP-PA fusion protein, whereas in the eucaryotic systems the degree o f purification was 
not su ffic ient to  completely exclude the copurification o f an unspecific ATPase w ith PA. To 
determ ine the nature o f the ATPase activ ity, d iffe rent anti-PA antibodies or antisera could 
be screened fo r spec ific  inh ib ition  or co p rec ip ta tion  o f p ro te in  and a c tiv ity . 
A lterna tive ly, point m utations in the presumed ATP binding m o tif o f PA m ight help to  
correlate ATPase activ ity  to  the PA protein.
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PA expression in wheat germ extracts was evaluated as a means to  study RNA binding 
activ ity . The efficiency o f PA coprecipitation with specific RNAs was low, but comparable 
to  previous work by Scherly e t al. (1 9 8 9 ). The present study suggests th a t in v itro  
translation o f the influenza virus polymerase subunits in d iffe ren t combinations and the 
production o f m utant proteins in this system might be an alternative to  the recombinant 
vaccinia virus system and constitu te  a promising way to  obtain more inform ation about 
the RNA binding determ inants o f the influenza virus polymerase. As an unexpected firs t 
result we obtained evidence th a t the PA prote in alone can specifically bind to  the 
conserved sequence at the 5' end o f influenza virus vRNA and mRNA. This dual binding 
specific ity  may be conferred by the very similar sequence o f these RNA ends and may 
explain how one protein could have a function in the genome binding o f the polymerase 
complex and outside the complex in virus specific gene expression. In the fu tu re  it could 
be tried  to  determ ine the physiologic role o f th is a c tiv ity  and establish the crucial 
parameters on the RNA and polypeptide sequences. A similar approach has resulted in the 
functional characterization o f o ther eucaryotic proteins, tha t were d ifficu lt to  express in 
standard protein expression system s. The determ ination o f the minimal RNA binding 
domain o f the spliceosomal U1A protein provided the basis fo r e ffic ien t expression and 
crysta lliza tion  o f the firs t RNA-binding-domain in the presence o f its  cognate RNA 
(Oubridge e t al., 1994; Scherly e t al., 1990; Scherly e t al., 1989 ). A previously 
unknown RNA-binding ac tiv ity  was shown w ith this technique fo r the FMR1 protein, and 
the loss o f the activ ity  seems to  be correlated with the development o f fragile X syndrome 
in humans (Ashley e t al., 1993 ). Finally, the in teraction o f the ribosomal L5 protein 
w ith  5S RNA was studied in the  in v itro  tra n s la tio n /b io tin y la te d  RNA system  to  
characterize this complex, which is im portant in nucleolar ribosome assembly (M ichael 
and Dreyfuss, 1996).
Taken together, all expression systems tha t have been tested in the present study are 
unlikely to  produce su ffic ien t fu ll-length  PA protein fo r crysta llographic studies. The 
m ost promising stra tegy for the fu ture  determination o f PA structure and function will be 
to  determ ine functional domains in this polypeptide th a t are easier to  express a t high 
levels. The in v itro  translation approach may help to  define such domains. An alternative 
approach m igh t be to  produce su ffic ien t PA in insect or yeast cells fo r a ffin ity  
purification, p ro teo lytic studies and microsequencing o f stable intermediates as a basis to  
id e n tify  the  regions to  be expressed in iso la ted  fo rm . Pre lim inary func tiona l 
characterization o f PA from d iffe ren t expression systems have suggested possible novel 
ac tiv ities  fo r th is protein. A t present, many fu rthe r experim ents are still needed to  
unequivocally establish and characterize these activ ities. However, an a c tiv ity  assay 
looking a t complex fo rm ation , RNA binding or ATPase a c tiv ity  is crucial fo r the  
development o f PA fragm ent expression.
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Chapter III
In v itro  transcription activ ity  o f Influenza virus RNPs
111.1 Introduction
The influenza virus possesses a unique, RNA-dependent RNA polymerase, which is a 
m ultifunctional protein complex consisting o f the three subunits PB1, PB2 and PA. As 
outlined above (1.4.2), two d iffe ren t forms o f the polymerase are presumably involved in 
transcription and replication events. The polymerase found in virus particles shows only 
transcrip tion  ac tiv ity , which is characterized by the use o f 5 ' capped (mZGpppNm- 
conta in ing) oligoribonucleotides as primers, and term ination o f RNA synthesis 17-22 
nucleotides before the 5' ends o f the vRNA templates. Polymerases capable o f replication 
in vitro , i.e. primerless in itia tion o f RNA synthesis and production o f fu ll-length copies 
o f the tem plate RNAs, have only been found in influenza virus infected mammalian cells at 
certain tim e-points a fte r infection (Krug e t al., 1989). Whereas the polymerase complex 
presumably carries all enzym atic activ ities required fo r transcrip tion  and replication, 
complete RNPs are the actual functional units. The packaging o f the tem plate  RNA into 
d is tinc t structures and the presentation o f the bases by nucleoprotein (NP) seem to  be 
required fo r e ffic ien t elongation during RNA synthesis. The RNPs, th a t are present in 
virus partic les, show several a c tiv itie s  in v itro , which can po ten tia lly  be used as 
markers fo r the screening o f potentia l antiviral compounds. They possess endonuclease 
activ ity , which means tha t they can characteristically cleave a variety o f capped RNAs at 
d is tinct positions (Plotch et al., 1981). Transcription is in itiated by the addition o f a GTP 
or a GTP to  a capped primer RNA. The transcripts are then elongated by the incorporation 
o f fu rthe r nucleotides. Finally, transcription term ination and polyadenylation occur at an 
oligoU stre tch  near the 5' end o f the vRNA (Hay et al., 1977a; Hay e t al., 1977b; Plotch 
and Krug, 1977 ; Robertson e t al., 1 981 ). In vitro , the  RNPs possess a low level 
transcrip tion ac tiv ity  even in the absence o f primer RNA, which can be stim ulated 1 0- 
100 fold by the addition o f the dinucleotides ApG or GpG (McGeoch and K itron, 1975; 
Plotch and Krug, 1977 ). The dinucleotides are incorporated in to  the  transcrip ts  at 
transcription in itiation and the RNA products are polyadenylated and can be translated in 
ce ll-free  system s (Bouloy e t al., 1978 ; Plotch and Krug, 1 9 7 8 ). Com plete RNPs, 
purified from egg-grown influenza A virus, have been used in this study to  determine the 
mechanism o f inhibition by 2 '-fluororibonucleotides, which show considerable antiviral 
activ ity  in cell culture and in the mouse pneumonia model (Tisdale e t al., 1993).
111.2 Principle o f influenza virus transcription assay systems
Since the discovery o f polymerase a c tiv ity  in influenza viruses, a number o f 
d iffe re n t in v itro  transcription assay systems have been developed to  study polymerase 
activ ities , p rom ote r structures and the mechanism o f inh ib ition by anti-polym erase
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compounds. In most cases, complete viral RNPs from detergent disrupted influenza virus 
are used as the polymerase source. The virus can be grown in fertilized chicken eggs or in 
mammalian cell cultures and be concentrated by sucrose gradient centrifugation. Lysis of 
the viral membrane is achieved in the presence o f 0.2-1%  Triton N101 or Triton X I00 
and 1% Lyso lec ith in , and RNPs can be fu r th e r purified  by g lyce ro l g rad ien t 
centrifugation  (Honda e t al., 1988; Plotch and Krug, 1977; Rochovansky, 1976). Both 
d isrupted viruses and purified RNPs show similar transcrip tion  ac tiv ity  in vitro, which 
can be measured by the incorporation o f radioactively labeled nucleotide-monophosphates 
(NMPs) in to  trich lo roace tic  acid (TCA) insoluble material. Complete viral mRNAs are 
only produced in the presence o f specific primers, e ither dinucleotides or capped and 
methylated mRNAs (Bouloy e t al., 1979; McGeoch and Kitron, 1975; Plotch e t al., 1979; 
Plotch e t al., 1981; Plotch and Krug, 1 97 7 ). The dinucleotide ApG primes transcription 
presumably by base-pairing w ith the  3' term inal bases o f the vRNA tem pla te  and is 
incorpora ted  in to  transcrip ts  (Honda e t al., 1 986 ). Labeled products o f in v itro  
transcrip tion  can be resolved on denaturing urea-polyacrylamide gels. Relatively sharp 
bands are obtained a fte r the removal o f the polyA tails by RNAse H digestion in the 
presence o f polyU RNA. These bands, a fte r ApG primed transcrip tion, m igrate slightly 
faste r than the vRNA molecules, because they are 17-22 nucleotides smaller than their 
tem plates (Plotch e t al., 1979; Plotch and Krug, 1978). With labeled mRNAs as primers 
o f influenza virus transcrip tion, the endonuclease reaction and transcrip tion  in itia tion 
can be studied as cleavage and elongation o f the precursor molecule. The reaction products 
are again visualized by denaturing gel e lectrophoresis (P lotch e t al., 1 98 1 ). In th is 
study, transcription in itia tion and elongation were studied using in v itro  transcribed and 
capped RNA as primer substrate together w ith labeled nucleotides and purified RNPs.
III.3 RNA substrates fo r influenza virus transcription
A large number o f d iffe rent RNAs can serve as substrates fo r the endonuclease activ ity  of 
the influenza virus polymerase complex. Several laboratories have sequenced the 5' ends 
o f viral mRNAs produced in infected cells, but the same host cell derived primer sequence 
has never been observed tw ice in these clones, suggesting th a t there is considerable 
redundancy in the mRNA substrate choice (Lamb and Choppin, 1983). Naturally occuring 
primer sequences imply a preference fo r the sequence PyGCA upstream o f the cleavage 
site , but cleavage a fte r G residues is also common. Studies w ith  capped nucleotide 
hom opolymers led to  the  suggestion th a t the polymerase m ight also recognize the 
nucleotide downstream adjacent to  the cleavage site (Kawakami e t al., 1983). It appears 
th a t the polymerase preferentially uses primers, th a t are able to  undergo base-pairing 
in te rac tion  w ith  the  3 '-te rm ina l uridine o f the viral RNA tem pla te , a lthough base- 
pairing between primer and tem plate are not required in v itro  (Beaton and Krug, 1981; 
Lamb e t al., 1981; Hagen e t al., 1995 ; Krug e t al., 1980 ). Consistent w ith  the 
heterogeneity observed in vivo, a number o f a rtific ia l RNAs can serve as specific
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endonuclease substrates in vitro, e.g. globin mRNA, reovirus mRNA, several in v itro  
capped plant virus RNAs, capped polyA and polyU and other synthetic RNAs (Bouloy e t al., 
1979; Bouloy e t al., 1980; Plotch e t al., 1979; Plotch e t al., 1981; Kawakami e t al., 
1983; Chung e t al., 1994). The presence o f a methylated cap structure is crucial for RNA 
molecules to  serve as substrates for the endonuclease. Uncapped RNAs or RNAs carrying a 
5 '-te rm ina l GpppG group are inactive as substra tes. RNAs w ith  cap 0 s tructu res 
(m 7G (5 ')ppp(5 ')X ) are usually active, but priming ac tiv ity  is stim ulated 2 -30  fold in 
the presence o f additional 2 '-0 -m e thy l groups in the cap o f mRNAs, so-called cap I 
s truc tu res  (m 7G (5 ')ppp (5 ')X m ) (Bouloy e t al., 1980 ). The distance between cap 
s truc tu re  and cleavage site  always ranges between 9 and 1 5 nucleotides. E ffic ient 
endonuclease substrates are presumed to  possess an optimal sequence surrounding this 
position, but the mechanism behind the observed cleavage site  se lec tiv ity  is not ye t 
understood. There is a preference fo r cleavage a fte r purines, but it  is unpredictable, 
which purine will be preferentia lly used on a given RNA w ith  several purines between 
position 9-1 5. Morevover, cleavage a fte r U residues has also been repeatedly observed 
a lbeit a t lower e ffic iency (Hagen e t al., 1995 ). In the present study, com m ercia lly 
available rabbit globin mRNA (GIBCO), tw o  synthetic RNAs, the pGEM transcrip t and the 
pUCT7GEM RNA, as well as the dinucleotide ApG were used as primers fo r influenza virus 
specific in v itro  transcrip tion  reactions. pGEM RNA was produced by SP6 polymerase 
directed, in v itro  run-o ff transcription reactions from  Sma I digested pGEM7Zf+ plasmid 
DNA (Prom ega), pUCTZGEM RNA by T7 polymerase d irec ted  tra n sc rip tio n  from  
pUCT7GEM plasmid (sequence, see table 11.3, page 78). A cap 0  structure  could be added 
w ith approxim ately 50% effic iency by including a cap analog (mZGpppGTP) in the in 
v itro  transcrip tion reaction. A lternative ly, an in v itro  capping reaction was performed on 
gel-purified RNAs using vaccinia virus guanylyltransferase, which has very recently 
been made commercially available (GIBCO). Unlike o ther mRNA substra tes, which are 
usually cleaved heterogeneously by the influenza virus polymerase, the capped pGEM RNA 
is specifically cu t at a single position, a fte r a G residue, 11 nucleotides downstream of the 
cap. The resulting endonuclease product is called G11 (Chung e t al., 1994 ). This unique 
qua lity  o f the pGEM RNA fac ilita tes  the  iden tifica tion  o f transcrip tion  p roducts on 
analytical gels. Figure III.1 schematically depicts the presumed base-pairing interactions 
between tem plate  and nascent RNA during transcription in itia tion  and the products of 
transcription initiation reactions in the presence o f CTP and GTP.
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Figure III.1: Products of RNP directed transcription initiation in the presence of CTP and GTP 
and pGEM RNA as primer. (A) shows the proposed base-pairing interaction 
between the endonuclease product and the genomic RNA template. Transcription 
can be initiated with CTP (B) or GTP (C) to form a 12 nt product. In the presence
of both GTP and CTP the G11 primer can be elongated with 1,2 or 3 nucleotides
(see figure III.7).
III.4 Influenza virus in wfro transcription
111.4.1 Characterization of general transcription conditions
Trichloroacetic acid (TGA) precipitation assays were performed to measure the relative 
transcrip tion  activ ity of purified RNPs from d ifferent in fluenza A/PR/8/34 virus 
preparations, that were obtained from Pasteur-Mérieux, Lyon. These assays measure the 
incorporation of radioactively labeled NMP into acid insoluble material. We found up to 
100-fold differences in transcription activity between different virus batches, but we 
have not yet an explanation for these differences. The Km values for ribonucleotides, as 
determined by double reciprocal plots, were similar for the high activity and low activity 
virus preparations examined. As shown in figures III.2, III.3 and table III.1, the Km 
values were comparable for either ApG primed or pGEM RNA primed transcription. The 
relative polymerase activities are depicted as incorporation of UMP or CMP (in moles) 
per mole of RNP. Because transcription was performed in a mixture of all 8 viral RNA 
segments, a mean vRNA length of 1700 nt (580 kD), packed with 85 NP monomers 
(4764 kD) and one polymerase complex (255 kD) was used as a basis to calculate 
specific polymerase activities. The concentration of purified RNPs was estimated from 
Coomassie-stained gels in comparison with BSA and optical density measurements at 260 
nm. These values correlated reasonably well with 1 OD26O corresponding to 60 jig/m l 
RNP.
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F igure  I I I .2: RNP activ ity assay of ApG primed transcription. Standard transcription assays 
(see chapter IV) were performed with two unlabelled NTPs at a concentration of 
500 pM , 400 pM ApG and 50 pM of one labelled NTP. The determination of 
[32p]UMP or [32p]CMP incorporation into trichloroacetic acid insoluble material 
was then performed in the presence of increasing concentrations of the fourth 
NTP as shown on the x-axis. Polymerase ac tiv ity  is depicted as relative 
incorporation o f UMP or CMP (in moles) per mole of RNP in the assay. The 
insets show double reciprocal plots of the same experiment. The calculated 
values are shown in table lll. l.
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Figure II I .3: RNP a c tiv ity  assay o f capped pGEM primed transcrip tion . Standard 
transcription assays (see chapter IV) were performed with two unlabelled NTPs 
at a concentration of 500 pM, 100 ng mRNA analog and 50 pM of one labelled 
NTP. The determ ination o f [32p]UMP or [32p]CMP incorporation into 
trich loroacetic acid insoluble material was performed in the presence of 
increasing concentrations o f the fourth  NTP, as shown on the x-axis. 
Polymerase activ ity is depicted as relative incorporation o f UMP (in moles) per 
mole of RNP in the assay. The insets show double reciprocal plots of the same 
experiment. The calculated values are shown in table l l l . l .
Chapter III : In vitro transcription 87
Tab le  l l l . l :  The Km values in pM for the four substrates of the influenza virus RNPs as
apparent from incorporation of radioactive nucleotides into acid insoluble 
material. The values for A /P R /8 /34  were taken from figures III.2 and III.3, 
those for A /V ic /3 /7 5  from (Stridh and Datema, 1984).
_______Primer______________ CTP____________ UTP____________ ATP____________ GTP
ApG
Km (A /P R /8 /3 4 ) 6 10 120 2
Km (A /V ic /3 /7 5 ) *  22 14 153 14
pGEM RNA
Km (A /P R /8 /3 4 ) 10 10 120 2
globin mRNA
Km (A /V ic /3 /7 5 ) *  0.5 0.5 82_____________ 1.2
The Km values for ATP were reproducibly found to  be about 10-fold higher than those for 
the other nucleoside triphosphates. The same phenomenon has been observed w ith other 
influenza virus strains (table l l l . l ) ,  as well as w ith o the r RNA and DNA-dependent RNA 
polymerases (Krakow e t a!., 1976; Testa and Banerjee, 1979). This d ifference in Km 
m ight simply re flect an adaptation o f the viral polymerase to  naturally occurring NTP 
concentrations in eucaryotic cells, where ATP levels are usually 7 to i  0-fo ld  higher than 
other NTPs (Fairbanks e t al., 1995; Stridh, 1983), but it  is also possible tha t ATP plays 
an additional role other than tha t o f a ribonucleoside triphosphate substrate used for chain 
elongation. ATP hydrolysis may be needed early in transcrip tion as was observed w ith 
vesicular s tom atitis  virus (VSV) RNPs, another negative strand RNA virus (Perrault and 
McLear, 1984; Testa and Banerjee, 1979). VSV polymerase showed a high Km for ATP 
during transcrip tion in itia tion, but a significantly reduced Km for ATP during elongation. 
One reason fo r th is special requirem ent o f ATP during transcrip tion  in itia tion  o f VSV 
polymerase may be the essential phosphorylation o f the polymerase co fac to r, the P 
protein, in this system (Chattopadhyay and Banerjee, 1987; Gao and Lenard, 1995). A t 
the moment, it is not clear if there is a co facto r functionally equivalent to  the  VSV P 
protein in the influenza virus system.
T7 RNA polymerase, which is independent o f ATP during transcrip tion in itia tion, 
shows a Km value fo r ATP similar to  those fo r o ther NTPs (7 -20  pM)(Chamberlin and 
Ryan, 1982 ; Osumi-Davis e t al., 1992 ). In terestingly, it  has been shown th a t T7 
polymerase undergoes a conformational change early in transcrip tion. The transcrip tion 
in itia tion  phase is characterized by a s ign ifican tly  higher Km fo r GTP, the in itia ting  
nucleotide, and the  production  o f abortive  transcrip ts  o f 1-2 nucleotides length. 
Especially the production o f short, abortive transcripts has been described fo r many RNA 
polymerases, tha t undergo conformational changes during RNA synthesis (Osumi-Davis et
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aL, 1 992; Sousa et al., 1 992). These examples show tha t RNA polymerases can go through 
a switch-like change in conform ation and/or protein composition between transcrip tion 
initiation and elongation phases.
Transcrip tion  by vesicular s tom a titis  virus RNPs has been analyzed in the 
presence o f ATP analogs. When ATP was replaced by AMPPCP no activ ity  was detectable in 
acid p rec ip ita tion  assays, a lthough the analysis o f reaction products revealed the 
fo rm ation  o f short, in terna liy in itia ted , abortive  transcrip ts  (Perrault and McLear, 
1984; Testa and Banerjee, 1979). Only when purified, ATP-preincubated RNPs were 
used, radioactive UMP incorporation in to  RNAs was observed, even when AMPPCP 
repiaced ATP. Similar results have now been obtained w ith influenza virus RNPs. The ATP 
analogs AMPCPP and AMPPCP, which conta in non-hydrolyzable a-p  and p-y bonds 
respective ly, could no t su bs titu te  fo r ATP in transcrip tion  assays (figu re  III.4A). 
AMPCPP serves as a control in this type o f assay, because due to  the blocked a-p bond it 
cannot be incorporated into any RNA transcripts. AMPPCP, on the other hand, possesses a 
hydrolyzable a -p  bond and could in principle be used fo r incorporation during RNA 
synthesis, as has been observed w ith VSV polymerase during elongation. The fac t th a t 
AMPPCP cannot su b s titu te  fo r ATP in influenza virus transcrip tion  may the re fo re  
indicate that, as in the VSV system, ATP p-y bond hydrolysis is required fo r transcrip tion  
initiation. However, it could also be tha t the influenza virus polymerase ju s t does not have 
a high enough a ffin ity  fo r AMPPCP in order fo r it to  support RNA synthesis. To get an idea 
fo r this a ffin ity , in a second type o f experiment elongation reactions were perform ed in 
the presence o f 500  pM ATP, and the ability o f ATP analogs to  compete w ith ATP during 
tra nsc rip tion  was measured. AMPCPP very s tro ng ly  inh ib ited  the  influenza virus 
polym erase (figu re  III.4B) w ith  half-m axim al inh ib ition  in the  range o f 100  pM 
AMPCPP. This suggests th a t AMPCPP can prevent ATP binding to  the active site o f the 
polymerase very e ffic ien tly  and the polymerase appears to  possess considerable a ffin ity  
fo r the ATP analog. However, because AMPCPP has a blocked a -p  bond, it cannot be 
incorporated in to  RNA and transcrip tion is inhibited. There was much less transcrip tion  
inhibition by AMPPCP and transcrip tion  could never be com plete ly inhibited. Even the 
increase o f ATP in the  reaction led to  a decrease in UMP incorporation during RNA 
synthesis (figure III.4B). The apparent d iffe rentia l inhibition o f influenza virus specific 
transcription by the tw o ATP analogs and the fact tha t AMPPCP failed to  completely inhibit 
influenza virus transcrip tion , is cons is ten t w ith  incorpora tion  o f AMPPCP, bu t no t 
AMPCPP, during elongation, although purely com petitive  inhibition by AMPPCP cannot be 
fo rm a lly  excluded from  these results. The d iffe rence  in inh ib ition  betw een high 
concentrations o f ATP and AMPPCP, as seen in figure III.4B, may be due to  a s ligh tly  
worse efficiency o f AMPPCP a -p  bond hydrolysis compared to  ATP. Radioactively labelled 
ATP analogs m ight be used in the fu tu re  to  decisively answer the question o f AMPPCP 
incorporation during elongation.
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F igure  II I .4 : ApG-primed in vitro  transcription with influenza virus RNPs in the presence of 
increasing amounts of ATP or ATP analogs. (A) Reaction with 500 pM CTP and 
GTP, 50 pM labelled UTP (5 pCi) and up to  1 mM ATP or ATP analogs as 
indicated. (B), transcription reaction as in (A) including 500 pM ATP. 
Reactions were at 3 I X  for 1 h, followed by precip ita tion  w ith 25% 
trichloroacetic acid.
C onsistent w ith  a role fo r ATP p-y bond hydrolysis in in fluenza virus spec ific  
transcrip tion, Influenza virus RNPs were found to  cosediment w ith  an ATPase ac tiv ity  on 
glycerol gradients (figure III.5). ATPase ac tiv ity  was strongest w ith  RNPs and RNP-ApG- 
C in itia tion  complexes. When GTP and UTP were added to  the reaction to  prom ote the 
form ation o f elongation compexes, ADP production from ATP decreased. The same set o f 
transcrip tion  reactions has been performed w ith saturating concentrations o f unlabelled 
ATP, and the reaction products could be separated by reverse phase HPLC. ADP production 
was again evident and about 2-fo ld  higher in in itia tion  reactions compared to  to ta l 
tra n sc rip tio n  reactions including both in itia tion  and e longation  (figu re  III.6 ). The 
successful production o f p re-in itia ted RNP-primer complexes will be required in order 
to  determine, if ADP production occurs exclusively during transcription initiation.
Taken together, both the increased Km fo r ATP in influenza virus transcrip tion  
compared to  the other NTPs, and the ATPase activ ity connected to  influenza virus RNPs are 
consistent w ith a possible requirement o f ATP (3-y bond hydrolysis early in transcrip tion  
and support the idea of a conform ational change between polymerase in itia tion  and 
elongation complexes. In an a ttem p t to  identify  the respective protein containing the 
ATPase a c tiv ity  in RNP preparations, we perform ed ATP-binding experim ents w ith 
oxidized ATP as described in chapter II, 11.2.1.3. However, the search fo r a specific ATP- 
binding protein in the RNP preparations has so far been unsuccessful, most likely due to 
m ethodological problems. Even PB1, which presumably contains the  RNA polymerase 
domain and was meant to  function as an internal ATP binding contro l protein, was not
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specifically labelled by oxidized ATP during transcrip tion elongation. In the fu tu re  it 
m ight also be tried to  separately purify in itiation and elongation complexes and perform 
comparative studies o f these tw o phases w ith  regards to  Km values fo r NTPs. Such 
experiments will hopefully help to  resolve the differences between the tw o  hypothetical 
polymerase conformations.
RNP, [a3zp]ATP 
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Figure III.5: ATPase ac tiv ity  o f influenza virus RNPs. (A ) 4 pg RNPs were incubated for 30 
min at 31X  in transcription buffer with 5 pCi [a^^P]ATP alone (lane 1 and 6), plus additionally 
400 pM ApG and 500 pM CTP (lane 2 and 7), 400 pM ApG and 500 pM CTP, GTP, UTP (lane 3), 
400 pM ApG and 500 pM CTP, GTP, UTP, ATP (lane 4 and 5). The RNPs were preincubated with 
5 pi monoclonal anti-PA antibody (L35E12) in the reactions of lanes 5, 6 and 7. Lane C depicts 
[a32p]ATP incubated in transcription buffer. Reaction products were separated in 1 M LiCI, 0.5 
M acetic acid on TLC plates. The positions of markers are indicated on the left. The arrowhead 
denotes a band, which is produced only in transcription initiation reactions. This band was not 
identified, but migrated similar to  an ApGp marker. The star shows the position of a band, which 
is only produced in elongation reactions and may constitute a RNA product of limited size. (B) 
Labelled ADP marker was produced by incubation of 10 pCi [a^^PJATP w ith 0.2 pi T4-PNK and 
100 ng DNA primer (lane 1), labelled ApGp marker from incubation of 600 pM ApG with 0.5 pi 
T4 PNK with 10 pCi [ f  ^ P]ATP (lane 2). Lane 3 is a phosphatase reaction with limiting amounts 
o f alkaline phosphatase, giving ATP and ADP marker. Lane 4, incubation of [a^ZpjATP in 
transcription buffer; lane 5, incubation of [a^^P]ATP with 4 pg RNPs in transcription buffer, 
Lane 6, Transcription initiation reaction with RNPs, [a ^^P]ATP, ApG and CTP.
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F igure  I I I .6: HPLC separation o f small nucleotides produced in RNP transcription reactions on a
2 ml Waters Symmetry C IS  column. The x-axis denotes the retention time of 
nucleotides on the column as indicated, the y-axis relative absorption units 
measured at 260 nm. The separate experim ents aligned along the 
z-axis show from front to  back 1 h incubations at 31 °C in transcription buffer of 
(1 ) Z ijg  RNPs with 1 mM ATP, (2 ) 1 mM ATP alone, (3 ) 2 ^g RNPs with 1 mM 
ATP and 0.4 mM ApG primer, (4) 1 mM ATP and 0.4 mM ApG alone, (5) 2 ijg  RNPs 
with 1 mM ATP, 0.4 mM ApG and 0.5 mM each CTP, UTP, GTP. The experiment 
shows ADP production only in the presence of RNPs and a 50% reduction in ADP 
production in a complete transcription reaction (5), compared to  free RNPs (1) and 
RNP-primer complexes (3). "p" denotes an additional peak, which only appears 
after transcription initiation and presumably constitutes a small RNA product. The 
chromatography was performed in 0.1 M potassium phosphate, pH 6.5, 5 mM 
tetrabutylammoniumhydroxide (TBA). Bound nucleotides were eluted with a 0-50% 
methanol gradient in the same buffer (20 min at 1 ml/min).
1.4.2 Transcription reactions primed w ith capped RNA molecules
III.4.2.1 Characterization o f transcription in itiation and elongation reactions 
As shown in Figure III.7A, a reaction including viral RNPs, pGEM RNA and labelled CTP 
leads to  the production o f a single 12 n t RNA product o f transcription in itia tion (lane 12, 
" in itia tio n  reac tion "), as also shown schem atica lly in figure l l l . l ,  page 84. In the 
additional presence o f unlabelled ATP, GTP and UTP, elongation to  fu ll-length RNAs is 
observed, which stay near the top  o f 20% urea-PAGE gels (figure III.7A, lanes 13-16, 
"elongation reactions"). In this, as well as in the following experiments, there was always 
some unspecific residual radioactiv ity, th a t stayed in the wells o f the 20% acrylamide 
gels. The origin o f this rad ioactiv ity  was not explic ite ly determ ined, but m ost likely 
reflects insoluble precipitates formed in the transcription reactions a fte r addition o f the
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formarnide loading buffer and heating to  95°C before loading. Therefore, only bands, tha t 
had a t least s ligh tly  entered the gel were considered as specific and included in 
quan tita tive  measurements. Lanes 1-8 in figure II.7A show a titra tio n  o f GTP in to  a 
tra n sc rip tio n  in itia tion  reaction w ith  pGEM RNA and labelled CTP. A t low GTP
concentrations, no GTP, but only the labelled CTP is exclusively added to  the primer RNA 
and a band corresponding to  G11+1 nt is visible (lanes 1 and 2). A band o f G 11+2nt is 
f irs t observed at considerable excess o f GTP (40 -fo ld ) in the reaction (lane 3). As shown 
on figure l l l . l ,  page 84, this second band can either be formed by transcription in itiation 
w ith CTP and incorporation o f GTP as the second nucleotide, or by initiation w ith GTP and 
incorporation o f CTP as the second nucleotide. A t very high GTP concentrations, G11 +3nt 
products are observed (lanes 7 and 8), tha t presumably stem from in itia tion w ith GTP 
and subsequent addition o f CTP and GTP (see also figure l l l . l ) .  According to  this 
experim ent the firs t nucleotide, CTP, seems to  be more e ffic ien tly  added to  the primer 
than the  second one, GTP. The band intensities decrease w ith  increasing GTP in the 
t itra tio n , because o f com petition  between GTP and labelled CTP fo r transcrip tion  
initiation.
Even in the presence o f all four nucleotide triphosphates, significant amounts o f 
doublet bands o f 1 2 and 1 3 nucleotide lengths were still produced toge the r w ith long 
transcrip ts  (figu re  III.7A, lanes 14, 15). These bands are m ost likely p roducts o f 
abortive  transcrip tion  in itia tion , and they are especially strong at lower nucleotide 
concen tra tions. The production  o f e ithe r very short, d is tin c t, abo rtive  in ita tion
transcrip ts  or large transcrip ts  in the  absence o f in te rm edia te  size RNAs can be 
considered as an indication fo r a lim iting step early in transcription, e.g. a conformational 
change between transcription in itiation and elongation complexes, as has been discussed 
before fo r o ther RNA polymerases (Jacob e t al., 1994; Kubori and Shimamoto, 1996; 
Sousa e t al., 1992). With influenza virus RNPs, the incorporation o f the firs t ATP, which 
has to  be used as the second or third nucleotide, appears to  be a rate lim iting step during 
early transcrip tion . C onsistent w ith  th is  notion, we never succeeded in e ffic ie n tly  
producing G11 +2nt RNAs in the presence o f CTP and ATP or G11 +3 RNAs in the presence 
o f CTP, GTP and ATP. Likewise we never captured G11+3, +4 and +5 RNAs. Instead, w ith 
CTP, GTP and ATP present, the  RNPs e ither produced abortive  transcrip ts  lacking
adenosine (A ) residues or RNAs o f 20 -30  nucleotides length, which are com plete
transcripts halted at the position, where the firs t U residue were to  be incorporated into 
mRNA (see figure III.9, page 97 and scheme in l l l . l ,  page 84). All these observations 
corre la te  well w ith  the previously discussed results o f transcrip tion  reactions in the 
presence o f ATP analogs and the ATPase ac tiv ity  o f RNPs and support a model o f the 
influenza virus polymerase complex going th rough a measurable change between 
transcription initiation and elongation phases.
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Figure III.7: In v itro  transcription activ ity  o f influenza virus RNP. 3 pg purified RNPs were 
incubated with 0.25 pM [a^^P]-CTP (5 pCi) and 0.1 pg capped pGEM RNA in transcription buffer 
to  which other nucleotides were added at variable concentrations. The reaction products were 
analyzed on 20% urea-PAGE gels. (A ), effect of GTP on transcription initiation. Both GTP and 
CTP can be incorporated during transcription initiation. Lanes, 1-8, transcription reaction with 
increasing concentrations of GTP (0.2, 1, 5, 10, 16, 50, 100, 200 pM respectively); lane 9 and 
10, addition o f 8 pM 2'-FdCTP w ithout (9) or with (10 ) 1 pM ATP, GTP, DTP to  the standard 
in itia tion reaction; lane 11, addition o f 8 pM CTP to  the initiation reaction; lane 12 , basic 
transcription initiation reaction with only [a^^P]-CTP, lanes 1 3 -1 6 , addition of ATP-GTP-UTP- 
mix at 1, 5, 10 and 100 pM. (B) Transcription inhibition by cap analogs. Reactions have been 
done and loaded in pairs. Uneven numbers are initiation reactions w ith 0.25 pM [a^^pj-CTP 
(5 pCi) as only NTP. Even numbers are elongation reactions with 100 pM ATP, GTP, UTP in 
addition to  the label. These reactions were performed in the presence of 0.2 mM cap I 
(mZGpppGm) (lanes 1, 2), 0.2 mM cap 0 (mZGpppG) (lanes 3, 4), 0.48 mM mZGTP (lane 5, 6), 
0.87 mM mZGDP (lanes 7, 8). Lanes 9, 10 are control reactions in the absence of inhibition.
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No transcription in itiation was observed w ith uncapped pGEM RNA, confirming the 
results o f Chung e t al. (1 9 9 4 ) and illustra ting the  sp ec ific ity  o f the transcrip tion  
reaction as well as the need fo r a cap structure. Transcription in itiation was specifically 
inh ib ited by cap analogs (figu re  III.7B). Consistent w ith  the  results o f Blaas e t al. 
(1 9 8 2 ), inh ib iting  a c tiv ity  o f cap aniogs in influenza v irus specific  transcrip tion  
decreased in the series cap I (m7GpppGm) > cap 0  (m7GpppG) »  m7GTP > m7GDP. These 
results demonstrate, tha t the present transcription assay really measures cap-dependent 
transcription initiation.
III.4 .2.2 Transcription inhibition by 2'-deoxy-2'-fluoroguanosine triphosphate
The above described transcrip tion  assay was used to  study the mechanism of 
influenza virus inhibition by 2 '-deoxy-2 '-fluororibonucleotides. The addition o f 40 juM 
2 '-deoxy-2 '-fluo roguanos ine -triphosphate  (2'-FdGTP) to  the  transcrip tion  in itia tion  
m ixture resulted in the appearance o f tw o products o f 1 2 and 1 3 nucleotides respectively 
(figure III.8, lane 5). The same doublet o f bands was produced, when 40 juM GTP replaced 
2'-FdGTP in the reaction (lane 6). This result strongly suggests th a t the nucleotide analog 
2 ’-FdGTP is recognized by the  influenza virus polymerase and can be incorporated into 
specific, capped mRNAs during the  in itiation o f transcrip tion, w ith an e ffic iency similar 
to  th a t o f GTP. The doublet o f bands showed 40-50%  reduced incorporation o f to ta l 
rad ioactiv ity compared to  a standard initiation reaction in the absence o f e ffec to r (lane 1 
o r 3 ), according to  band density scanning o f autoradiographs. This reduction in band 
in tens ity  is m ost likely due to  com petition between unlabelled GTP and labelled CTP fo r 
being used during transcrip tion in itia tion (see above in III.4 .1 .1 ). From the  comparable 
reduction o f to ta l rad ioactiv ity it  can be concluded th a t both 2 ’ -FdGTP and GTP compete 
w ith  comparable e ffic iency w ith labelled CTP at transcrip tion  in itia tion. The sim ilarity 
o f the  double t bands produced in the presence o f GTP or 2'-FdGTP implies th a t no 
s ign ifican t inhibition o f the  influenza virus polymerase complex occurs prior to  the  
incorporation o f the second nucleotide during mRNA synthesis. Specific inhibition o f 
transcrip tion  became apparent only in elongation reactions w ith  all fou r NTPs and 
including 2'-FdGTP. The production o f long transcrip ts was sign ificantly reduced in the 
presence o f 2'-FdGTP compared to  control reactions w ith  GTP (figure III.8, lanes 7 and 
8). The lower intensities o f the  transcription elongation products in the presence of 2 '- 
FdGTP, toge the r with the fac t th a t 2 ’-FdGTP can be incorporated by the influenza virus 
polymerase into nascent mRNAs, suggested tha t the nucleotide analog may function as a 
chain term ina to r a fte r incorporation.
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Figure III.8: In vitro  transcription in the presence of the nucleotide analog 2 '-deoxy-2'fluoro-
guanosine-triphosphate (2'-FdGTP). The figure shows two separate experiments 
for the standard initiation (lanes 1 and 3) and elongation (lanes 2 and 4) reactions. 
All reactions were performed with 3 pg RNPs, 0.1 pg pGEM RNA and 0.25 pM 
[a^^P]-CTP (5 pCi). The reactions loaded in lanes 2, 4, 7 and 8 additionally 
contained 5 pM each ATP, UTP and GTP. Either 40 pM 2'-FdGTP or 40 pM GTP 
were added to  the reactions as indicated above the lanes (lanes 5-8). The reaction 
products were analyzed by autoradiography of 20% urea-PAGE gels.
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Limited elongation reactions in the absence of UTP also support the idea o f a chain 
term ination mechanism o f transcription inhibition by the fluorinated nucleotide analogs. 
In the absence o f UTP, the polymerase protein can only elongate the nascent mRNAs until 
the firs t adenine residue on the vRNA template. According to  the sequence variation in the 
d ifferent RNA segments, mRNA molecules o f 21-31 nucleotides length can be produced in 
transcrip tion  reactions w ith  pGEM RNA primer, viral RNPs, CTP, ATP and GTP (figure 
III.9, lane 2; figure III.9 shows tw o d iffe rent exposure times o f the same gel in order to  
resolve in itia tion  bands as well as lim ited elongation bands). A parallel se t o f lim ited 
elongation reactions like the ones in figure III.9, lanes 1 and 2 were preincubated for the 
same tim e as in lanes 1 and 2 and then provided with additional NTPs (ATP, UTP, GTP) to  
allow complete elongation. Lane 4 shows tha t in this way large amounts o f long transcripts 
can be produced from such preincubated lim ited elongation reactions. In the presence o f 
2'-FdGTP, replacing GTP during lim ited elongation, v irtua lly  no RNAs between 21-31 
nucleotides are synthesized (lane 1 ). Apart from the 1 2 n t and 1 3 n t transcrip ts only a 
very low in tensity band o f about 1 9 n t length is synthesized in the presence o f 2'-FdGTP, 
labelled CTP and ATP (lane 1). Transcription in lane 1 compared to  lane 2 appears to  be 
blocked at G11 +2nt, i.e. at the position, where the firs t G residue is incorporated into the 
nascent RNA (see sequence scheme in figure III.1, page 4). This result supports the 
concept th a t incorporation o f 2'-FdGTP early in transcrip tion  blocks the elongation of 
mRNAs by the influenza virus polymerase.
However, both prematurely term inated bands o f 1 3 nt and 1 9 nt diminish a fte r the 
addition o f fu rthe r nucleotides, during elongation (lane 3), suggesting tha t the apparent 
block o f transcrip tion  by 2'-FdGTP incorporation is reversible. Consistent w ith  the 
revers ib ility  o f inh ibition by 2'-FdGTP was the observation th a t RNA synthesis was 
strongly inhibited in reactions w ith viral RNPs, ApG primer, ATP, CTP labelled UTP and 
2'-FdGTP. But even a fte r extensive preincubation o f th is reaction in order to  produce 
maximal amounts o f blocked transcrip ts, transcrip tion e ffic ien tly  resumed, when large 
amounts o f GTP were added to  the preincubated reactions (Tisdale e t al., 1 9 9 5 ). These 
results suggest th a t the  influenza virus RNPs are capable o f regenerating blocked 
transcrip ts . Before going in to  fu rthe r discussion o f th is  unusual a c tiv ity  fo r a RNA 
polymerase, the following paragraph will show examples o f transcrip tion reactions in the 
presence o f another fluorinated nucleotide analog, 2'-FdCTP. The observations w ith the 
cytid ine  analog support the  model o f transcrip tion  inh ib ition caused by compound 
incorporation and elongation block. Finally, it will be shown th a t the above results were 
also confirmed by perform ing the transcription reactions w ith  globin mRNA as a primer 
o f influenza virus transcription instead o f the pGEM RNA.
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F igure  III.9: In vitro  transcription in the presence of the nucleotide analog 2 '-deoxy-2'fluoro- 
guanosine-triphosphate (2'-FdGTP). The figure shows two different exposure times o f the same 
experiment. 2'-FdGTP prevents lim ited elongation and blocks transcrip ts at the position 
G 11+2nt, where it  is presumably incorporated (see scheme in figure III.1, page 84). 
Transcription from 3 pg RNPs was primed with 0.1 fjg pGEM RNA and 0.25 pM [a^^P]-CTP (5 
IjC\) and 5 pM ATP in the additional presence of either 40 pM 2' F-dGTP (lane 1 ) or 40 pM GTP 
(lane 2). To switch from limited to  complete elongation, 5 pM ATP, UTP and GTP were added to 
p re in cu b a te d  lim ited elongation reactions. Lanes 3 and 4 show the products o f complete 
elongation when the samples of lanes 1 and 2 were supplemented with 5 /jM ATP, UTP and GTP. 
The reaction products were analyzed by autoradiography of 20% urea-PAGE gels.
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lli.4.2.3 Transcription inhibition by 2 '-deoxy-2 '-fluorocytid ine triphosphate
Similar experiments as described above for 2'-FdGTP were performed w ith the nucleotide 
analog 2 '-deoxy-2 '-fluo rocytid ine-triphospha te  (2'dFCTP). Figure 111.10 shows on the 
le ft panel one more standard transcription initiation and one elongation reaction. The right 
panel o f figure 111.10 shows th a t prematurely term inated transcrip ts accumulate during 
elongation in the presence o f 2'-FdCTP (righ t panel, lane 3), but not when 2'-FdCTP was 
replaced by CTP (lane 4; both panels o f figure 111.10 were cu t ou t from  the same 
autoradiograph). These reactions were done w ith very low amounts o f inhibitor (0.8 ijM) 
in order to  avoid too  strong a com petition o f the unlabelled CTP analogs w ith the labelled 
CTP in these transcription reactions. This is the reason tha t, apart from  the apparent 
inh ib itory e ffe c t on elongation, there were also reasonable amounts o f long transcrip ts 
produced in lane 3. In the experiments w ith 2'-FdCTP the com petition w ith  the labelled 
CTP reduced the overall signal obtained in the reactions in the presence o f the e ffectors. 
CTP appeared to  be a 3-fold be tte r com petito r than 2'-FdCTP fo r the labelled CTP, as 
determ ined by density scanning o f the corresponding bands on the autoradiograms. In 
figure 111.10, the form ation  o f the labelled G l l + I n t  transcrip tion  in itia tion  band was 
reduced to  20% o f the control in the presence o f cold CTP as e ffec to r contro l (compare 
righ t panel, lane 2 w ith le ft panel, lane 1), but the G 11+1nt in itia tion  band was only 
reduced to  60% o f the contro l w ith 2'-FdCTP (compare righ t panel, lane 1 w ith le ft 
panel, lane 1). This result strongly suggests tha t, as before w ith 2'-FdGTP, transcription 
in itia tion and earlier steps (cap-binding, endonuclease ac tiv ity ) are not inhibited by the 
fluorinated nucleotide analogs. Both guanosine and cytid ine analogs appear to  mainly 
inhibit transcription elongation.
In the following, preincubation o f RNPs w ith 2'-FdCTP was used to  address again 
the question o f reversibility o f transcription inhibition, tha t had before become apparent 
w ith the guanosine analog 2'-FdGTP. The experiments shown above in paragraph 111.4.2.2 
established th a t 2'-FdGTP could be incorporated into transcrip ts early in transcrip tion, 
and blocked transcripts corresponding to  G11 +2nt accumulated in the reactions (figure 
III.9). We also obtained evidence tha t 2'-FdCTP could be incorporated into transcripts in a 
similar manner, an exemplary gel o f which will be shown and discussed fu rthe r below 
(figu re  111.13, lanes 17-20 ). From a tim e course reaction it appeared th a t a 30 min 
incubation was su ffic ien t fo r maximal CMP incorporation during transcrip tion  in itia tion 
to  form  maximal amounts o f G l l + I n t  in itia tion products. We there fo re  expected to  
produce significant amounts o f blocked G11+1 nt products when incubating RNP-primer 
complexes w ith  only 2'-FdCTP. Interestingly, the preincubation fo r 30 min o f RNP- 
primer complexes w ith only 2'-FdCTP before adding labelled CTP for another 30 min had 
only a minor e ffect on the production of the G11 +1 nt RNA product compared to  reactions, 
where both compound and label were added simultaneously (figure III.11, compare lanes 1 
and 5).
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elongation reactions in the absence of compound. Transcription from 3 /L/g RNPs 
was primed w ith 0.1 /L/g pGEM RNA and 0.25 pM [a^^P]-CTP (5 juCi) in the 
additional presence of either 5 pM ATP, GTP and UTP, 0.8 /lvM 2'-FdCTP or 0.8 
/vM CTP, as indicated above each lane. In the presence of the nucleotide analog, 
the transcript lengths are reduced during elongation, consistent with the idea of a 
transcription block or low efficiency elongation after compound incorporation. 
There are still long transcripts produced in the presence of compound, because 
the reaction was done at the lower detection level o f the inhibitory effect. The 
reaction products were analyzed by autoradiography of a 20% urea-PAGE gel.
Chapter III : In vitro transcription 100
preincub atlon  
RNP/  pGEM RNA / e f f e c t o r
1
a ddi t i on  o f  [ « 3 zp]CTP
NTPs addition of
2 '-  FdCTP CTP 2*- FdCTP CTP
1 II
ATP 
— UTP -  
GTP
ATP
UTP
GTP
ATP ATP 
UTP UTP 
GTP GTP 
CTP CTP
1 2 3 4 5 6 7
•  •  • •
prein cu bat ion  
RNP /  pGEM R N A / e f f e c t o r  
[«3ZP]CTP
IOOavM NTPs
f
O il *  2nt 
-# -01 1  fC TP
Figure III. 1 1 In v itro  transcription in the presence o f the nucleotide analog 2'-deoxy- 
2 'fluoro-cytidine-triphosphate (2'-FdCTP). The reaction conditions were as 
described in figure 111.10. Lanes 1-4, preincubation of RNP, pGEM RNA and 0.8 
pM 2'-FdCTP (1, 2) or CTP (3, 4) for 30 min, then addition o f 0.25 
[a32p]-CTP (5 pCi) (lanes 1, 3) or 0.25 pM [a^ZpjcTP plus 5 pM ATP, UTP, 
GTP (lanes 2, 4) for another 30 min. Lane 5, incubation of RNP, pGEM RNA, 
0.8 avM 2'-FdCTP and 0.25 pM [a^^pjCTP for 30 min; lane 6, preincubation as 
in lane 5, then addition of 100 pM NTPs and incubation for further 30 min; 
lane 7 reaction as described for lane 6 w ith 0.8 pM CTP replacing 2'-FdCTP.
To account fo r th is  observation, e ither there  was no incorpora tion  and block o f 
transcrip tion at in itia tion ( G l l + I n t  production), or the RNPs regenerated G11 primers 
fo r de novo transcrip tion from  blocked G l l + I n t  transcrip ts, as seen before a fte r 2 '- 
FdGMP incorporation. An inhibitory e ffec t o f the compound still became clearly apparent 
during elongation, when the length o f the transcripts was again reduced in the presence o f 
2'-FdCTP compared to  the contro l reaction w ith CTP replacing the compound (figure 
III.11, compare lanes 2 and 4). In both CTP control reactions the G11 +1 nt bands were o f 
lower in tens ity  than in the corresponding compound reactions due to  the previously 
mentioned threefold higher competition o f CTP compared to  2'-FdCTP for labelled CTP. A t 
th is stage, the experim ents w ith the cytid ine analog could not ye t exclude a purely 
com petitive  inh ib ition mechanism by 2'-FdCTP, although th is would mean th a t the 
cy tid ine  com pound behaved d iffe re n tly  than the  guanosine analog. Pulse-chase 
experiments were used to  fu rthe r study the mechanism o f transcrip tion inhibition by 2 '- 
FdCTP in this system. The RNP-primer complexes were firs t preincubated w ith  labelled
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CTP and 2'-FdCTP (figure 111.11, lane 5), before being chased w ith 100 pM ATP, GTP, 
CTP and UTP, i.e. a 1000-fo ld  excess o f the nucleotides over the label CTP and 125-fo ld 
excess over 2'-FdCTP (figure III.11, lane 6 ). The pattern o f transcrip tion inhibition was 
similar to  the previously shown reactions. Even in the presence o f excess nucleotides in 
the reaction the amount and the length o f the transcripts were reduced w ith 2'-FdCTP 
compared to  contro l reactions w ith CTP replacing 2'-FdCTP (compare lanes 6 and 7). If 
inhibition were exclusively at transcrip tion  in itia tion, then in pulse-chase experiments 
the fraction o f non-blocked transcripts should be com pletely elongated. The preferential 
form ation  o f shortened transcrip ts in the chasing period implies an influence o f the 
inh ib itor during elongation even at very low concentrations relative to  the homologous 
NTP. The fa c t th a t an inh ib itory e ffec t, i.e. the reduction o f transcrip t length, is still 
measurable under those  cond itions supports the  chain b locking mechanism o f 
transcrip tion inhibition rather than a purely com petitive  mechanism. The form ation o f a 
labelled, blocked G11+1 nt product could not be explicitely shown w ithou t having labelled 
2'-FdCTP available. However, the observation th a t the fluorinated compound could be 
incorpora ted during early transcrip tion  w ith  another prim er RNA (discussed below, 
figure  111.13, lanes 1 7 -20 ), to g e th e r w ith  the absence o f s ign ifican t inh ib ition  o f 
G11+1 n t RNA production a fte r preincubation o f RNPs w ith 2'-F-dCTP can be considered 
as a fu rthe r evidence fo r a regeneration ac tiv ity , i.e. the ab ility  o f the RNP to  take 
presumably blocked G11 +1 nt products and use them to  regenerate G11 primers.
The resu lts  so fa r suggested th a t inh ib ition  o f in fluenza virus specific  
tra nsc rip tion  by the  nucleotide analogs 2'-FdGTP and 2'-FdCTP fo llow ed a sim ilar 
mechanism and occurred mainly, if not exclusively, during elongation, m ost likely due to  
chain term ination a fte r incorporation into nascent RNAs. This mechanism is also the most 
plausible to  account fo r the remaining inhibitory e ffe c t even during chasing w ith large 
excess homologous nucleotides.
111.4.3 Influenza virus transcription reactions primed w ith globin mRNA
The follow ing experim ents, using globin mRNA as primers in com bination w ith 
labelled GTP instead o f labelled CTP, were used to  study the im pact o f the nucleotide 
analogs on influenza virus transcription in ye t another system. One in terest was to  use a 
d iffe rent, labelled nucleotide in order to  exclude tha t the previously apparent mechanism 
o f transcrip tion inhibition was influenced by the com petition o f the compounds w ith the 
label. Also it was possible to  d irectly visualize the incorporation o f unlabelled 2'-FdCTP 
during early transcrip tion into primers in itiated w ith GTP, as seen before w ith 2'-FdGTP 
in the  pGEM system  in itia ted w ith CTP. Rabbit globin mRNA is a m ixture o f a- and (3- 
g lobin mRNAs. Plotch e t al. (1 9 8 1 ) have shown th a t influenza virus endonuclease 
preferentia lly  cleaves (3-globin mRNA in a mixture o f globin mRNAs and produces a capped 
primer RNA o f 1 3 nucleotides, called G1 3 (figure III.1 2).
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Figure 111.12: Schematic representation of the presumed primer-vRNA interactions and the 
nucleotides incorporated by influenza virus RNPs during transcription initiation 
with globin mRNA according to Plotch et al. (1981). p-globin is the mRNA, that is 
preferentially used for transcription initiation in the globin mRNA mixture. The 
influenza virus endonuclease cleaves mainly 3' of G13 (A), and the first 
nucleotide incorporated in vitro is a GTP (B). In the presence of elevated 
concentrations of GTP as only NTP, several G residues can be incorporated into 
the nascent RNA (B). In the presence of both GTP and CTP, only one GTP and one 
CTP are incorporated (C). When a-globin is used as endonuclease substrate, it is 
cleaved S' of GIG (D) and initiated exclusively with CTP (E).
T h e  in flu e n za  v irus p o ly m e ra s e  in itia tes  transcrip tio n  from  p -g lo b in  m R N A  d e riv e d  
prim ers p referentia lly  with G T P . In the p resence of G T P  as  the only nucleotide, severa l G  
res idues can  be ad ded  to the  p rim er seq uen ce  in a  stuttering m echan ism  (P lotch et a l., 
19 8 1 ). A sim ilar phenom enon w as  observed in the present study: w hen  globin m R N A  w as  
incubated  with viral R N P s  and  labelled  G T P , tw o bands m igrating at 14 nt and 16 nt w ere  
g e n e ra te d , p resu m ab ly  correspond ing  to G 1 3 + 1 n t and  G 1 3 + 3 n t (figure  111.13, lan e  3 ). 
Both band s  d is a p p e a re d  w h en  C T P  w as  a v a ila b le  and  w e re  re p la c e d  by a  b and  of 
in te rm ed ia te  m obility (15  nt, i.e . G 1 3 + 2 n t; figure 111.13, lane  2 ). Th is  suggested  that in 
the p resence of only G T P  one or th ree  G  residues w ere  added  to the prim er, w h ereas  with 
both G T P  and C T P  present, only one of each  nucleotide w as  incorporated (see schem e in 
figu re  111.12). Long tran scrip ts  w e re  e ffic ien tly  p ro du ced  in th e  p re s e n c e  of all four 
nucleotides (lane 4).
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Similar to  CTP (lane 2), 2'-FdCTP induced the form ation o f a single 1 5 n t band in 
the presence o f viral RNPs and labelled GTP (lane 17). This clearly dem onstrated tha t 2 '- 
FdCTP, as described above for 2'-FdGTP, could be incorporated into nascent mRNAs by the 
influenza virus polymerase w ith  an effic iency similar to  CTP. The band in tens ity  was 
again reduced compared to  the standard reaction (compare lanes 2 and 17; 2 and 19), 
presumably due to  a competing side reaction, similar to  the one described above. It is 
known, tha t a-globin mRNA can serve as an endonuclease substrate, when only CTP is 
present. In th is case, a-globin is cleaved 10 nt downstream o f the cap s truc tu re  and 
transcription in itiates by incorporation o f a C residue (Plotch et al., 1 981 )(see scheme, 
figu re  111.12). This a lte rna tive  in itia tion  from  a -g lob in -d e rive d  p rim er w ith  CMP 
incorporation m ight com pete w ith transcrip tion in itia tion  from  p-globin using labelled 
GTP. This com petition appears to  be strong enough tha t in the presence o f elevated CTP 
levels (100  /vM), re lative to  labelled GTP (0 .25  juM), transcrip tion  in itia tion  from  p- 
g lobin is s trong ly  reduced (lane 19). Lanes 18 and 20 illus tra te  the  inh ib ition  o f 
elongation by 2'-FdCTP compared to  CTP. As before, both the amount and the lengths o f the 
transcripts are reduced.
In the globin mRNA system, the nucleotide analogs had again no detectable e ffect on 
transcrip tion  in itia tion , but s ign ifican tly  reduced the  am ount and lengths o f RNAs 
synthesized during elongation relative to  control reactions w ith  CTP replacing 2'-FdCTP 
and GTP replacing 2'-FdGTP respectively. In figure 111.13 lanes 5 -10  are transcrip tion  
reactions w ith  0 .8  ijM 2'-FdGTP or GTP, lanes 11-16  w ith  4 //M 2'-FdGTP or GTP 
respectively. Lanes 5, 7, 11 and 1 3 show no significant d ifference during transcription 
in itiation in the presence o f e ither nucleotide analog or GTP. However, incorporation o f up 
to  4 G residues during transcrip tion in itia tion is only seen w ith  4 /lvM GTP alone, (lane
13). The presence o f 2'-FdGTP does not inhibit the form ation o f the G 13+3nt in itiation 
product, tha t is formed in the presence o f only GTP. (compare lanes 5 and 11 w ith lane 
3). A t higher concentrations o f 2'-FdGTP or GTP (lanes 11-16), com petition  o f GTP for 
the labelled GTP (0 .25  pM) became apparent, as seen before w ith CTP in the pGEM-RNA 
system  w ith labelled CTP. The com petition between GTP or 2'-FdGTP fo r labelled GTP led 
to  an overall decrease in the in tensity o f transcription products. As observed before, the 
unlabelled nucleotide was a stronger com petitor for the incorporation o f homologous label 
than the nucleotide analog. Therefore, the intensity o f the initiation bands was lower in the 
GTP reaction (lane 13) than in the 2'-FdGTP reaction (lane 11). Nevertheless, only 2 '- 
FdGTP prevented the polymerase from effic ien tly  synthesizing long RNAs (lanes 1 2 and
14). During elongation, both the amount and the lengths o f the synthesized RNAs were 
reduced. The 30 min preincubation o f RNP-primer complexes w ith 2'-FdGTP, in order to  
incease the number of RNAs initiated with the nucleotide analog, did not change the pattern 
o f RNA synthesis during elongation and did especially not fu rthe r inh ib it transcrip tion  
(compare fo r example lanes 15 and 16 a fte r preincubation w ith lanes 12 and 14 w ithout 
preincubation).
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Figure III.1 3: In v itro  transcription in the presence of nucleotide analogs and with 0,1 /L/g globin 
mRNA as primer. For standard reactions 0.25 a^ M [a^^P]-GTP (5 /^Ci) was used alone (lane 3, 
initiation), or in combination with 5 A/M CTP and ATP (lane 1, limited elongation), 5 ijM CTP (lane 
2, incorporation of 2nd nucleotide), 5 A/M CTP, ATP and UTP (lane 4, elongation). Compounds were 
added to such standard reactions as indicated above the gel, i.e. 0.8 A/M 2'-FdGTP (lane 5), 0.8 A/M 
2'-FdGTP plus 5 a/M CTP, ATP, UTP (lane 6 ), 0.8 a/M GTP (lane 7), 0.8 a/M GTP plus 5 a/M CTP, 
ATP, UTP (lane 8 ). For lanes 9 and 1 0 0.8 a/M 2'-FdGTP or 0.8 a/M GTP were preincubated for 30 
min with RNP-primer complexes before 5 a/M CTP, ATP, UTP were added. Lanes 11-16 correspond 
to lanes 5-10 with 4 a/M instead of 0.8a/M 2'-FdGTP and GTP respectively. Lane 17 corresponds to 
a transcription reaction with 5fjC\ [a^^P]-GTP and 100 A/M 2'-FdCTP, lane 18 included 5a/CI 
[a^2p]-GTP, 100 A/M 2'-FdCTP and 5 a/M CTP, ATP, UTP. Lanes 19 and 20 correspond to lanes 17 
and 1 8 with 100 a/M CTP replacing 2'-FdCTP.
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III.5 Discussion
In v itro  transcription assays based on the incorporation o f labelled nucleotides into acid 
insoluble material or on separation o f the reaction products on polyacrylamide gels were 
established to  characterize and compare d iffe ren t virus and RNP preparations used for 
s tru c tu ra l s tud ies  (c h a p te r I) and to  s tu d y  the  im p a c t o f 2 '-d e o x y -2 '-  
fluororibonucleo tides on d iffe re n t stages o f influenza virus specific  transcrip tion . 
Capped, mRNA-like RNAs were produced by in v itro  transc rip tion  w ith  SP6 or T7 
polymerase from plasmid DNA. These mRNA analogs function as substrate for the influenza 
virus endonuclease, which produces short primer RNAs fo r transcrip tion  in itia tion . In 
the presence o f such mRNA-like molecules and one labelled nucleotide-triphosphate, 
prim er-plus-one-nucleotide RNAs can be visualized on acrylam ide gels. A fte r  such a 
transcrip tion in itiation reaction, the nascent RNAs can be elongated by the addition of 
fu rthe r nucleotide triphosphates. The fluorinated nucleotide analogs 2'-FdGTP and 2 '- 
FdCTP behaved similarly in such in v itro  transcription assays. There was no significant 
change in the product pattern from  transcription in itia tion reactions in the presence or 
absence o f compound. The analysis o f transcription in itiation was slightly complicated by 
the fac t th a t the respective e ffec to rs  to  be studied could com pete w ith the  labelled 
nucleotide triphosphate used to  visualize inhibitory effects. This means tha t product bands 
were o f lower in tensity in the presence o f e ffectors than in the absence o f e ffectors. To 
overcome this lim itation, transcription assays have been performed in d iffe ren t systems, 
using tw o d iffe ren t mRNA molecules and using either labelled CTP or labelled GTP in the 
reactions. In all cases, the conclusions drawn from  the experim ents concerning the 
mechanism o f transcrip tion  inhib ition were the same. We obtained no evidence fo r 
transcrip tion  inhibition during in itia tion . Both compounds could be incorporated in to 
nascent transcrip ts w ith  efficiencies similar to  the corresponding NTPs. These results 
suggest th a t the form ation  o f the firs t phosphodiester bond, or previous steps, in 
particu lar cap-binding and endonuclease ac tiv ity  are not a ffec ted  by the fluorinated 
nucleotide analogs. Inhibition o f transcrip tion became only apparent during elongation, 
when both the amount and the length o f the RNA products were significantly decreased. 
This, and the  results o f lim ited elongation reactions suggest as the  mechanism o f 
inhibition th a t the compounds are incorporated into nascent RNAs, which leads to  a block 
o f transcription, or at least to  a strong reduction o f elongation efficiency.
Kinetic studies w ith influenza virus RNPs showed th a t 2'-FdGTP com petitive ly  inhibits 
incorporation o f GTP in to  trich loroacetic  acid insoluble material. Both mRNA and ApG 
primed transcrip tion  reactions behaved sim ilarly and were half-maximally inhibited by 
about 100 A/M 2'F-dGTP (Tisdale e t al., 1995). These observations are consistent w ith 
endonuclease and in itiation independent inhibition o f transcription. Taken together, these 
results are rem iniscient o f reports concerning FIIV and duck hepatitis  B virus specific
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reverse transcription in the presence o f dideoxynucleotide analogs. Antiviral compounds 
like AZT-TP ( 3 '-a z id o -3 '-deoxy thym id ine -triphospha te ) or 3TC-TP (2 ',3 '-d id e o x y - 
3 '-th iacy tid ine -triphospha te ) are both com petitive  inh ib ito rs w ith  regards to  the ir 
homologous dNTPs, as determ ined by incorporation o f labelled nucleotides into acid 
insoluble DNA products, and they inhibit reverse transcrip tion mainly during elongation 
by chain term ination a fte r being incorporated into nascent DNA (Severini e t al., 1995; 
Goody et al., 1 991 ; Huang et al., 1990; Parker e t al., 1 991 ; St.Clair e t al., 1 987).
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F ig u re  111.14: Structures of antiviral nucleoside analogs. AZT and 3TC are approved from FDA
for first-line treatm ent o f HIV infection. Acyclovir, Ganciclovir and araA are 
active against viruses of the human herpes virus group. Acyclovir is approved 
for treatm ent o f herpes virus infections. Ganciclovir fo r cytomegalovirus 
infections.
Incorporation o f dideoxy-nucleotide analogs can lead to  suicide inhibition, when the halted 
po lym erase-tem p la te -p rim er com plex is stable. This phenom enon is fo r example 
observed w ith inhibition o f E.coli DNA polymerase by ddTTP or herpes simplex virus DNA
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polymerase by the triphosphate o f 9 - [ ( 2-hydroxyethoxy)-m ethyl]guan ine  (acyclovir) 
(A tkinson e t al., 1969 ; Furman e t al., 1984). Studies on the Epstein-Barr virus DNA 
polymerase, on the o the r hand, showed considerable reve rs ib ility  o f inh ib ition  by 
acyclovir triphosphate  and in particular, no increase o f transcrip tion  inh ib ition  by 
preincubation o f tem plate-primer with enzyme and compound, as was seen w ith E.coli and 
herpes simplex virus DNA polymerases (Datta e t al., 1980). The reversib ility in the case 
o f Epstein-Barr virus DNA polym erase inh ib ition  is presum ably due to  a 3 '-5 ' 
proofreading exonuclease activ ity  o f the DNA polymerase. Another example o f reversible 
inh ib ition  is the com bination o f herpes simplex virus DNA polymerase and 9-(3-D- 
arabinosyladenine triphosphate (araATP) (Derse and Cheng, 1981): araATP does not 
substitu te  fo r dATP during DNA synthesis, but can be incorporated by the polymerase in 
e longation reactions. A lthough incorporation o f araATP occurs and blocks fu rthe r 
elongation, the preincubation o f tem plate-prim er-polym erase complexes w ith  araATP 
does not s ign ificantly  reduce the subsequent incorporation o f [^HJdTTP. Derse and 
coworkers observed maximally 1 0% reduction o f a c tiv ity  a fte r araATP preincubation. 
The reve rs ib ility  o f the  incorporation-b lock inhibition mechanism in th is  example is 
again caused by the  3 '-5 ' exonuclease a c tiv ity  o f the herpes simplex virus DNA 
polymerase. Some o f the above described observations are rem iniscient o f the results 
from  the influenza virus system . Inhibition o f influenza virus RNA polymerase by 2 '- 
deoxy-2 '-fluo ro ribos ides also showed a high degree o f reve rs ib ility . In [^HJUM P 
incorporation assays 2'-FdGTP could not subs titu te  fo r GTP, as expected fo r chain 
term inating nucleotide analogs. However, the addition o f excess GTP to  a transcription 
reaction resulted in s ign ificant UMP incorporation even a fte r extensive preincubation 
with the compound (Tisdale e t al., 1 995). The same effect was observed on analytical gels 
resolving the products o f transcrip tion . Preincubation o f compound w ith RNP-primer 
complexes had no detectable e ffec t on the amounts or sizes o f RNA molecules produced by 
the influenza virus polymerase. In contrast, inh ib ito ry e ffec ts  during elongation were 
observed, even w ith considerable excess o f nucleotides in pulse-chase reactions (figure 
111.10). Is th is evidence fo r a proofreading ac tiv ity  associated w ith  the influenza virus 
polymerase or are there  o the r possibilities to  explain th is apparent revers ib ility  o f 
inhibition? In the presence o f saturating amounts o f primer, transcrip tion  inhibition o f 
HIV reverse transcriptase by dideoxy-nucleotides also requires the continous presence o f 
compound. Transcription can resume when large amounts o f corresponding dNTP are added 
to  a reaction, and the inhibitory mechanism can therefore resemble reversible inhibition 
in vitro, although it is clear tha t dideoxy compounds irreversibly block nascent DNAs, and 
tha t reverse transcriptase does not possess a proofreading exonuclease activ ity  (Goody et 
al., 1 9 9 1 ). This observation can be explained by the fa c t th a t the  HIV reverse 
transcriptase is not trapped in replicative complexes and can continually resume DNA 
synthesis w ith new primer molecules. The difference to  the influenza virus system  is, 
th a t the  influenza virus RNA-dependent RNA polymerase is apparently able to  reuse
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previously blocked transcrip ts . This became fo r example apparent in the  lim ited 
elongation reaction, when blocked prim er-plus-two RNA products were produced in 30 
min preincubation reactions and then partially disappeared in subsequent elongation chase 
reactions. There are also observations from other laboratories, tha t support the idea of 
some kind o f proofreading ac tiv ity  to  be associated w ith the influenza virus polymerase. 
Trim m ing o f prim er RNA 3 '-ends has been observed in v itro  a fte r excessive GMP 
incorpora tion  during transcrip tion  in itia tion . As m entioned above, w ith  increasing 
am ounts o f GTP in transcrip tion  in itia tion  reactions, the  influenza virus polymerase 
complex can add increasing numbers o f G residues to  nascent RNAs. A fte r addition o f 
fu rthe r nucleotides these RNAs are cu t down to  the right length before being elongated 
w ith tem plate specified nucleotides (Ishihama et al., 1986; Plotch e t al., 1 981 ).
A t present it  is not known which subunit o f the polymerase is responsible fo r the 
observed RNA primer trim m ing reactions. A lthough it  is possible th a t the polymerase 
associated endonuclease m ight recleave erroneously in itia ted transcrip ts back to  primer 
length, Ishihama and coworkers found it  unlikely because they observed s tringen t 
coupling between removal o f excess G residues and transcription elongation, whereas the 
endonuclease has been shown to  be independent o f transcription. However, the apparent 
e rro r ra te  in vivo  o f the influenza virus polymerase is similar to  th a t o f o the r RNA 
polymerases lacking proofreading exonuclease functions, so the significance o f the 
apparent primer regeneration ac tiv ity  is a t present unclear. The nucleotide analogs may 
be invaluable tools to  s tudy in more detail this unique a c tiv ity  o f the influenza virus 
polymerase, which itse lf constitu tes a promising ta rge t o f fu ture  antiviral compounds. In 
particu lar, it  will be in te res ting  to  determ ine if the  endonuclease a c tiv ity  o f the 
polymerase complex is responsible fo r the primer RNA regeneration, or if there is ye t 
another active site involved in this process. In the case o f fluorinated nucleotide analogs, 
the  apparent prim er regeneration reaction can be assumed to  lower the  antiv ira l 
e fficiency o f the compounds. The successful shut-o ff o f this regeneration mechanism can 
there fo re  be expected to  increase the inh ib itory e ffe c t o f fu tu re  polym erase-directed 
nucleotide analogs.
The above shown experim ents could not exp lic itly  establish if  the nucleotide 
analogs were mainly incorporated early in transcrip tion or any tim e during elongation. 
This question became im portan t a fte r obtain ing several lines o f evidence fo r the 
polymerase undergoing a conformational change between early and late elongation. It also 
remained open if incorporation o f nucleotide analogs was possible as the firs t nucleotide, 
i.e. fo r the firs t phosphodiester bond form ation. A modified transcrip tion assay will be 
needed to  answer this question. Polymerase preparations tha t are active on artific ia l RNA 
tem plates and a m ethod to  stepwise walk the polymerase along the tem plate  will be 
essential to  study transcrip tion  elongation in vitro. As an a lte rna tive , rad ioactive ly 
labelled nucleotide analogs would be useful to  analyze in more detail the kinetics o f 
compound incorporation, elongation inhibition and RNA regeneration. They would also help
Chapter III : In vitro transcription 1 09
to  answer another question tha t arises from the above shown results. Whereas dideoxy­
nucleotide analogs inevitab ly cause chain te rm ina tion  a fte r incorpora tion, antiv ira l 
compounds w ith residual hydroxyl groups can theore tica lly  be internally incorporated 
in to  nucleic acid products by polymerase proteins. This has been described w ith the 
triphosphate  o f 9 -(1 ,3-d ihydroxy-2 -p ropoxym ethyl)guanine  (Ganciclovir) and araATP 
(see above), which are c o m p e tit ive  inh ib ito rs  o f herpes sim plex v irus and 
cytomegalovirus DNA polymerases with regard to  dGTP. (Derse and Cheng, 1 981 ; Frank et 
al., 1 984; Mar e t al., 1 985). Due to  additional hydroxyl groups these compounds are not 
absolute chain term inators, but the araAMP-terminated primers are only elongated at a 
very slow rate, and most primers end up being regenerated by the exonuclease activ ity  o f 
the polymerase. However, internal araAMP residues were detected in viral DNA. For the 
influenza virus system, labelled nucleotide analogs could help to  distinguish between the 
three possible scenarios o f influenza virus specific transcrip tion inhibition by 2 '-deoxy- 
2 '-fluororibosides: is inhibition caused by a defin itive  incorporation block o f nascent 
transcripts, is there no real block, but only a significant decrease o f elongation from 2 '- 
FdNMP-terminated primers or is it  a combination o f both processes, determ ined by the 
e ffic iency o f the RNA regeneration a c tiv ity . In te resting ly , these com pounds were 
originally perceived as deoxynucleoside analogs and initia lly tested  fo r antiviral activ ity  
w ith  DNA viruses o f the herpes virus group (W ohlrab e t al., 1985 ). Several lines o f 
evidence suggest tha t also cellular enzymes recognize the compounds as deoxyriboside 
ra ther than riboside analogs. Influenza virus inhib ition by 2'-FdGTP in cell cultures 
could only be reversed by the addition o f deoxyribosides and deoxycytid ine was more 
e ffec tive  than cytidine in the reversal o f inhibition by 2'-FdCTP (Tisdale e t al., 1993). 
Phosphorylation to  triphosphates in vivo is essential fo r an tiv ira l a c tiv ity  o f the 
compounds and it was found tha t they were good substrates fo r eucaryotic deoxycytidine 
kinase in v itro  (Tisdale e t al., 1 993 ). Finally, the  nucleoside analogs measurably 
inhibited DNA polymerase a in v itro  (Ki = 48 pM), whereas ra t liver RNA polymerase II 
was not inhibited by up to  850 pM 2'-FdGTP (Tisdale e t al., 1995). 2'-FdCTP was found 
to  be ineffic iently, but measurably incorporated into DNA molecules by DNA polymerase 
a, w ith  a Km o f 7 mM compared to  a Km o f 0.6 pM for CTP, and more e ffic ien tly  by AMV 
reverse transcriptase w ith a Km o f 7 pM compared to  0 .14  pM fo r CTP (Aoyana et al., 
1985 ). Influenza virus specific transcrip tion  assays underline the d ifference between 
ce llu la r and v ira l RNA po lym erase  and d e m o n s tra te  th a t  2 '-d e o x y -2 '-  
fluororibonucleotides can also be recognized as ribonucleotide analogs and be incorporated 
into RNA molecules.
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Materials and Methods 
(A ) Materials, Cells, Buffers
A1 Viruses and Cells
Influenza virus A /P R /8 /3 4  (H IN T ) was purchased from  Pasteur-M érieux, Marcy 
L'Etoile, France. Influenza virus reassortant strain X31, prepared from  in fected hen's 
eggs at Wellcome Research Laboratories, Beckenham, Kent, U.K, was provided by Dr. 
Martin Ford. X31 virus contains the  haem agluttin in and neuraminidase genes from  
influenza virus A /A ic h i/2 /6 8  (H3N2) and the residual genes from A /P R /8 /3 4 .
Baculovirus BacPAKG, derived from  AcMNPV C6 , as well as SF9 (Spodoptera frugiperda 
ovarian cell derived) and High Five^ "^  ^ {T richop lusia  n i egg cell hom ogenate derived) 
insect cells were provided by Dr. Filippo Voipe and Peter ErtI, Wellcome Research 
Labo ra to ries , Beckenham, Kent, U.K (K it ts  and Possee, 1 9 9 3 ). Recombinant 
baculoviruses containing the coding sequences fo r influenza virus A /P R /8 /3 4  PB1, PB2 
and PA genes were produced as described in chapter 11.2.2.
Pichia p a s to r is  yeas t stra ins GS115 (h is4 ), GS11 5 /H is+  M ut^ A lbum in and 
GS11 5/H is+ Mut+ p-galactosidase were purchased from Invitrogen, San Diego, Ca.
Escherichia coli bacterial strains:
Strain source genotype reference
BL21
BL21 (DE3)
Novagen F" ompT[lon] hsdS^ (rg- mg-) DE3, a X 
prophage, carries the T7 polymerase 
gene
Studier, F.W. et al. 
(1990)
Meth.Enzymol. 185: 
60-89
HMS174 
HMS174 (DE3)
CGSC F" re cA l rpoB331 hSDR19 r^i 2 " 
Riff
Campbell, J. (1978). 
Proc.Natl.Acad.Sol. 
USA 75: 2276
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Strain source genotype reference
JM 109 NEB F" t r a D 3  6 r e c A l  la c l^  A{lacZ)M15 
proA^B^/rpsL(S tr'') th r leu thi lacY galK 
galT ara fhuA dam dcm supE44 A(lac- 
proAB)
Yanisch-Perron, C. et 
al. (1985)
Gene 33: 103-1 19
X L I-B lu e Stratagene F '::T n  7 0 proA'^B^ la c l^  A{lacZ)M15 
re c A l endAI gyrA 96  (NaF) thi hsdR 17 
(rk* iTik+) supE44 re lA l lac
Bullock, W.C. et al. 
(1987)
B io /T echn iques 5: 
376-382
A2 Media, growth conditions, transfections and transformations
A.2.1 Sf9 and High Five™ insect cells and baculoviruses 
A 2 .1 .1. General cell culture conditions
Insect cells were grown in TCI 00 medium (GIBCO BRL) supplemented w ith 10% fetal 
ca lf serum (FCS) and 0.1 m g/m l gentamicin (GIBCO BRL). All solutions, plastic flasks, 
pe tri dishes, p ipe ttes etc. were o f cell cu lture quality. Culture conditions were as 
described in (King and Possee, 1992). Sf9 cells were cultured in plastic flasks or in I I  
Techne b io logical s tirre r bo ttle s . High Five^"^ cells only in p las tic  flasks. For 
subculturing, the medium from  confluent cell monolayers was decanted and the cells 
dislodged in to  fresh medium fo r counting in an improved Neubauer counting chamber 
(count 25 medium sized squares and m ultiply by 10^ to  obtain the number o f ce lls/m l). 
150 cm^ flasks were routinely seeded w ith 2 x 1 0 ^  cells in 10 ml TCI 00 medium and 
incubated a t 28°C at atmospheric conditions. Subculturing was routinely perform ed by 
1-8 or 1-10 dilu tion o f confluent cell layers. Sf9 cell cu lture in I I  s tirre r bo ttles  is 
done in 200 ml medium, seeded with 2 x 1 0 ^  cells/m l (about 1 confluent 1 50 cm^ flask) 
and subcultured, when a cell density o f 2 x 10^ ce lls/m l was reached. S tirre r bottles 
were maintained at room temperature.
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A 2 .1 .2 Freezing and defrosting of insect cells
Cell density was brought to  2 x 10® ce lls/m l w ith cu lture medium and cell v iability, 
tes ted  w ith  0 .2% trypan blue staining (cell sample stained w ith trypan blue before 
counting; live cells exclude the stain, dead cells are stained), should be high (90-95% ). 
An equal volume o f ice-cold freezing mix, i.e. 20%  DMSO, 80%  grow th  medium 
containing 10% FCS, was added to  the cells and 1 ml aliquots pipetted into cryogenic vials, 
immediately placed at -70°C in an insulated freezing box fo r overnight slow freezing. The 
cells were then transferred to  liquid nitrogen containers. To resusitate cells were rapidly 
thawed at 37°C and seeded into a 25 cm^ flask in 10 ml grow th  medium. A fte r cell 
a ttachm ent ( 1-2 h), the medium was replaced w ith fresh growth medium to  remove the 
DMSO.
A2.1.3. Baculovirus propagation
Routine insect cell passaging was done in a room separate from baculovirus propagation to  
avoid contam ination o f cell stocks. Virus containing solutions and labware were either 
decontam inated w ith  70% ethanol or by autoclaving. Gilson p ipe ttes were regularly 
decontaminated w ith detergent and/or 70% ethanol.
A 2 .1 .4 Baculovirus plaque assav to  determine virus titre
35 mm dishes ( 6-well p lates) were seeded w ith 2 x 10® cells fo r 1 h or 1 x 1 0 ® cells 
overnight. A fte r cell attachm ent the growth medium was removed and virus dilutions (e.g. 
1 0 '^  to  10’ ®) in 200 -500  pi medium was added, w ith care taken tha t all cells were well 
covered w ith liquid. A fte r 1 h the virus inoculum was aspirated and replaced by 1.5 ml 
1% agarose overlay consisting o f a m ixture o f one volume 3% Seaplaque LMP agarose, 
melted and cooled to  37°C in a water bath, and two volumes o f growth medium. The agarose 
was allowed to  set fo r 1 5 min and then overlayed w ith 1 ml growth medium. The plates 
were placed in a plastic box lined w ith moist tissue paper and incubated at 28°C fo r 2 
days. A t tha t time a 1:5 dilution o f Neutral Red in PBS was added to  the liquid overlay and 
the plates incubated overnight at 28°C. Then the liquid was tipped o ff  and the plates 
drained in an inverted position fo r up to  1 h. Virus plaques were picked w ith a 1 ml Gilson 
p ipette  into 500 pi o f growth medium and stored at 4°C.
A .2 .1 .5 Virus stock preparation
Flalf the volume o f a plaque pick was used to  infect 2 x 1 0 ®  cells in a 25 cm^ flask in 4 ml 
grow th medium. A fte r 4 days the virus containing medium was harvested and cleared by 
centrifugation at 1000 rpm, 10 min, 4°C and stored at 4°C. 0.5 ml o f this seed stock was 
used to  in fec t 5 x 1 0 ®  cells in a 75 cm^ flask and 10 ml medium resu lting in an 
interm ediate virus stock. 0.5 ml o f this intermediate virus stock was used to  in fect 2 x 
1 0 ^  cells in a 150 cm^ flask and 30 ml medium. The maximum virus t it re  w ith
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recombinant PA expressing viruses was w ith 2 x 1 0 ®  p fu /m l about 10-fo ld lower than 
tha t obtained with control virus expressing (3-galactosidase.
A 2 .1 .6 Infection o f insect cells w ith virus stock for experimental work 
For prote in expression in flask culture, 3 x 1 0 ^  cells were seeded in a 150 cm^ flask, 
the medium removed a fte r cell attachm ent, and virus inoculum added at a m ultip lic ity o f 
infection (moi) o f 10 (10 p fu /ce ll) in 10 ml medium. A fte r an 1 h incubation at RT, the 
inoculum was removed and replaced by 30 ml fresh medium. The cells were then 
incubated at 28°C fo r 3-5 days before being harvested by centrifugation a t 1000 rpm, 
10 min, 4°C.
For virus propagation, the same amount o f cells was inoculated w ith  0.1 moi o f virus 
stock to  avoid the production o f defective interfering particles.
A 2.1.7 Transfection o f Sf9 cells bv the calcium phosphate m ethod
2 pg BacPACS virus DNA was digested w ith 10U Sau I in 100 pi volume at 37°C, 5 h and 
com plete restric tion  was controlled by comparison w ith  1 00 ng circular viral DNA on 
0.6%  agarose gels. In order to  produce recombinant baculoviruses, 1 pg o f Saul digested 
BacPAC5 DNA and 2 pg o f transfer plasmid DNA were mixed w ith 750 pi o f transfection 
buffer (25 mM HEPES, pH 7.1 (±0 .05 ), 1 50 mM NaCI, 1 25 mM CaClz).
The growth medium was removed from 2 x 1 0 ®  cells in a 25 cm^ flask and replaced by 
750 pi fresh medium. The DNA solution was then added dropwise to  the cells, and the flask 
incubated at 28°C for 4 h. The inoculum was removed, the cells washed tw ice w ith 5 ml 
grow th medium and incubated at 28°C fo r 4 days. A t the end o f this tim e, the culture 
supernatant was harvested, clarified by centrifugation and screened in a plaque assay for 
recombinant viruses. 500 pi o f pure virus, a 1:5 and a 1:50 dilution were employed for 
this purpose on preseeded 6-well plates. Recombinant viruses were characterized by DNA 
do t-b lo t assays and Western blots a fte r protein production in Sf9 cells.
A 2.2 Pichia pastoris cell culture
All cell culture work, transform ation and characterization o f yeast cells was essentially 
done as recommended in the Pichia Expression Kit manual o f Invitrogen (Catalog no. 
KI 71 0 -01) Yeast cells were usually grown at 30°C and stored at 4°C on RDB agar plates 
w ith or w ithou t 0 .004%  histidine. For other purposes, liquid cultures in complex YPD or 
selective RDB medium were done in standard, baffled culture flasks covered w ith 2-3 
sterile cheese cloth layers. 5 ml medium in 50 ml Falcon tubes were used as standard 
overnight cultures. Cells from liquid cultures could be harvested and washed w ith sterile, 
ice-cold w ater by centrifugation  at 1 500 x g, 5 min, 4°C. Methanol u tiliza tion  (M ut)
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phenotypes of cells were determined by comparative growth o f colonies on methanol-free 
MD agar and methanol containing MM agar plates. Colonies were picked from plates with a 
sterile too thp ick and streaked firs t on MM, then on MD plates.
A2.2.1 Transformation bv electroporation
500 ml YPD medium was inoculated w ith 0 .1-0.5 ml o f overnight culture and grown for 
another night to  reach an ODgoo = 1.3-1.5. Cells were harvested, washed tw ice w ith 250 
ml water, once w ith 20 ml o f ice-cold 1 M sorbitol, before being resuspended in 1 ml 1 
M sorb itol. 80 pi o f these cells were mixed w ith 5-10 pg linearized DNA and pulsed in a 
0.2 cm cuvette  fo r 10 ms with a field strength o f 7500 V /cm , i.e. 1 500 V, 50 pF, 200 L2 
using an Invitrogen E lectroporator II. The cells were rapidly recuperated in 1 ml ice-cold 
1 M sorb ito l and 200  pi spread on RDB plates lacking histidine. Recombinant colonies 
appeared a fte r 2-4 days incubation at 30°C.
A2.2.2 Protein expression in veast cells
MUT+: 25 ml BMGY medium in a 250 ml flask was inoculated w ith a single colony and 
grown to  ODgoo = 2-6 (16 -18  h). The cells were then diluted to  ODgoo = "I in to  1 00-200  
ml BMMY medium in a 1 I flask. Methanol was added to  a final concentration o f 0.5% 
every 24 h to  maintain induction conditions.
MUT®: 100 ml BMGY medium in a 1 I flask was inoculated w ith a single colony and 
grown to  ODgoo = 2-6 (16 -18  h). The cells were then harvested and concentrated to  
ODgoo = 10-15 in BMMY medium (approxim ately 10-20 ml in 100 ml flask). Methanol 
was continously added as described above.
A2.2.3 Preparation o f to ta l veast cell extracts
(a) glass bead method fo r small volumes: 100 pi Breaking Buffer and 100 pi acid washed 
glass beads (SIGMA) were added to  the water washed pellet o f 1 ml yeast cell culture 
(centrifugation  1 min bench centrifuge). Cells were lysed by 8 cycles o f 30 s vortexing 
pulses a lternating w ith 30 s recuperation on ice, and cell debris was pelleted during 10 
min in a bench centrifuge. Aliquots o f the supernatant were mixed w ith 2x SDS-loading 
buffe r and 2 -10  pi used fo r analytical gel e lectrophoresis. Breaking Buffer: 50 mM 
NaFl2 P04  (6 g / l) ,  1 mM EDTA (372  m g /l), 5% glycerol (50  m l/I), pFI 7.4 set w ith 
NaOH.
(b) French Press method: The cells from  a 1 50 ml culture fo r protein expression were 
resuspended in 10 ml o f the buffer o f choice for a following chromatography step, lysed at 
10000 psi in a French pressure cell apparatus and cleared by centrifugation at 15000 
rpm in SS34 tubes.
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A2.2.4 Yeast Media
All media were sterilized by autoclaving at 120°C, 1.2 bar, 20 min.
YPD (rich medium): 1% yeast extract, 2% peptone, 2% glucose, ± 20 g /l agar 
RDB (h istid ine free regeneration medium): 1 M sorb ito l, 1% glucose, 1.34%  Yeast 
n itrogen base (YNB), 0 .0 0 00 4 %  b io t in ,  0 .0 0 5 %  amino acids. [YNB (YNB without 
(NH4 )2 S0 4 , w ithout amino acids, added together with 1 OOg (NH4 )2 S0 4  to  1 I H2 O; SOOx b io tin  
s tock solution (0.02%, i.e. 20 m g/100 ml H2 O), stored at 4°C; 1 OOx amino acid stock 
solution (0.5%, i.e.500 m g/100 ml H2 0 o f L-glu, L-met, L-lys, L-leu, L-ile)].
MD (histid ine free Mut phenotype screen medium): 1.34% YNB, 0 .00004%  bio tin , 1% 
glucose
MM (h istid ine free Mut phenotype screen medium): 1.34%  YNB, 0 .0 0 00 4 %  b io tin , 
0.5%  methanol
BMGY/BMMY (protein  expression): 1% yeast extract, 2% peptone, 100 mM potassium 
phosphate buffer, pH 6.0, 1.34% YNB, 0 .00004%  biotin, 1% glycerol or 0.5%  methanol 
(1 M potassium phosphate buffer: 132 ml 1 M K2 HPO4 , 8 6 8  ml 1 M KH2 PO4 , pH 6.0 
adjusted with phosphoric acid or KOH)
A 2.3 Escherichia coli cell culture
E. co li cells were routinely grown in LB medium at 30°C or 37°C either in baffled glass 
flasks, 50 ml Falcon tubes fo r overn ight cultures, or on petri dishes contain ing LB 
medium w ith 1 5 g /l agar. Cell growth was monitored by absorption measurements at 600 
nm (ODgoo)-
A .2.3.1 Transformation o f E.coliceWs
(a) Hanahan method: Bacteria were spread on LB agar plates and single colonies used to  
inoculate 30 ml SOB medium supplemented w ith  0.3 ml SOB-complement. Growth was 
stopped a fte r 2-3 h at 37°C, when the ODeoo had reached 0 .4 5 -0 .55 . The cells were 
recovered by centrifugation at 4000  rpm, 1 0 min, 4°C, washed w ith  1 0 ml ice-cold TFB 
and finally resuspended in 2.4 ml TFB. Then 84 pi DMSO was added and incubated 5 min 
on ice, followed by the addition o f 84 pi 2.25 M DTT, incubated 10 min on ice and 84 pi 
DMSO added and incubated another 5 min on ice. The cells were then either frozen in liquid 
nitrogen and stored at -70°C, or used d irectly fo r transform ation. In the la tte r case, 210 
pi com petent cells were incubated w ith 1-10 pi DNA fo r 30 min on ice, followed by a 90 
s heat shock at 42°C and a 45 min regeneration period in SOC medium at 37°C, before 
being spread onto LB agar plates containing the appropriate antib io tic , e.g. 100 pg /m l 
carbenicillin or 50 pg /m l kanamycin.
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(b) CaCl2 method: 1 ml o f an E.coli overnight culture was grown in 100 ml SOB medium 
until the ODeoo had reached 0 .45-0 .55. The cells were incubated on ice fo r 10 min. Then 
they were centrifuged at 4000  rpm, 10 min, 4°C, then washed w ith 1 0 ml ice-cold 1 00 
mM CaCl2 solution, finally resuspended in 2 ml ice-cold 100 mM CaCl2 and stored 12- 
24 h at 4°C. 200 pi bacterial suspension was added to  1-10 pi DNA, incubated on ice for 
30 min, followed by a 90 s heat shock at 42°C, a 2 min incubation on ice and a 45 min 
regeneration at 37°C (the last step skipped in the case o f ampicillin resistance). The cells 
were then plated onto prewarmed LB agar plates containing the appropriate antib iotic.
(c) Electroporation
E lectropora tion  o f E .co li cells was perform ed on a E .co li Pulser^^ Transform ation  
Apparatus (BIORAD). A one lite r cu lture o f E .co li cells at an ODgoo = 0 .5 -0 .7  was 
centrifuged in 4 cycles at 4000  x g^ax, 1 5 min, 4°C and the pellet gently resuspended in 
successive steps o f 1 I, 0.5 I, 250  ml and 4 ml 10% glycerol to  maximally remove salts 
from  the solution. The cells were e ither stored in 80 pi aliquots a t -70°C a fte r rapid 
freezing in liquid nitrogen, or used immediately. 40 pi cell suspension was mixed w ith 
1-2 pi salt-free DNA, placed in 0.1 cm or 0.2 cm cuvettes and pulsed at 1.8 kV or 2.5 kV 
respectively. The cells were recuperated in 800 pi SOC medium, incubated fo r 45 min at 
37°C ( la tte r step om itted  w ith  apicillin resistance plasmids) and spread on LB agar 
plates containing the appropriate antibiotic.
A 2.3.2 E.coliceW Ivsis
(a) Sonication: Cell suspensions up to  1 5 ml were treated w ith 8 cycles o f 1 5 s pulses at 
maximal ou tput o f a Misonix XL Sonicator and 30 s incubations on ice.
(b) Lysozyme: Cells were harvested in a Sorvall GSA ro to r a t 7000  rpm, 10 min, 4°C 
and resuspended in 20 ml Lysozyme buffer (50  mM Tris-HCI, pH 8 , 2 mM EDTA, 0.1 % 
TritonX I 00, 0.2 mM PMSF). Lysozyme was added to  1 m g/m l and incubated a t 4°C, 20 
min. Then 100 pi 10% DOC, 250 pi 1 M MgCk and DNAse I to  0.05 m g/m l were added 
and incubated at 4°C for 10 min. Cell debris was separated by centrifugation  in SS34 
tubes at 1 2000-20000rpm , 1 5 min, 4°C
A 2.3.3 6 co//related Media and Buffers
LB (standard medium): 10 g /l Bactotryptone, 5 g /l Yeast extract 1 0 g /l NaCI 
SOB (transform ation): 20 g /l Bactotryptone, 5 g /l Yeast extract, 0.5 g /l NaCI 
SOC (transform ation): SOB medium plus 250 mM Glucose, 1 mM MgCk, 1 mM MgS04,
0.25 mM KCI (200  pi 20% glucose stock solution and 100 pi 1 OOx complem ent solution 
(Mg, K salts) were sterile filtra ted  and added to  10 ml o f SOB to  produce SOC).
TFB (Hanahan-type transform ation): 10 mM Mes-KOH, pH 6.2, 100 mM RbCI, 45 mM 
MnCl2, 10 mM CaOz, 3 mM Co(hexamine)Cl3
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T B  (p ro te in  exp ress io n ): 1 2 g / l  B a c to try p to n e , 24 g / l  Y e a s t e x tr a c t . 4 m l/I g lycero l, 
a u to c la v e d , and su p p le m e n te d  w ith  1:10 s te rile  f i lt r a te d  p h o s p h a te  b u ffe r  (23.1 g / l  
KH2PO4: 1 25.4 g /l  K2HPO4)
In certain cases the media were supplemented w ith 50-100  p g /m l IPTG (in w ater), 20 
p g /m l X-gal (in d im e thy lfo rm am ide ), 100  p g /m l carben ic illin  or am picillin  (in
water), 50 pg /m l kanamycin (in water).
A3 Commonly used buffers
5x ATP-binding buffer
BC buffer (-)4 .5  
10x PBS
CDI modification buffer 
10x (native)
50x Denhardt's
DMS modification buffer 
10x (native)
5x DNA loading buffer
K T T /K T N
2x Loading buffer proteins
Modification stop buffer 
lOx
2.5 M KCI 
25 mM MgClz 
5 mM DTT 
5 mM EGTA
20 mM sodium citra te, pH 4.5
1 mM EDTA
80 g /l (1 .37 M) NaCI
2 g /l (27 mM) KCI
7.7 g /l (43 mM) Na2HP04 
1.9 g /l (14  mM) KH2PO4
500 mM sodium borate, pH 8-10 
100 mM magnesium acetate 
900 mM KCI
1 % BSA
1 % polyvinylpyrrolidon-40 
1 % Ficoll-400
500 mM sodium cacodylate, pH 7.5 
1 M KCI 
50 mM MgCl2
30% glycerol 
bromophenol blue
100 mM KCI
50 mM Tris-HCI, pH 7.5
1 % TritonXI 00 /  1 % NP40
100 mM Tris-HCI, pH 6.8 
20% glycerol 
4% SDS
1.43 M p-mercaptoethanol 
small amount o f Bromophenol blue
200 mM Tris-HCI, pH 7.5 
10 mM EDTA 
5% SDS
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RNA extraction buffer
5x RNA Ligase buffer
RNA loading buffer, 
denaturing
5x RTB
2 Ox SSC
T1 buffer (+ )4.5
lO x TBE, pH 8.3
lO x TE
5x transcription buffer 
T7/SP6/T3
U2 buffer (+ )3 .5
0.75 M ammonium acetate 
0.1% SDS 
0.1 mM EDTA
250 mM Hepes-NaOH, pH 7.5 
50 mM MgCl2 
1 5 mM DTT
20% saccharose 
7 M urea
250 mM Tris-HCI, pH 8.3 
30 mM MgCl2 
200 mM KCI
3 M NaCI
0.3 M sodium citrate, pH 7
20 mM sodium citra te, pH 4.5 
1 mM EDTA 
7 M urea
xylencyanol, bromophenol blue
108 g /l Tris base 
55 g /l boric acid
9.3 g /l EDTA
100 mM Tris-HCI, pH 8 
10 mM EDTA
200 mM Tris-HCI, pH 8 
30 mM MgCl2 
50 mM DTT 
10 mM spermidine 
50 mM NaCI
20 mM sodium citrate, pH 3.5 
1 mM EDTA 
7 M urea
xylencyanol, bromophenol blue
A4 Plasmids and oligonucleotides
A4.1 Plasmids for protein expression
pXA3 (3 .3kb), Promega, Ampicillin resistance, ColEI ori. Derivatives:
pXA3-PA-wt (5 .5kb), contains the complete PA coding sequence (obtained by PCR from
pAc373-PA) in the Sac \/Eco Rl sites (11.2.1.2)
pXA3-His-PA (5 .6 kb ) corresponds to  pXA3-PA-wt w ith  additional 6 His residues 
encoded at the C-terminus.
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pXA3-NT (3 .4kb) contains the PA sequence 1-641, encoding amino acids 1-214 plus an 
additional peptide (QLGSGTDIRSPGAAAIWFYSVT) at the C-terminus.
pRSETa (3kb), Invitrogen, Ampicillin resistance, ColEI ori. Derivatives:
pRSETa-PA (5.2kb), contains the complete coding sequence o f PA in the Bam h\\/Hin  dill
sites (amino acids 1-716).
pRSETa-PA.N (4kb) contains the PA sequence 1-1037, encoding amino acids 1-346 plus 
an additional peptide (LVPWNSKLDPAANKARKEAELAAATAEQ) at the C-terminus. 
pRSETa-PA.L (4.2kb) contains the PA sequence 642-1952, encoding amino acids 21 5- 
651 plus an additional peptide (KLDPAANKARKEAELAAATAEQ) at the C-terminus. 
pRSETa-PA.E (3.7kb) contains the PA sequence 11 76-1952, encoding amino acids 393- 
651 plus an additional peptide (KLDPAANKARKEAELAAATAEQ) at the C-terminus. 
pMALcZ (6.7kb), NEB, Ampicillin resistance, ColEI ori. Derivatives: 
pMAL-PA-M2 (8 .8 kb), contains the complete coding sequence o f PA. 
pMAL-PA-NT ( 6 .8kb), contains the PA sequence 1-641, encoding amino acids 1-214, 
plus an additional peptide at the C-terminus.
pRSETa and pMALc2-derived plasmids coding fo r PA subunits were provided by Dr. 
Martin Ford.
pTAg (3 .8kb), R&D systems, ampicillin resistance, ColEI ori.
plasmid used fo r subcloning o f PCR products exploiting the single A overhangs created by 
non-proofreading DNA plymerases like Taq or Tub polymerase.
p U B S 5 2 0  (5 .4kb ), Boehringer, (Schenk e t al., 1995 ), kanamycin resistance, pACYC 
ori. The plasmid contains the argU gene, coding fo r a rare E.coli arginine specific tRNA. 
p A c 3 7 3 - P A ,  p A c 3 7 3 - P B 1 ,  p A c 3 7 3 - P B 2  (Matsuura e t al., 1987; St. Angelo e t 
al., 1 9 8 7 ); baculovirus transfer vectors containing the complete coding sequences of the 
influenza virus A /P R /8 /3 4  cloned in to  the  unique Bam  HI s ite  o f pAc373 (pUC8 
derivative). Plasmids were provided by Dr. Robert Krug. 
pHil-D2 (8 .2kb), Invitrogen, Ampicillin resistance, ColEI ori. Derivative: 
pHil-D2-PA-wt (10 .4  kb), containing the complete coding sequence o f PA (obtained by 
PCR from  pAc373-PA) cloned into the unique Eco Rl site.
A4.2 Plasmids fo r in v itro  RNA svnthesis
pGEM7Zf+ (3kb), Promega, ampicillin resistance. Derivatives:
pGEM-PA-wt contains the complete PA coding sequence o f PA (obtained by PCR from  
pAc373-PA) cloned into the Apa 1/Eco Rl sites w ith pGEM-PAL21 9F being a point m utant 
o f the same plasmid.
pGEM-PANT contains the PA coding sequence from nucleotides 1-653, encoding amino 
acids 1-218, cloned into the Apa 1/ Eco Rl sites.
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pGEM-PACT contains the PA coding sequence from  nucleotides 1377 -2148 , encoding 
amino acids 460-71 6 , cloned into the Apa \/Eco Rl sites.
p U C T Z G E M  (2 .7 k b ) is a d e riva tive  o f pUCI 8 (NEB) w ith  the  sequence 
TAAACGACTCACTATAGGGCGATCAAGCTATGCATCTCGAGGAATTC between the Hin  dill and 
Bam HI sites. The additional sequence adds a T7 promoter, an influenza virus compatible 
mRNA primer sequence and Nsi I, Xho I, Eco Rl sites to  pUCI 8 . The plasmid produces RNA 
by T7 polymerase transcrip tion  to  be used in influenza virus endonuclease and 
transcription assays.
p V N I , (Baudin e t al., 1994) ,  contains the sequence for a 81 nt RNA with the influenza 
virus specifc, conserved vRNA 3' ends ("panhandle RNA") under the contro l o f a T3 
polymerase promoter.
A4.3 Oligonucleotides
All chemically synthesized DNA oligonucleotides, tha t have been used in this study, have 
been purchased in purified form  from  either Genosys, Camebridge, U.K. or Eurogentec, 
Belgium. RNA oligonucleotides have been synthesized and HPLC purified by Viviane Adam 
a t EMBL Heidelberg (sequences shown in 11.4, page 74, table 11.2). The follow ing table 
comprises all o ligonucleotides related to  the present study, even if no t all o f the 
experiments in which they were employed appear in the previous chapters. The aim is to  
give an overview o f all the PA-specific oligonucleotides, th a t are d irectly  available fo r 
forthcom ing studies.
Primers, specific fo r the influenza virus A /P R /8 /34  PA gene sequence
Name sequence (5 ' to  3 ') position in the 
PA sequence
comments
PAGEMAPA1
PAXA3SAC5
PÂ235R
504RSFIPA
PAStuI
PAXA3HIND3
PAHINDRS
904FRCAPA
PACTM460F
GAATTCGGGCCCACCATGGAAG 
ATTTTGTGCGACAATG (38nt) 
TCGAGCTCATCGAAGGTCGCATG 
GAAGATTTTGTGCGACAA 
(41 nt)
GTGCATTAGGATCACCAAGTTC
(22nt)
GTCGGCCTTTGTGCCATT (IB n t)
AGCAGAGGCCTCTGGGAT
(IS n t)
TGGTCGGCAAGCTTGCGCATT 
(21 nt)
GAATTCCTAACTTTGGTCGGCA 
AGCTTGCG (30nt) 
GACCCAAGTCATGAAGGAG 
(19nt)
GAATTCGGGCCCACCATGAAGG 
GGGTGTACATCAATAC (38nt)
1-23
1-21
211-190 
480-462
550-567
650-630
654-634
898-880
1378-1400
EcoRI, Apa! and ACC Kozak 
sequence at 5' end.
Sad and 1 2 n t pXAS 
intermediate sequence at S' 
end.
silent A204T mutation.
PA unique Bgll site; 
s ile n t G477T m u ta tion  
deletes Sfil site.
PA unique StuI site.
PA unique Hindi!! and FspI 
sites.
PA unique Hind!!! site; EcoRI 
and Stop codon at 5' end.
EcoRI, Apal and ACC Kozak 
sequence at 5' end.
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P AAflll
PASA
PARK
PARC
1920FPA
1937RPA
PACTBGLECOR
PAHISCR
AAGGAAGATCCCACTTAAGG
(20nt)
CATTCCTTAAGTGGGCTCTTCCT 
TTTATGA (30nt)
CATTCCTTAAGTGGGATTTTCCT 
TTTATGA (30nt) 
CATTCCTAAAGTGGGATCCTCCT 
TTTATGA (3 Ont) 
CATTGGGAAGGTCTGCAG 
(18nt)
CTGCAGACCTTCCCAATG
(18nt)
AGATCTGAATTCCTAACTCAAT 
GCATGTGTAAG (33nt) 
AGATCTGAATTCCTAATGATGA 
TGATGATGATGACTCAATGCAT 
GTGTAAGGAAG (55nt)________
1517-1536 
1540-151 1
1540-151 1 
1540-151 1 
1896-1913 
1913-1896 
2131-2148 
2127-2148
PA unique Aflll and BstYI 
sites.
PA unique Aflll site, BstYI 
site lost;
m u ta tio n  A1 525C,  i.e. 
S509A.
m u t a t i o n  C 1 5 2 3 T ,
i.e.R508K.
m u ta tio n  T 1 5 2 2C, i.e 
R508G.
Pst I site.
Bglll, EcoRI and Stop sites 
at 5' end.
Bglll, EcoRI, Stop sites and 
6 His codons at 5' end.
Other DNA oligonucleotides
Name sequence (5* to  3 ') comments
Prim erN S
PB1GEMAPAKP
N
PB1CTSMAHIN
D
PB11275C
PB2GEMAPASM
A
PB2CTN0TXBA
PB2544C
NA1125C
HAPR81
CATTTATGCAAGCCTTAC
(18nt)
GGTACCAAGGAGGGCCCACCAT
GTCAATCCGACCTTACTTTTC
(43nt)
CCCGGGAAGCTTCTATTTTTGCC 
GTCTGAGCTC (33nt)
CTGTATTAGGCGTCTCCATCC
(21nt)
CCCGGGAAGGAGGGCCCACCAT
GGAAAGAATAAAAGAACTAAG
(43nt)
GCGGCCGCTCTAGACTAATTGA 
TGGCCATCCGAAT (35nt)
GGAGCCAGGATACTAACATCG 
(21 nt)
GATAGTAAGTTCTCTGTGGAGG 
C (23nt)
GAGGATGAACTATTACTGGACC 
(22nt)______________________
Sequence complementary to  nucleotides 100- 
83 o f influenza A /P R /8 /34  segment 8 vRNA 
Sequence complementary to  nucleotides 1-23 
o f in fluenza A /P R /8 /3 4  PB1 coding 
sequence, with Kozak sequence, Apa I and Kpn 
I sites at 5' end.
Sequence inverse ly com p lem enta ry  to  
nuc leo tides  2 2 5 2 - 2 2 7 0  of  in fluenza  
A /P R /8 /34  PB1 coding sequence, w ith Sma I 
and Hind III sites at 5' end. 
nuc leo tides  1 246-1 262 o f in fluenza
A /PR /8/34 PB1 coding sequence; PB1 unique 
BsaHI site.
nucleotides 1-23 o f influenza A /P R /8 /3 4  
PB2 coding sequence, with Kozak sequence, 
Apa I and Sma I sites at S' end.
Sequence inverse ly com plem enta ry  to  
nuc leo tides  2 2 6 2 - 2 2 8 0  of  in fluenza
A /P R /8 /34  PB2 coding sequence, with Not I 
and Xba I sites at 5' end. 
nucleotides 51 7-537 of influenza A /P R /8 /34  
PB2 coding sequence.
nuc leo tides  1 105-1 1 26 of  i nf l uenza
A /PR /8/34 NA coding sequence, 
nucleotides 726-747 of influenza A /P R /8 /34  
HA coding sequence._______________________
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(B) Methods for the RNA modification analysis of viral RNPs 
B1 Purification of influenza virus RNPs
B1.1 Centrifugation, concentration and washing o f virus particles 
Virus particles, purified by sucrose gradient centrifugation o f infected egg allantoic 
fluids, were concentrated and washed w ith PBS by centrifugation 2 h, 50000  x g, 4°C,
i.e. 20 krpm with the Beckman SW27 rotor. The following equations were used to  
calculate centrifugation conditions for o ther ro tor types. The relative centrifugal force 
(RCF) [g ] is related to  the speed in revolutions per minute (rpm):
/  rpm Y
loooj ( 1 )
To adapt centrifugation protocols to  d iffe rent rotors, both Beckman and Kontron provide 
as a practical parameter the k-factor, which can be used to  calculate the tim e required to  
pellet particles o f known sedim entation coeffic ien ts (s). The smaller the  k -fac to r the 
greater the pelleting efficiency o f the ro tor. The k-factors are related to  the ro to r speed 
and can be calculated using equations (2 ) and (3):
2 .5 3 1 0 ' In
V min / (2)
rpm ^ a c tu a l ~  ^
(3)
The centrifugation times can then be determined by equation (4):
^  ^  (4 )
h h
Accordingly, influenza virus particles were sometimes pelleted 1.5 h, 36 krpm w ith the 
Kontron TST41.14 ro tor, or 20 min, 45 krpm w ith  the  Beckman SW55 ro to r. Virus 
pellets were washed w ith PBS to  maximally remove traces o f ribonuclease activ ity , tha t 
has been reported to  be a common contaminant in commercially available sucrose used for 
gradient centrifugations of virus.
B1.2 Influenza virus genomic RNP preparation
Virus particles were lysed by incubation at RT fo r 10 min w ith  1% T ritonX I 00, 1 
m g/m l lysolecithin, 5 mM MgCI2, 100 mM KCI, 1.5 mM DTT, 5% glycerol and 10 mM 
Tris-HCI, pH 8 . This m ixture was cen trifuged  th rough  a linear 30 -60%  glycerol 
gradient in 100 mM NaCI, 50 mM sodium cacodylate (pH 7 .5) or Tris-HCI (pH 8 ), 1 mM 
DTT. According to  the actual volume o f virus lysate the centrifugation was done w ith the 
SW27 ro to r (25  krpm, 16.5 h, 4°C) or w ith  o the r ro to rs  under corresponding 
conditions, calculated as outlined above. The glycerol gradients were loaded w ith virus 
lysate to  1 /10  o f the to ta l volume or 1 m l/cm  tube diameter, and fractions were collected
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from  the bo ttom  using a Buchler Auto-Densi-Flow II fraction co llector connected to  a 
peris ta ltic  pump. RNP containing fractions were identified by coomassie staining o f 
proteins a fte r 12% SDS-PAGE. Under the above described conditions, RNPs sedimented to  
regions o f 40-50%  glycerol and could therefore be stored at -20°C w ithou t freezing. 
M icro-ProD iCon''’ '^  u ltra filtra tion  tubes (Spectrum, Breda, NL) were used fo r bu ffe r 
changes or to  concentrate RNPs. The u ltra filtra tion device consists o f cylindrical cellulose 
ester dialysis membranes placed in a plastic chamber w ith an o u tle t connected to  a 
vacuum pump. The system showed a nonspecific adsorption o f 100-300  pg RNP protein 
a fte r overnight d ia lys is /50-fo ld  concentration. DOC treated or salt trea ted  RNPs were 
centrifuged, dialyzed and concentrated as described fo r complete RNPs.
B2 Conditions for chemical and enzym atic probing o f RNA under native  
conditions
Generally 20 -30  pg RNP or 0 .1-5 pg RNA were used in m odification experiments. The 
exact conditions to  achieve statistica l modification were determined empirically fo r each 
RNA preparation. The modification reactions were performed in 20 -300  p\ to ta l volume 
and term inated by the addition o f 1x Modification Stop buffer. In the case o f RNPs and 
enzym atic reactions, the RNAs were purified by phenol extraction a fte r m odification. In 
all cases the RNAs were ethanol precip ita ted before being fu rthe r analyzed by reverse 
transcription or chemical cleavage.
DMS modification: 0-1 p\ DMS (Fluka) in 1 x DMS buffer, 5-1 5 min a t 37°C.
Kethoxal modification: 3 p\ 20 m g/m l kethoxal in 20% ethanol were added to  RNA in 1 x 
DMS buffer, 0-1 h at 20°C. The reaction was brought to  50 mM potassium borate, pH 7, 
before addition o f 1 x Modification Stop buffer.
RNAse T1 (Pharmacia): 0-1 U in 1 x DMS buffer fo r 1 5 min 37°C.
B3 Primer extension analvsis o f modified positions
A fte r enzym atic and chemical m odification reactions, the RNA was eventually phenol 
e x tra c te d , e thano l p re c ip ita te d , washed and resuspended in 3 p\ HgO. A 
oligodeoxyribonucleotide was labelled at its 5' end by phosphorylation w ith [y^^PJATP and 
T4 PNK and used as a primer fo r reverse transcription in the following reaction mixture:
1 p\ 5x RTB, 1 p\ 0.1 M DTT, 0.1 p\ RNAsine (Promega), 1.35 p\ 2.5 mM dNTP mix, 
10^  cpm primer DNA, 0.1 p\ 10 \J/p\ AMV reverse transcrip tase, H2O to  5 pi to ta l 
volume. The reactions were incubated 30 min at 37°C, term inated by adding 20 pi 
Modification Stop buffer and the RNA hydrolyzed a fte r adding 3 pi 3 M KOH by incubation 
fo r 3 min at 95 °C and 1 h at 37°C. The DNA was recovered by centrifugation a fte r adding 
6 pi 3 M acetic acid, 100 pi 0.3 M sodium acetate, pH 5.2 and 300 pi ethanol. The pellet
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was washed w ith 70% ethanol, resuspended in 3 pi H2O and 6 pi formamide loading 
buffer and half o f it loaded onto a 12% urea-PAGE gel (C4.2)=
B4 Chemical detection o f modified positions
To analyze the positions o f N3-methylated cytosines, the modified RNA molecules were 3' 
end labelled by pCp ligation and repurified on urea-PAGE gels. The precip ita ted RNAs 
were resuspended in 10 pi 10% hydrazine, 5 pi 1 p g /p l E.coli tRNA (Boehringer) and 
incubated 5 min on ice, before being precipitated w ith 100 pi 0.3 M sodium acetate and 
300 p i ethanol. The washed pellets were resuspended in 20 pi aniline, pH 4.5 (stock 
solution 100 pi aniline, 60 pi acetic acid, 930 pi H2O) and incubated 15 min a t 60°C in 
the dark. The RNAs are again ethanol precipitated and washed tw ice w ith 70% ethanol to 
completely remove all traces o f aniline, then resuspended in H2O and RNA loading buffer.
B5 Dideoxv-sequencing o f RNA
AMV reverse transcriptase (Appligene) was used for RNA sequencing reactions.
3-6.2 pi (about 5 pg) RNA was mixed w ith 8 pi 5x RTB, 0.8 pi 1 M DTT, 2 pi RNAsine 
(Promega), 10^ cpm 5'-labelled DNA primer, 0.6 pi (12 U) reverse transcrip tase and 
H2O up to  40  pi to ta l volume. 5 pi o f this reaction was added to  tubes containing 2 pi 
ddNTP mixtures (e.g. ddATP mix: 1 mM dCTP, dGTP, dTTP, 250  pM ATP, 100 pM ddATP) 
and incubated fo r 30 min a t 37°C. The reaction was term inated and analyzed as described 
in B3.
B6 Enzvmatic sequencing o f RNA
RNAses for enzymatic sequencing o f RNA were purchased from Pharmacia, dissolved to  1 0 
U /p l in H2O and stored at -20°C. All reactions were performed w ith 10^ cpm labelled 
RNA in 3 pi H2O, in 9 pi to ta l volume and in the presence o f 1 pg E.coli tRNA as carrier 
fo r 1 5 min at 55 °C.
RNAse T1 (cuts a fte r G residues): 0.05 U in 4 pi T1 buffer (+); RNAse U2 (cu ts a fte r A 
residues): 0.5 U in 4 pi U2 buffer (+); RNAse PhyM (cuts a fte r A and U residues): 0.5 U 
in 4 pi T1 bu ffe r (+ ); RNAse BC (cu ts  a fte r C and U residues): 0.5 U in 4 pi 
BC buffe r (-). The reactions were stopped in liquid n itrogen, followed by storage at 
-20°C and heating 1 min 95°C ju s t before being loaded onto analytical urea-PAGE gels. 
Alkaline hydrolysis RNA ladder: 2 x 1 0 ^  cpm o f RNA n 6 pi H2O are incubated w ith 0.35 
pi 0.5 M NaHC03, pH 9.5 and 2 pi H2O fo r 3min at 95°C. Then RNA loading buffe r is 
added before urea-PAGE analysis (C4.2).
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(C ) Basic methods for nucleic acid analysis, adapted from  
(Sambrook et al., 1989).
Cl Preparation of plasmid DNA from E.coli
Cl .1 Small scale ( 10-20 ua) plasmid preparation
Sol I: 50 mM glucose, 25 mM Tris-HCI, pH 8 , 10 mM EDTA
Sol II: 0.2 M NaOH, 1% SDS
Sol III: 60 ml 5 M potassium acetate, 11.5 ml acetic acid, 28.5 ml H2O 
The bacteria l cells from  1.5 ml overn igh t cu ltu re  suspension were pelle ted  by 
centrifugation  fo r 30 s a t maximal speed in a bench centrifuge and the supernatant 
removed by aspiration. The cells were resuspended in 1 00 pi Sol I and lysed by the 
addition o f 200  pi freshly prepared Sol II and 3 min incubation on ice. Care was taken to  
avoid surplus mechanical force in order to  avoid the fragm entation o f chromosomal DNA. 
Cell fragm ents, proteins and chromosomal DNA were se lectively precip ita ted  by the 
addition o f 1 50 pi ice-cold Sol III and 3 min incubation on ice. The plasmid DNA was 
fu rth e r purified by phenol ex trac tion , i.e. addition o f an equal volume o f bu ffe r 
equilibrated phenol, chloroform, isoamylalcohol (25:24:1 v /v /v ,  pH 6 .6 , ICN) and phase 
separation by centrifugation. The plasmid DNA in the top  phase was precipitated by the 
addition o f 900 pi ethanol and recovered by centrifugation at maximal speed in the bench 
centrifuge for 5 min. The pellet was washed with 70% ethanol to  remove traces o f salt and 
phenol and the DNA resuspended in 50 pi H2O. The Promega Magic Minipreps DNA 
purification system, based on DNA binding columns, was sometimes used as an alternative 
to  phenol extraction.
Cl .2 Large-scale (1-2 mg) preparation o f plasmid DNA.
The above mentioned Mini-prep procedure was scaled up to  larger culture volumes in the 
follow ing way: Cells from  a 500 ml overnight culture were sedimented at 7000  rpm, 5
min, 4°C, resuspended in 6.5 ml Sol I, lysed by addition o f 1 3 ml Sol II (5 min on ice)
ând cleared w ith 6.5 ml Sol III (5 -10  min on ice). The plasmid contaning supernatant 
was recovered a fte r centrifugation o f cell lysates at 20 000  rpm, 1 0 min, 4°C in SS34 
tubes and the DNA precipitated by the addition o f 0.6 volumes isopropanol (2 min, RT). 
The pellet obtained a fte r centrifugation at 8000  rpm, 5 min, 4°C was dissolved in 1.5-3 
ml 50 mM Tris-HCI, pH 8 , 1 mM EDTA and firs t supplemented w ith  1.12 g /m l CsCI 
followed by 80 p l/m l ethidium bromide (10  m g/m l stock). This solution was cleared by 
centrifugation at 8000  rpm, 1 0 min, RT, transferred to  Beckman Quick-Seaiï'^ tubes and 
the  volume adjusted w ith  80 p g /m l ethid ium  bromide, 1.12 g /m l CsCI solution. 
Isopycnic centrifugation was performed w ith a Beckman 70.1 Ti ro to r at 60000  rpm, 24 
h, 20 °C and plasmid DNA containing bands collected w ith a syringe. Ethidium bromide
___________ Chapter IV:_________________Materials and Methods___________________1 26
was removed by 4 cycles o f butanol extraction and the DNA precipitated a fte r dilution 
w ith 2 volumes o f H2O by the addition o f 2 volumes o f ethanol. The DNA was resuspended 
in TE buffer and the concentration determined w ith the following estimations (Sambrook 
e t al., 1989):
1 A 260 unit = 50 pg /m l fo r double-stranded DNA, 40 pg /m l fo r single-stranded DNA or 
RNA, 20 pg /m l for oligonucleotides.
C2 Preparation of genomic DNA from Pichia pastoris
2 ml o f overnight culture suspensions (ODgoo = 0 .7 -1 ) were centrifuged at 3000  rpm, 
30 s in the bench centrifuge, the pellet washed w ith 500 ml H2O and the cells lysed by 
adding 200 p\ Breaking Buffer (see A2.2 .3), 200 p\ acid washed glass beads (SIGMA) and 
200  p\ equilibrated phenol/chloroform /isoam ylalcohol, vortexing 30 s, addition o f 200 
p\ H2O and placing 5 min into a shaking device a t high speed. The DNA was precipitated 
from  the aqueous phase by the addition o f 1 ml ethanol, centrifuged 3 min at maximal 
speed in the bench centrifuge, and the pellet resuspended in 20 p\ H2O supplemented with 
0.1 pg /m l RNAse A.
C3 DNA dot blot
C3.1 from veast genomic DNA preparation
5pl genomic DNA from C2 were incubated fo r 5 min at 65°C in the presence o f 75 pi 0.1 
M NaOH, cooled on ice, supplemented with 80 pi 2Ox SSC buffer and filtered onto Hybond 
N membranes (Amersham), presoaked in 2Ox SSC, 0.3 M sodium acetate, pH 5.2. The 
DNA was fixed by baking fo r 30 min at 1 20°C.
C3.2 from baculovirus DNA in in tact insect cells
A 96-well plate was seeded w ith 3 x 1 O'  ^ cells/well and in fected w ith  virus (e.g. 1 /1 0  
volume o f a virus plaque pick). A fte r infection, the cells were incubated at 28°C for 3-4 
days, then washed with PBS, harvested and disrupted by the addition o f 40 pi 1 00 pg/m l 
proteinase K in TE buffer and 0.1% SDS (37°C, 30 min). The DNA was denatured by the 
addition o f 20 pi 0.5 M NaOH and incubation at 65°C, 5 min, followed by cooling on ice 
and neutra lization w ith 55 pi 2 Ox SSC, 0.3 M sodium acetate, pH 5.2. Transfer to  
membrane as in C3.1.
C3.3 Hvbridization and Detection 
C3.3.1. Radioactively labelled DNA probe:
Prehybridization was performed fo r 1-4 h, 68°C in 6x SSC, 5x Denhardt's, 0.5%  SDS. 
Radioactively labelled DNA probe (e.g. produced by PCR or random labelling procedures)
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was added to  an activ ity  o f 1-10 x 10^ cpm /m l and incubated 2-12 h at 68°C. The filters 
were usually washed tw ice, 5 min w ith  2x SSC, 0.1%  SDS, tw ice, 15 min 0.1%  SSC, 
0.1 % SDS before being wrapped into clingfilm and analyzed by autoradiography.
C3.3.2. Non-radioactive labelling and detection with the DIG system:
The DIG system (Boehringer) is based on modified nucleotides carrying the steroid hapten 
digoxigenin, which can be incorpora ted in to  DNA during PCR reactions, thereby 
generating stable and reusable DNA probes. The hybrid ization conditions were as 
described in C3.3.1, except for the use o f a specific blocking reagent provided in the kit 
system. Hybridized, DIG labelled nucleic acids are detected in an enzym atic assay using 
alkaline phosphatase coupled anti-DIG antibodies w ith any available alkaline phosphatase 
substrate, e.g. NBT/X-phosphate. Antibody binding, washing and detection was according 
to  the DIG system manual and similar to  the standard development o f Western blots (see 
D4).
C4 Electrophoretic separation and recovery of nucleic acids from gels
C4.1 Agarose gel electrophoresis (AGE)
Submerged, horizontal AGE was performed to  separate DNA or RNA molecules o f moderate 
to  large sizes (0.2-1 5 kb). 0.8% w /v  agarose gels were routinely prepared by boiling a 
suspension o f nucleic acid grade agarose powder in water, cooling, adding 10x TBE to  a 
final concentra tion  o f 1 x TBE and pouring the solution in to  special rectangular gel- 
formers (e.g. Eurogentec). Gels were run at 50-1 50 V according to  gel size and nucleic 
acids visualized by submerging the gel in a 1 pg /m l ethidium bromide solution follwed by 
fluorescence d e tec tion  in UV238nm th rough-ligh t. DNA was usually recovered from 
Seaplaque™ low melting point agarose gel slices a fte r breaking the gel mechanically with 
a sterile  plastic bar and incubation at -80°C or in liquid nitrogen fo r 1-30 min. The gel 
slurry was then transferred to  a SpinX filtra tion  unit (Costar, Cambridge, MA), the DNA 
containing solution centrifuged through the filte r and the DNA precipitated by the addition 
o f 1 /1 0  volume 3 M sodium acetate, pH 5.2, 2.5 volumes ethanol.
C4.2. Denaturing polvacrvlamide ael electrophoresis furea-PAGEI
Urea-PAGE was used fo r RNA and DNA sequencing reactions, RNA m odification analysis, 
analysis o f o ligonucleotides and products o f in v itro  transcrip tion  reactions. Premixed 
40%  acry lam ide /b isacry lam ide  (1 9 :1 ) and 6-8%  Sequageiï'^ so lu tions (N ational 
Diagnostics, A tlanta, GA) were used to  prepare PAGE gels supplemented w ith  7 M urea. 
Electrophoresis was performed in 1x TBE buffer at 40 mA. Analytical gels were usually 
fixed by incubation in 10% ethanol, 10% acetic acid, 20 min, transferred onto Whatman 
3MM filte r paper and dried at 80°C under vacuum. Nucleic acids were recovered from
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urea-PAGE gels by incubation o f gel slices overnight a t RT in RNA extraction  buffe r 
(REB) and ethanol precipitation o f the supernatant.
Enzymatic modifications of nucleic acids.
C5 Sequence-specific hvdrolvsis and dephosphorvlation o f DDNA
Restriction endonucleases were used in the m anufacturer's recommended buffers at a 
concentration o f 1-3 U/pg DNA in a volume o f 20-50 pi. Enzymatic digestion was carried 
out a t the recommended tem perature fo r 1-2 h. Several enzymes were used together, 
when they had identical or similar buffer requirements. Otherwise, e ither an adjustm ent 
was made to  the buffering system, or the DNA was purified and desalted between 
digestions. A typical DNA endonuclease reaction contained 10 pi DNA (1 -1 0  pg), 5 pi 
10x reaction buffer, 2 pi restric tion  enzyme (10  U /p l), 33 pi H2O. Shrimp alkaline 
phosphatase (0.5-1 U; USB) was added to  dephosphorylate DNA 5' ends concom itantly 
w ith the endonuclease reaction.
C6 Ligation o f DNA molecules
Ligation o f DNA molecules was carried out w ith T4 DNA Ligase (Pharmacia). For plasmid 
preparations, vec to r and insert DNAs were mixed in molar ratios o f 1:1 to  1:5 and 
incubated overnight a t 12-14°C in a 10 pi reaction comprising x pi vec to r DNA, y pi 
insert DNA, 2 pi 5x Ligase Buffer (50  mM Tris-FICI, pFI 7.6, 20 mM MgCl2, 2 mM DTT,
10% PEG 8000), 2 pi 10 mM ATP and 6-(x+y) pi H2O.
C7 Ligation o f RNA molecules (pCp labelling)
Ligation o f radioactive pCp to  the 3' ends o f RNAs was carried out w ith T4 RNA Ligase 
(Pharmacia). 6 pg RNA (6 p i), 8 pi 5x RNA Ligase bu ffe r w ith 50 p g /m l BSA, 1 pi 1 
mM ATP, 3 pi DMSO, 20 pi 1 OmCi/ml (3 0 00  C i/m m ol) [^^P jpC p, 2 pi T4 RNA Ligase 
were mixed and incubated overnight at 4°C. The RNAs were then purified by urea-PAGE. 
vRNAs from  30 pg RNP m odification reactions were resuspended in 3.5 pi H2O a fte r 
phenol extraction and the reaction contained 3 pi 5x RNA Ligase buffe r plus BSA, 1 pi 
100 pM ATP, 5 pi [32p]pCp, 1.5 pi DMSO and 1 pi T4 RNA Ligase.
C8 Phosphorvlation o f DNA and RNA 5' ends
1-5 pg nucleic acid (1 -50  pmol) was incubated in a to ta l volume o f 1 0 pi 30 min at 
37°C w ith 1 U T4 polynucleotide kinase (PNK, Pharmacia), 1 pi 1 Ox PNK bu ffe r (one- 
fo r all buffer, Pharmacia) and 1-5 pi 3000  Ci/mm ol [y32p]ATP. Labelled nucleic acids 
were e ithe r purified  by urea-PAGE or N u c - T r a p ^ ^  (S tra tagene ) gel f i lt ra t io n  
chromatography.
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C9 Dideoxv-seouencina o f double-stranded DNA
The sequencing reaction was performed using the Sequenase™ version 2.0 sequencing kit, 
which includes as the polymerase prote in a variant o f the bacteriophage T7 DNA 
polymerase (USB). The sequencing procedure o f the k it manual was slightly changed for 
convenience. 2-4 pg plasmid DNA (e.g. 8 pi Miniprep DNA) was incubated w ith 3 pi 2 M 
NaOH 5 min at RT. Then 2 pi 2 pm ol/pl primer DNA, 3 pi 3 M sodium acetate, pH 5.2 and 
70 pi ethanol were added and, a fte r centrifugation, the precipitated DNA was washed with 
70%  ethanol and resuspended in 8 pi H2O. For the prim er extension reaction 2 pi 
Sequenase buffer Rxn, 0.4 pi dGTP, 1.6 pi H2O, 0.5 pi 600  Ci/mm ol [a^^SJdATP, 1 pi 
100 mM DTT, 0.25 pi Sequenase and 1.75 pi dilution buffer were mixed and added to  the 
DNA fo r a 5 min incubation a t RT. Then 3.5 pi o f the reaction were spotted  onto a petri 
dish, prepared w ith 4 spots o f 2.5 pi ddNTPs ( and incubated fo r a fu rthe r 5 min at 37 
°C. The reaction was term inated by the addition o f 4 pi Stop solution to  each drop, 2 pi 
were loaded onto  a pretem perated 55°C, 6% urea-PAGE gel in a BIORAD sequencing 
apparatus. A fte r the run the gel was dried fo r 1 h at 80°C on the glass plate and exposed 
overnight to  Bio-Max X-ray film (Kodak).
C l 0 Amplification o f DNA bv the polvmerase chain reaction (PCR)
PCR reactions were used in this study to  amplify PA coding sequences, to  add restriction 
sites o f choice to  the ends o f PA sequences and to  produce PA deletion m utants. PCR 
reactions consist o f cycles o f therm al DNA tem plate  dénaturation, tem pla te -p rim er 
annealing and primer elongation. Thermostable DNA polymerases are used, tha t w ithstand 
the  e levated tem pera tures during tem pla te  dénaturation. The PCR reactions were 
perform ed w ith  a B iometra TRIO therm oblock according to  the  fo llow ing standard 
protocol:
Dénaturation o f tem plate  and primer in reaction m ixture a t 95°C fo r 4 min. Addition o f
2-5 U Tub~^^ DNA polymerase (Amersham) or Tag^M polymerase (S tra tagene) and 
in itia tion  o f reaction cycles, i.e. 45 s 95°C dénaturation, 1 min 50-68°C annealing, 2 
min 72°C primer extension. Between 10 and 25 cycles were run according to  the  
experim ent. The annealing tem perature was chosen 2-5°C below the theore tica l T ^ ,  
ca lcu lated w ith  the  equation Tm (°C) = 4(G+C) + 2 (A +T). 100 pi PCR reactions 
contained PCR buffe r (Amersham), 50 mM Tris-HCI pH9, 20 mM (NH4)2S0 4  ^ 1.5 mM 
MgCl2, 250  pM dNTP mix, 50 -100  pmol primer DNA, 0 .5 -2  pg tem pla te  DNA. The 
m ixture was overlayed w ith  paraffin oil during the PCR reaction. PCR products were 
analyzed by AGE and ethid ium  bromide staining. The incorporation o f labelled dNTPs 
during PCR reactions resulted in the production o f probes fo r DNA dot blots.
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C^^ In v itro  RNA svnthesis w ith DNA-dependent RNA polymerases
Plasmids containing promoters for the RNA polymerases o f bacteriophages T3, T7 or SP6 
were linearized with an appropriate restriction enzyme ju s t downstream o f the desired 3' 
end o f the RNA coding sequence. Standard transcription reactions contained 40 mM Tris- 
HCI, pH 8, 20 mM DTT, 15 mM MgClz, 10 mM NaCI, 1 U/pl RNAsine, 3 mM NTPs, 1% 
T ritonX I 00, 0.2 p g /p l linearized plasmid DNA, 1-2 U /pl RNA polymerase. To produce 
capped RNAs, the concentration o f GTP was lowered to  0.3 mM and 1.5 mM m7GpppG was 
included in the reaction. To produce labelled RNAs, the NTP concentration was lowered to  
0.5 mM and UTP was replaced w ith 36 pM UTP and 0.2 pM [a^^PjUTP. The RNAs 
produced in this way were purified by denaturing gel electrophoresis and eluted with RNA 
extraction buffer. The RNA concentration was determined by measuring the OD260 a fte r 
ethanol precipitation and resuspension in H2O using the following estimation: 1 OD260 = 
40 pg /m l RNA
C^Z In v itro  RNA capping reaction
Capped RNAs were e ither produced by including cap analog in RNA synthesis reactions 
(see C l 1, i.e. reduced yield o f RNA) or w ith vaccinia virus capping enzyme in a reaction 
containing in 15 pi to ta l volume 5-20 pg RNA, 50 mM Tris-HCI, pH 8, 1.25 mM MgCl2 , 
6 mM KCI, 0.1 p g /p l BSA, 5 mM DTT, 1 U/pl RNAsine, 100 pM S-adenosylmethionine,
1 pM [a32p]GTP, 0.1 U /pl guanylyltransferase. The reaction was incubated fo r 1 h at 
37°C and capped RNA purified by denaturing acrylamide gel electrophoresis.
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(D) Basic methods for protein analysis
D1 Determination o f protein concentration 
D1.1 Absorption o f UV light
Protein concentrations were estimated by measuring the absorbance at 280 nm and using 
the Lam bert-Beer law A = e-l-C, w ith A being the absorption, e the molar absorption 
coe ffic ien t (M'^ cm ^), I the pathlength (cm) and C the protein concentration (M). The 
following equation, based on the number o f chromophoric amino acids in a specific protein 
sequence, has been described to  well predict the e(280) o f folded proteins in w ater (Gill 
and von Hippel, 1 989; Pace et al., 1 995):
6(280) [M-T-cm-1] = (#Trp) 5500 + (#Tyr)-1490 + (#Cys) 125 
D1.2 Coomassie staining
Protein concentrations were estimated by coomassie staining o f SDS-PAGE gels and band 
density comparison to  known amounts o f protein on the same gel. A lternative ly, 200 pi 
prote in d ilution was mixed w ith 800 pi Bradford solution (0 .01%  w /v  Coomassie blue 
G250, 4 .75%  v /v  ethanol, 8.5% v /v  phosphoric acid), absorption measured a t 595 nm 
and compared to  a protein standard series, usually made w ith BSA.
D2 Denaturing protein polvacrvlamide gel electrophoresis (SDS-PAGE)
The BIORAD Mini-Protean system  or the equivalent Hoefer gel stand were used to  cast 
7 .5 -12%  discontinous SDS-polyacrylamide gels o f 0 .75 -1 .5  mm thickness. National 
Diagnostics 37.5:1 premixed acrylamide/bisacrylamide solution was used to  prepare the 
separating gel (w ith  375 mM Tris-HCI, pH 8.8, 0.1 % SDS) and the 4% stacking gel 
(w ith  125 mM Tris-HCI, pH 6.8, 0.1%  SDS) adapted from  (Laemmli, 1 970)Laem m li, 
1 9 7 0 . P ro te in  samples were denatu red  in reducing SD S-Sam ple-Buffer and 
electrophoresis performed at 40 mA in 1x Running Buffer.
D3 Staining o f proteins in SDS-PAGE gels 
D3.1 Coomassie staining
Acrylam ide gels were fixed and stained in 0.25%  Coomassie blue R250, 50% ethanol, 
10% acetic acid and destained in 7% acetic acid, 5% ethanol.
D3.2 Silver staining
For silver staining the gel was firs t soaked in 50% ethanol, a t least 2 times 1 h, then 
incubated fo r 1 5 min w ith staining solution (1.6 g AgNOg in 8 ml H2O added dropwise to 
42 ml 0.36%  NaOH, 3.5 ml 28% ammonia, then brought to  200  ml w ith  H2O), washed 
thoroughly w ith H2O and developed with 0.0025%  citric acid, 0.025%  formaldehyde. The 
colouring reaction was stopped by washing with H2O or destaining solution (D3.1 ).
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D4 Western blot
In Western b lo tting electrophoretically separated proteins are transferred from  a gel to  a 
p ro te in  binding membrane. Homemade e lectrophoresis tanks w ith  gel-m em brane 
sandwich holders or a BIORAD sem idry b lo ttin g  apparatus were used fo r the 
e lectrophore tic  protein transfer, which was in both cases perform ed in Tris-glycine 
transfer buffe r (3 g /l Tris base, 14.4 g /l glycine). E fficient transfe r was obtained w ith 
1 50 V, 3h or 30 V, overnight w ith wet b lo tting and 1 5 V, 30 min semidry b lo tting . A fte r 
the transfer, Hybond C nitrocellulose membranes (Amersham) were blocked fo r 30 min 
to  1 h in 5% w /v  milk, washed with PBS and incubated for 1 h at room tem perature with 
primary antibody. Primary antibody was removed in PBS and PBS/0.5% NP40 washing 
steps before peroxidase-coupled secondary antibody or radioactively labelled prote in A 
were added diluted 1 :1000 in 5% milk fo r 1 h a t room tem pera ture. The b lo t was 
deve loped  a fte r  washing w ith  PBS and P BS /0 .5%  NP40 e ith e r w ith  the  
chemoluminescence k it o f Amersham or by incubation w ith 1 0 mg diaminobenzidene, 
0.01%  H2 O2 .
D5 Protein concentration and dialvsis 
D5.1 Ammonium sulfate precipitation
Ammonium sulfate was used at saturation (697 g /l)  to  quantita tive ly precip ita te proteins 
from  solution, or a t lower concetrations fo r lim ited fractionations, according to  standard 
tables, e.g. (Englard and Seifter, 1990). The desired amount o f solid ammonium sulfate 
was added to  protein solutions, which were then incubated at 4°C fo r a t least 1 h, before 
being centrifuged and resolubilized.
D5.2 Dialysis
S pe c tra /P o r®  dialysis membranes (Spectrum, Breda, NL) were p re trea ted by boiling 
fo r 10 min in 2% NaHCOg, 1 mM EDTA, then thoroughly washed w ith H2O and stored in 
20% ethanol, 0.05%  NaNg at 4°C.
D5.3 U ltrafiltra tion
Micro-ProDiCon™ tubes (see B 2.1 ) were used fo r s im u ltaneous d ia lys is  and 
concen tra tion  o f p ro te in  solutions up to  50 ml, Centricon tubes (A m icon) were 
a lternatively used at 4000  x g fo r the concentration o f solutions up to  5 ml.
D6 Circular Dichroism Spectroscopv
CD spectra were collected on a JASCO 600 spectrapolarim eter in a 1 mm path length 
rectangular cuvette  therm osta tted  at 25°C in 50 mM sodium phosphate, pH 7.6, 50 mM 
NaCI, 2 mM DTT. The measurement was performed at a scan rate o f 50 nm /m in , 1 s 
integration tim e and 2 nm band width.
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D7 ChromatoaraDhi^rngtbods
D7.1 Nickel chelate a ffin ity  chromatography
The p u rifica tio n  o f h is tid ine -tagged  po lypep tides was done according to  the 
recommendations in the Novagen pET system manual. A ffin ity  columns were prepared 
w ith Chelating Sepharose 6B (Pharmacia) and 1 5 ml plastic columns (Pierce), charged 
w ith 50 mM NiS0 4 . Chromatography was performed in 5 mM imidazole, 500 mM NaCI, 
20 mM Tris-HCI, pH 7.9 (native conditions) or in the presence o f 8 M urea (denaturing 
conditions). Proteins were eluted with a 30-100 mM imidazole gradient.
D7.2 Streptavidin a ffin ity  chromatography
The purification o f biotin-tagged polypeptides was done according to  the recommendations 
in the Promega PinPoint system manual. 1 ml SoftLink resin columns (1 cm diam eter) 
were prepared and run in 50 mM Tris-HCI, pH 7.5, 100 mM NaCI, 10% glycerol. Bound 
proteins were eluted in the presence o f 5 mM biotin.
D7.3 Amylose a ffin ity  chromatography
Amylose resin was purchased from NEB and chromatography on 2 ml columns performed 
in 50 mM Tris-HCI, pH 7.5, 200 mM NaCI, 2 mM EDTA, 10 mM (3-mercaptoethanol, 5% 
glycerol. Columns were usually washed w ith 1 M NaCI and bound protein eluted w ith 20 
mM maltose in the same buffer.
D7.4 Ion exchange chromatography
Ion exchange chromatography was carried out using MonoQ or MonoS resins in prepacked 
columns from  Pharmacia (HR 5 /5 )  or BIORAD (Econo-RAC cartridges) a t a flow  rate o f 1 
m l/m in. The columns were run w ith the  following buffers; A, 0 -1 0 0  mM NaCI, 5 mM 
MgCIZ, 1 mM PMSF, 1 mM DTT, 50 mM Tris-HCI, pH 7.5 or 20 mM Bis-Tris-HCI, pH 
6 ; B, buffer A plus 1-1.5 M NaCI).
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(E) Protein activity assays
El Influenza virus RNP transcription assay (see III.2)
El .1 TCA precipitation assay
Approxim ately 20 pg  o f detergent d isrupted virus, or 0 .03 -3  pg  purified RNPs were 
added to  a reaction m ixture containing, in a final volume o f 50 p\: 50 mM Tris-HCI, pH 
7.8, 100 mM KCI, 10 mM NaCI, 1 mM DTT, 5 mM MgCI2, 0.4 mM ApG or 100 ng primer 
RNA, 0.5 mM GTP, CTP, 1 mM ATP, 50 pM UTP, 0.1 pM 3000  C i/m m ol [a32p]UTP. 
Reaction mixtures were incubated fo r 1 h at 31°C, then stopped by the addition o f 50 p\ 
20% trich loroacetic acid (TCA), 2% casamino acids, incubated 30 min on ice, filte red 
through Whatman GS/A filte r disks, washed w ith 20 ml 10% TCA, dried and quantified by 
liquid scintillation counting.
El .2 Gel analvsis o f transcription products
Reactions similar to  the one described in El .1 were e ither phenol extracted and ethanol 
precip ita ted, or d irectly  denatured in RNA loading buffer, 2 min a t 95°C, before being 
analyzed on 20% urea-PAGE gels.
E2 In v itro  ATP binding assav. adapted from /C lertant and Cuzin. 1982) .
[a32p]ATP (80  pC\) was oxidized by incubation w ith 4 mM HCI and 4 mM Nal04 in 1 2 pi 
to ta l volume for 30 min at room tem perature in the dark. Then 3 p\ 50% glycerol were 
added to  quench the reaction, followed by a fu rthe r incubation fo r 20 min, room 
tem perature, in the dark. Finally the reaction was diluted by adding 5 p\ HgO ju s t and 
d irectly  used fo r labelling reactions. The labelling reaction was performed fo r 1-15 min 
at room tem perature in 50 p\ volume in the presence o f 1x ATP-binding buffer and 0.25 
pM oxidized ATP (2 pi). Sometimes unlabelled NTPs or casamino acids were added at this 
stage. The protein-ATP complexes were stabilized by incubation overnight on ice w ith 1 9 
mM NaCNBH3 (adding 2 pi 0.5 M stock solution to  the binding reaction). The reactions 
were stopped by the addition o f SDS sample buffer and the proteins were analyzed by SDS- 
PAGE and autoradiography. To analyze ATP binding o f the influenza virus polymerase 
complex, 2 pi oxidized ATP was added to  standard transcrip tion  reactions (E.1) w ith 
d iffe ren t combinations o f NTPs.
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E.3 In v itro  ATPase assav
E.3.1 Thin Layer Chromatography (TLC) separation o f reaction products.
ATPase activ ity  in protein samples was analyzed by the release of from  [y^^PJATP, or 
[32p]ADP from  [«32p]ATP. Reactions were in 20 pi to ta l volume and contained 50 mM 
Tris-HCI, pH7.5, 1-10 mM MgClg, 1 mM DTT and 0.5 pM labelled ATP. A fte r incubation 
fo r 1 h at 37°C, the reaction was stopped by the addition o f 2 pi 0.5 M EDTA. 1 pi was 
spo tted  onto  a polyethylenim ine (PEI) coated TLC plate, dried, and the nucleotides 
separated by ascending chromatography in 1 M LiCI, 0.5 M form ic acid. The plates were 
then dried and subjected to  autoradiography with Kodak XAR-5 films.
E.3.2 Colorimetric assay
In this assay an ATPase activ ity  is quantified by measuring the rate o f phosphate release 
into solution. The amount o f phosphate was determined as a phosphomolybdate-malachite 
green complex. The ATPase reaction was performed in a to ta l volume o f 50 pi w ith a 
freshly prepared buffe r mix containing 50 mM Tris-HCI, pH 7.5, 1-10 mM MgClg, and 
1 mM DTT. The reaction was started by adding ATP to  a final concentration o f 1 mM. A fte r 
an incubation at 37°C between 30 min and 2 h, the reaction was term inated by the 
addition o f 200  pi malachite green reagent, freshly prepared by mixing the stock 
solutions 5.72%  w /v  ammonium m olybdate in 6 M HCI, 2.32%  w /v  polyvinylalkohol, 
0 .0812%  w /v  malachite green and H20 at a ratio  o f 1:1:2:2. The coloured phosphate 
complex was measured a fte r a 5 min stabilization period in an ELISA plate reader using 
dual wavelength se ttings  o f 620  nm and 4 50  nm fo r te s t and re ference filte rs  
respectively. Inorganic phosphate standards were prepared using 10-200  pM KH2PO4 
solutions in ATPase buffer mix.
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Conclusions and Perspectives
The goal o f this study was to  provide data fo r a be tte r understanding o f the relationship 
between the influenza virus RNP structure  and the  RNP transcrip tiona l a c tiv ity . The 
RNPs can be regarded as small RNA synthesis machines, which produce tw o  d iffe ren t 
kinds o f RNA in a regulated fashion by using only a small number o f proteins. Although 
influenza virus RNPs have already been stud ied fo r many years, the  im po rtan t 
determ inants o f RNP assembly and the mechanisms o f regulated RNA synthesis have 
largely remained elusive. The major problem has been the lack o f suitable systems to  
express and purify single components o f the RNP, so tha t functional reconstitu tion o f the 
particle has not ye t been achieved. In the present study the problem o f RNP structure and 
function has been approached from two different sides. On the one hand, in vivo  assembled, 
viral RNPs have been purified from  virion preparations and used fo r s truc tu ra l and 
functional studies, and on the other hand it was attem pted to  establish an expression and 
purification scheme fo r the PA polymerase subunit in order to  obtain evidence fo r a 
possible function o f this essential, viral polymerase cofactor and to  get a step closer to  the 
production and purification o f functional, recombinant polymerase protein.
The secondary structure  o f the influenza virus genomic RNA was studied in the 
context o f the in vivo assembled, functional RNP particle using RNA modification analysis. 
The results suggest th a t the  RNA molecule is held in a single stranded form  by 
nucleoprotein, which binds to  the RNA w ithout causing base protection  at Watson-Crick 
positions and prevents the  fo rm ation  o f RNA secondary s tru c tu re  elem ents. The 
polymerase complex appears to  be binding to  both conserved vRNA ends o f the genome and 
causes protection o f Watson-Crick positions from  chemical m odification and enzym atic 
hydrolysis o f 1 5 bases at the 3'-end and at least 14 bases at the 5'-end. In the absence of 
the  polymerase prote ins the  bases a t the  vRNA extrem ities become reactive  to  
modification, suggesting tha t the vRNA is completely single-stranded on polymerase-free 
RNPs despite a partial, inverted complem entarity o f the vRNA ends. The RNPs have been 
found to  partially unwind under both high and low salt conditions and could then be 
visualized as circular structures by electron m icroscopy (courtesy o f Dr. Rob Ruigrok). 
In the  absence o f the polymerase only linear s tructures are observed. Together, the 
results suggest tha t the vRNA ends are brought toge the r by the polymerase to  form  a 
ternary complex, but tha t a double-stranded RNA secondary structure  does not exist in 
the absence o f the polymerase. These observations make it unlikely tha t the formation of a 
stable double-stranded panhandle s truc tu re  is needed fo r polymerase binding or fo r 
transcrip tion  term ination and they will demand a reexam ination o f the transcrip tion  
te rm ina tion  mechanism in the fu tu re . We have proposed a possible model fo r an 
alternative transcriptional mechanism independent o f a stable RNA secondary structure, 
th a t is also consistent with most o f the previously published observations. In this model
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the polymerase is expected to  stay bound to  the conserved vRNA 5' end during 
transcription, while advancing along the tem plate RNA from the 3' end. To te s t this model 
it will be necessary to  harvest RNPs at d iffe ren t times a fte r transcription in itia tion and 
m onitor the accessibility o f the bases at the vRNA 5'-end fo r chemical modification. In 
parallel, the elongating RNPs may be studied by electron microscopy. Unwinding in high 
or low salt will then be expected to  produce lariat-shaped elongation complexes, provided 
th a t the po lym erase-tem pla te  in te rac tion  is stable enough under changing ionic 
conditions. Further evidence fo r or against the new model will come from  topological 
studies o f the RNP, because the proposed mechanism predicts a relative underwinding o f 
the  RNP supercoil to  drive polymerase elongation, analogous to  transcrip tion  from  
supercoiled plasmids. First evidence fo r the relative underwinding is provided by the fact 
th a t the com pact RNP s truc tu re  opens up when ionic s treng th  is changed in e ither 
direction, i.e. the RNP supercoil appears to  be poised to  be unwound. If th is is the case, 
polymerase-free RNPs, th a t are allowed to  freely ro ta te  and unwind beyond the circular 
stage, will have the opposite type  o f supercoil than com plete RNPs. In addition, this 
mechanism predicts a novel, topoisomerase-like ac tiv ity  to  be required fo r the formation 
o f transcriptionally active RNPs.
RNP a c tiv ity  assays confirm ed th a t the  RNP preparations used fo r s tructura l 
studies were functional and in a physiologically re levant conform ation. Furthermore, 
several lines o f evidence suggested th a t the influenza virus polymerase undergoes a 
conformational change between transcription initiation and elongation. The RNPs produced 
sign ificant amounts o f short transcrip ts (prim er -h in t, primer + 2n t) even in complete 
transcrip tion  reactions, presumably from  abortive cycling o f the in itia tion  complex, as 
has also been described fo r o ther RNA polymerases. The RNPs showed a ten-fo ld  higher 
Km fo r ATP than for the other NTPs and were found to  copurify on glycerol gradients with 
a s ign ifican t ATPase a c tiv ity , th a t was higher in in itia tion  reactions than in lim ited 
elongation reactions or complete transcription reactions. Finally, transcrip tion assays in 
the presence o f ATP analogs gave results consistent w ith the idea th a t ATP p-y-bond 
hydrolysis is required fo r transcrip tion  in itia tion, but not during elongation reactions. 
The presumed energy consuming reaction can be expected to  be a ra te-lim iting step in 
influenza virus transcrip tion  and it  will be in teresting to  iden tify  the  nature o f this 
reaction in detail, because cap-binding, endonuclease a c tiv ity  and incorporation o f the 
firs t nucleotide appear to  be independent o f ATP hydrolysis. For fu rther studies it will be 
crucial to  succeed in the separate preparation o f in itiation and elongation complexes fo r 
comparative studies o f these tw o phases.
RNP ac tiv ity  assays were also used to  study the mechanism o f influenza virus 
inhibition by fluorinated nucleotide analogs. The results suggest th a t both cytid ine and 
guanosine d e riva tive s  o f 2 '-d e o x y -2 '- f lu o ro r ib o n u c le o tid e  tr ip h o sp h a te s  were
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incorporated in to nascent mRNAs by the influenza virus polymerase and blocked, or 
strongly slowed down, elongation from such transcripts. Evidence obtained from  pulse- 
chase reactions and RNP-primer preincubations w ith the nucleotide analogs suggested 
th a t transcrip tion  inhibition is not irreversible and implies th a t influenza virus RNPs 
possess the ability to  regenerate blocked primers. A proofreading-like ac tiv ity  would be 
unique fo r a RNA polymerase, and it will be in teresting to  fu rthe r determ ine, if the 
endonuclease ac tiv ity  o f the polymerase is responsible fo r the apparent reversib ility o f 
inh ibition. Both an endonuclease assay w ith  labeled prim er RNA as well as labeled 
nucleotide analogs may be useful in the future to  approach this question.
The influenza virus RNA polymerase complex is a m u ltifunctiona l protein. The 
currently  known functions, cap-binding, endonuclease ac tiv ity  and RNA synthesis, are 
essential fo r virus m ultip lication and constitu te  potentia l ta rge ts fo r antiviral therapies, 
but it  is likely tha t a number o f other polymerase functions are still to  be identified. The 
active site perform ing RNA synthesis has been mapped to  the PB1 polymerase subunit, 
PB2 is the  cap-binding subunit and presumably harbours the  endonuclease activ ity . 
However, no function whatsoever has been proposed ye t to  explain why PA is essential for 
viral replication. It is not known, which polymerase subunits in te ract w ith the genomic 
RNA on RNPs and it appears tha t at least one additional, energy consuming function may be 
needed to  generate the final RNP topology o f functional RNPs. In addition, there is evidence 
fo r an ATPase ac tiv ity  copurifying w ith the RNPs, which may be required fo r abortive 
cycling during transcription in itiation and /or the transition from  in itia tion to  elongation. 
In an a ttem p t to  address some o f these open questions and to  reveal a function fo r the PA 
polymerase subunit, several protein expression systems were tested fo r the production of 
recombinant PA protein. In most expression systems the PA protein production was very 
low and there was evidence fo r significant tox ic ity  in both procaryotic  and eucaryotic 
cells. Extensive fragm entation and insolubility were additional problems encountered in 
bacterial systems. Both baculovirus infected insect cells and recombinant Pichia pastoris 
clones produced fu ll-length  PA prote in , bu t the yields were to o  low to  achieve 
purification to  homogeneity. Taken together, none o f the systems appears as ye t suited for 
the expression and purification o f full-length PA fo r s tructura l and functional studies. 
A ff in ity  purified PA prote in  from  bacteria l cells as well as sem ipurified PA from  
eucaryotic cells copurified w ith ATPase activ ity , which was absent in corresponding 
fractions o f PA-free cell extracts. Because o f extensive PA prote in fragm entation in E. 
c o li and the  large am ount o f residual host cell pro te ins in PA preparations from  
eucaryotic cells, it was not possible to  exclude tha t the observed ATPase activ ity  was due 
to  a contam inating protein. Preliminary results w ith the coexpression o f a rare tRNA in 
E .co li suggested th a t the PA codon bias, which largely d iffe rs  from  th a t o f highly 
expressed genes in E.coli, may be one reason for the low protein yields in the bacterial
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system. It may be tried in the future to  obtain further evidence for an ATPase activ ity  o f 
PA by the  comparison o f w ild -type  PA w ith  parallel preparations o f PA prote ins 
contain ing point m utations in the presumed ATP-binding m otif. Eucaryotic system s 
produced PA protein mainly in full-length form albeit a t low levels. It has not been tried 
to  a ffin ity  purify PA from  these systems w ith e ither anti-PA antibodies or a fte r the 
addition o f specific purification tags.
PA protein was also produced by in vitro  translation in wheat germ extracts. This 
system was established to  determine if PA has RNA binding activ ity . Preliminary results 
have been obtained, which suggest sequence specific binding o f PA to  the conserved 5' end 
o f the genomic RNA and to  the conserved sequence near the 5' end o f influenza virus 
specific mRNAs, but not to  the 3' end o f genomic RNA. Other unspecific RNAs did not bind 
to  PA in this assay consistent w ith a considerable sequence specific ity o f the interaction. 
In addition, molar excess o f poly A RNA, poly U RNA or tRNA did not com pete w ith PA 
binding to  the specific RNA sequence. These results support the idea o f PA playing a role 
both as an integral part o f the polymerase complex as well as in isolated form. The binding 
o f PA to  a conserved, influenza virus specific sequence, which is assumed to  be im portant 
in transcrip tion  and replication o f the genome as well as in influenza virus specific 
translation, gives a firs t idea o f how one protein m ight influence both viral replication 
and gene expression. The in v itro  translation system may become useful fo r a pro ject to  
determine the exact RNA sequence specificity and to  determine im portant regions on the 
PA primary sequence involved in RNA binding.
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